Curriculum Vitae - Dipartimento di Biotecnologie

Transcript

FORMATO EUROPEO
PER IL CURRICULUM
VITAE
INFORMAZIONI PERSONALI
Nome
Indirizzo
Telefono
Codice Fiscale
E-mail
Nazionalità
Data di nascita
ESPERIENZA LAVORATIVA
GIUSEPPE LIPPI
VICOLO SATIRO 9, 37121 – VERONA (ITALIA)
045-8124308
LPPGPP67R04B563I
[email protected]; [email protected]; [email protected]
Italiana
4 OTTOBRE 1967
CARRIERA ACCADEMICA
• Dal 01.06.1999 al 30.05.2000 è titolare di un assegno per la collaborazione ad attività di
ricerca dell'Università degli Studi di Verona dal titolo “Valutazione dell’impatto epidemiologico
di alcuni tra i principali fattori di rischio cardiovascolare in categorie di individui selezionati
nella Regione Veneto”, responsabile scientifico Chiar.mo Prof. Gian Cesare Guidi.
• Dal 01.10.2001 al 15.10.2004: Ricercatore non confermato, settore scientifico-disciplinare
BIO/12 Biochimica clinica e biologia molecolare clinica presso il Dipartimento di Scienze
Morfologico-Biomediche dell’Università degli Studi di Verona, equiparato alla qualifica
ospedaliera di Dirigente Medico ai sensi del D. Leg.vo n. 502/1992 e successive integrazioni e
modificazioni.
• Dal 16.10.2004 al 30.09.2005: Ricercatore confermato, settore scientifico-disciplinare BIO/12
Biochimica clinica e biologia molecolare clinica presso il Dipartimento di Scienze MorfologicoBiomediche dell’Università degli Studi di Verona, equiparato alla qualifica ospedaliera di
Dirigente Medico ai sensi del D. Leg.vo n. 502/1992 e successive integrazioni e modificazioni.
• Dal 01.10.2005 al 30.09.2008: Professore Associato non confermato, settore scientificodisciplinare BIO/12 Biochimica clinica e biologia molecolare clinica presso il Dipartimento di
Scienze Morfologico-Biomediche dell’Università degli Studi di Verona, equiparato alla qualifica
modificazioni.
• Dal 01.10.2008 al 07.09.2009: Professore Associato confermato, settore scientificodisciplinare BIO/12 Biochimica clinica e biologia molecolare clinica presso il Dipartimento di
Scienze Morfologico-Biomediche dell’Università degli Studi di Verona, equiparato alla qualifica
modificazioni.
• Dall’A.A. 2010/11 all’A.A. 2014/15: Professore a Contratto, discipline affini al settore
scientifico-disciplinare BIO/12 Biochimica clinica e biologia molecolare, Università degli Studi
di Parma.
• Dal 16.06.2014: Abilitato a Professore Ordinario, settore concorsuale 05/E1 (validità al
16/06/2020), secondo Legge 30/12/2010, n. 240.
• Dal 01.10.2015: Professore Ordinario settore scientifico-disciplinare BIO/12 Biochimica clinica
e biologia molecolare clinica presso il Dipartimento di Scienze Neurologiche Biomediche e del
Movimento dell’Università degli Studi di Verona, equiparato alla qualifica ospedaliera di
Direttore di Unità Operativa Complessa.
• Dall’A.A. 2015/16 Direttore della Scuola di Specializzazione in Patologia Clinica e Biochimica
Clinica, Università degli Studi di Verona.
Curriculum vitae on-line:
 Curriculum Vitae
 Google Scholar Citations
 Researchgate
STAGE DI RICERCA
Curriculum Vitae Prof. Giuseppe Lippi - Ultima revisione: 25 febbraio 2017; Pag. 1
• Negli anni 1988, 1989 e 1990: frequenza volontaria nei laboratori di ricerca della Ares Serono
a Woking (Londra - U.K.).
• Dal 1990: frequenza volontaria nell’Istituto di Chimica e Microscopia Clinica dell’Università di
Verona ove collabora a ricerche sperimentali su nuove procedure per lo studio della
funzionalità dei polimorfonucleati neutrofili.
• Dal 05.11.1993 al 17.02.1994 e dal 24.10.1994 al 22.12.1994: Scientific Visitor, Northwest
Lipid Research Laboratories (Seattle - WA - USA); Referente scientifico: Chiar.ma Prof.ssa
Santica Marcovina.
• Dal 30.11.1998 al 18.11.1998: Scientific Visitor, laboratori di ricerca del Centro Emofilia e
Trombosi “A. Bianchi Bonomi” (Milano); Referente Scientifico: Chiar.mo Prof. Pier Mannuccio
Mannucci.
CARRIERA CLINICO-ASSISTENZIALE
• Dal 1988 al 1990: frequenza volontaria, Laboratorio di Analisi Chimico Cliniche ed Ematologia
dell’Ospedale Maggiore di Borgo Trento (Verona) collaborando ad attività in ambito
ematologico.
• Dal settembre 1992 al novembre 1996: Specializzando, per il tirocinio previsto
dall’ordinamento della Scuola di Specializzazione, Laboratorio di Analisi Chimico - Cliniche e
Microbiologiche del Centro Ospedaliero Clinicizzato di Valeggio sul Mincio (VR).
• Dal Novembre del 1996 al Maggio 1997: frequenza volontaria, Laboratorio d’Analisi Chimico
Cliniche e Microbiologiche del Centro Ospedaliero Clinicizzato di Valeggio sul Mincio
(Verona).
• Dal 06.05.1997 al 26.08.1997: Dirigente Medico di I livello, Laboratorio di Chimica Clinica ed
Ematologia dell’Ospedale di Lungodegenza di Marzana (VR), ULSS n. 20 della Regione
Veneto.
• Dal 27.08.1997 al 07.09.2009: Dirigente Medico di I livello, Laboratorio di Chimica Clinica ed
Ematologia dell’Ospedale Policlinico di Verona, Azienda Ospedaliera di Verona.
• Dal 16.02.2009 al 07.09.2009: Incarico di Alta Specializzazione “Diagnostica Ematologica
speciale”, Laboratorio di Chimica Clinica ed Ematologia dell’Ospedale Policlinico di Verona,
Azienda Ospedaliera di Verona.
• Dal 08.09.2009 al 30.09.2015: Direttore di UnitàOperativa Complessa di Patologia Clinica,
Diagnostica Ematochimica, Dipartimento Diagnostico, Azienda Ospedaliero-Universitaria di
Parma.
• Dal 22.04.2014 al 30.09.2015: Vice-Direttore di Dipartimento ad Attività Integrata (DAI) Dipartimento Diagnostico, Azienda Ospedaliero-Universitaria di Parma.
• Nel 2014 ha ottenuto il Certificato per il Corso di Formazione Manageriale per i Direttori di
Struttura Complessa, organizzato dalla Regione Emilia-Romagna.
• Dal 01.10.2015: Direttore di Unità Operativa Complessa, Laboratorio Analisi, Azienda
Ospedaliera Universitaria Integrata (AOUI) di Verona.
ISTRUZIONE E FORMAZIONE
MADRELINGUA
ALTRE LINGUE
• Capacità di lettura
• Capacità di scrittura
• Capacità di espressione orale
• Diplomato al Liceo Scientifico "Istituti Filippin" di Paderno del Grappa (TV) con votazione
56/60.
• Laureato in Medicina e Chirurgia presso la Facoltà di Medicina e Chirurgia dell’Università
degli Studi di Verona il 17/07/1992 con votazione 110/110 e Lode con Tesi di Laurea: “Messa
a punto di un test per la misura simultanea del metabolismo ossidativo e della adesione di
granulociti neutrofili umani”, Relatore Chiar.mo Prof. Mario Zatti, Correlatore Chiar.mo Prof.
Paolo Bellavite.
• Abilitato all’esercizio della Professione Medica presso l’Università degli Studi di Verona nella
seconda sessione relativa all’anno accademico 1992.
• Iscritto all’Ordine dei Medici Chirurghi di Verona dal 06/04/1993.
• Specializzato in Biochimica e Chimica Clinica presso la Facoltà di Medicina e Chirurgia
dell’Università degli Studi di Verona il 24/10/1996 con votazione 50/50 e Lode con Tesi di
specializzazione “Problemi di standardizzazione in tema di misurazione della lipoproteina(a)”,
Relatore Chiar.mo Prof. Mario Zatti, Correlatore Chiar.mo Prof. Gian Cesare Guidi.
ITALIANO
INGLESE
Eccellente
Eccellente
Eccellente
SOMMARIO
ATTIVITÀ DIDATTICA (NUMERO DI MODULI/CORSI)...................................................................................................... 4
Titolarità di docenze nei rispettivi Corsi di Laurea presso l’Università degli Studi di Verona: ........................ 4
Titolarità di docenze nei rispettivi Corsi di Laurea presso l’Università degli Studi di Parma: ......................... 4
Docenze e partecipazione a Collegi di Dottorato ....................................................................................................... 5
PARTECIPAZIONE A CONSIGLI DI CDL E COMMISSIONI DI ESAMI DI PROFITTO ...................................................................... 5
ATTIVITÀ DI TUTORAGGIO............................................................................................................................................. 5
ALTRE ATTIVITÀ ACCADEMICHE ..................................................................................................................................... 6
ATTIVITÀ SCIENTIFICA ..................................................................................................................................................... 6
PROGETTI DI RICERCA FINANZIATI ................................................................................................................................. 6
PROGETTI DI RICERCA SOTTOMESSI (IN VALUTAZIONE) ............................................................................................. 7
PROGETTI DI RICERCA SOTTOMESSI MA NON FINANZIATI ........................................................................................... 7
PREMI E RICONOSCIMENTI ............................................................................................................................................... 7
SINTESI DELLA PRODUZIONE SCIENTIFICA AL 2 NOVEMBRE 2016 .......................................................................... 8
SINTESI DELLE PUBBLICAZIONI SCIENTIFICHE AL 2 NOVEMBRE 2016 ....................................................................... 9
SINTESI DELLE PUBBLICAZIONI SCIENTIFICHE AL 2 NOVEMBRE 2016 ....................................................................... 9
PUBBLICAZIONI IN EXTENSO SU RIVISTE SCIENTIFICHE INDICIZZATE DA PUBMED, ISI E SCOPUS ....................... 10
PUBBLICAZIONI IN EXTENSO SU RIVISTE SCIENTIFICHE INTERNAZIONALI NON INDICIZZATE ............................... 51
PUBBLICAZIONI IN EXTENSO SU RIVISTE SCIENTIFICHE NAZIONALI NON INDICIZZATE ........................................ 52
MONOGRAFIE .................................................................................................................................................................. 53
CAPITOLI IN MONOGRAFIE ............................................................................................................................................ 53
COMMENTARIES/RAPID RESPONSES/E-LETTERS SU RIVISTE SCIENTIFICHE INDICIZZATE ...................................... 54
POSTER E COMUNICAZIONI AD INCONTRI NAZIONALI ED INTERNAZIONALI ............................................................ 54
COMUNICAZIONI ORALI AD INCONTRI INTERNAZIONALI ............................................................................................ 54
COMUNICAZIONI ORALI E SEMINARI D'AGGIORNAMENTO AD INCONTRI NAZIONALI .............................................. 56
RECENSIONI E TRADUZIONI ........................................................................................................................................... 61
PARTECIPAZIONE A CONGRESSI, CORSI, SEMINARI .................................................................................................... 61
A.
B.
ORGANIZZAZIONE CONGRESSI ........................................................................................................................... 61
PARTECIPAZIONE A CONGRESSI, CORSI, SEMINARI .............................................................................................. 61
AFFILIAZIONE A SOCIETÀ SCIENTIFICHE E GRUPPI DI STUDIO INTERNAZIONALI ................................................... 61
AFFILIAZIONE A SOCIETÀ SCIENTIFICHE E GRUPPI DI STUDIO NAZIONALI ............................................................. 61
ATTIVITÀ REDAZIONALE E DI "PEER REVIEW" ............................................................................................................. 63
Attività didattica (Numero di moduli/corsi)

Dall'anno 1994 svolge lezioni accademiche, seminari, e collabora ad esercitazioni pratiche di Tirocinio per e
post laurea per gli studenti del Corso di Laurea in Medicina e Chirurgia dell'Università degli Studi di
Verona, nell'ambito dell’insegnamento di Medicina di Laboratorio. Partecipa regolarmente agli esami per la
valutazione degli Studenti.
Titolarità di docenze nei rispettivi Corsi di Laurea presso l’Università degli Studi di Verona:
A.A.
Corso di laurea
Insegnamento
2001/02
CdL per Tecnico di Laboratorio Biomedico
Patologia molecolare
-
2002/03
CdL in Tecniche di Laboratorio Biomedico
2
2003/04
2
2003/04
CdL in Medicina e Chirurgia
Biochimica clinica
-
2004/05
2
2004/05
CdL in Medicina e Chirurgia
Biochimica clinica
-
2005/06
2
2005/06
CdLS in Medicina e Chirurgia
Biochimica
-
2005/06
Didattica pratica di Medicina di Laboratorio
-
2006/07
2
2006/07
Biochimica clinica
-
2006/07
-
2007/08
2
2007/08
Biochimica clinica
-
2007/08
-
2007/08
CdLS in Scienze e Tecniche dello Sport
Biochimica clinica e Biologia molecolare clinica
2
2008/09
2
2008/09
Biochimica clinica
-
2008/09
-
2008/09
Disordini della coagulazione. Diagnosi e Terapia
1
2009/10
Disordini della coagulazione. Diagnosi e Terapia
1
2015/16
3
2015/16
CdLS in Tecniche di laboratorio biomedico
Metodologia clinica e medicina di laboratorio - BIOCHIMICA CLINICA - MEDICINA DI
LABORATORIO
Scienze di medicina di laboratorio - BIOCHIMICA CLINICA
2015/16
Biochimica clinica applicata allo sport
3
Sistemi e processi informativi di laboratorio
3
2016/17
CDL in Scienze dello sport e della
prestazione fisica
CDL in Bioinformatica e biotecnologie
mediche
MEDICINA DI LABORATORIO
5
2016/17
CdLS in Tecniche di laboratorio biomedico
Scienze di medicina di laboratorio - BIOCHIMICA CLINICA
2
2016/17
CDL in Scienze dello sport e della
prestazione fisica
Biochimica clinica applicata allo sport
3
2015/16
CFU
2
Per l’a.a. 2007/2008 è affidatario dei sottoindicati corsi ufficiali di lezione presso le sottonotate Scuole di
Specializzazione annesse alla Facoltà di Medicina e Chirurgia dell ’Università degli Studi di Verona:
 Scuola di Specializzazione in Anestesia e rianimazione - “Patologia Clinica” - 4° anno; indirizzo
Anestesiologia e rianimazione e Terapia intensiva.
 Scuola di Specializzazione in Biochimica Clinica - “Biochimica clinica (analitica)”- 1° anno, indirizzo
Analitico-Tecnologico e Diagnostico.
 Scuola di Specializzazione in Chirurgia Generale II - “Patologia clinica” – 1° anno.
 Scuola di Specializzazione in Endocrinologia e malattie del ricambio - “Patologia clinica” – 1° anno;
“Patologia clinica” – 2° anno.
 Scuola di Specializzazione in Nefrologia - “Metodologia di laboratorio” – 3° anno
 Scuola di Specializzazione in Oncologia - “Patologia clinica oncologica” – 1° anno.
Titolarità di docenze nei rispettivi Corsi di Laurea presso l’Università degli Studi di Parma:
A.A.
2009/10
Corso di laurea
Classe 3 Professioni Sanitarie Tecniche
2009/10
Classe L-22 Scienze Motorie, Sport e Salute
2010/11
Classe 76/S Specialistica in Sc. e Tec. delle Attiv.
Motorie Prev. ed Adatt.
2010/11
SCIENZE DELLE ATTIVITA' MOTORIE
2010/11
Classe 76/S Specialistica in Sc. e Tec. delle Attiv.
2009/10
Insegnamento
Biochimica Clinica
Analisi di Laboratorio Applicate
allo Sport
Analisi di Laboratorio Applicate
allo Sport
Biochimica Clinica
Biochimica Clinica e Biologia
Molecolare Clinica
Biochimica Clinica
CFU
1
4
4
1
1.5
1
Curriculum Vitae Prof. Giuseppe Lippi - Ultima revisione: 25/02/2017; Pag. 4
2014/15
Motorie Prev. ed Adatt.
2014/15
Biochimica Clinica
Biochimica Clinica e Biologia
Molecolare Clinica
1
4
Dall’a.a. 2009/2010 ad oggi è affidatario dei sottoindicati corsi ufficiali di lezione presso le sottonotate Scuole
di Specializzazione annesse alla Facoltà di Medicina e Chirurgia dell’Università degli St udi di Parma:

Scuola di Specializzazione in Endocrinologia, insegnamento di “Patologia Clinica”.

Scuola di Specializzazione in Anatomia Patologica.

Seminari per la Scuola di Specializzazione in Medicina Interna.
Dall’a.a. 2009/2010 ad oggi è affidatario de i sottoindicati corsi ufficiali di lezione presso le sottonotate Scuole
di Specializzazione annesse alla Facoltà di Medicina e Chirurgia dell’Università degli Studi di Parma:

Scuola di Specializzazione in Endocrinologia, insegnamento di “Patologia Clinica” .
Per l’a.a. 2014/2015 è affidatario dei sottoindicati corsi ufficiali di lezione presso le sottonotate Scuole di
Specializzazione annesse alla Facoltà di Medicina e Chirurgia dell’Università degli Studi di Verona:
 Scuola di Specializzazione in Reumatologia - “Biochimica clinica e biologia molecolare clinica ”.
 Scuola di Specializzazione in Neurologia - “Biochimica clinica e biologia molecolare clinica ”.
 Scuola di Specializzazione in Medicina d'Emergenza-Urgenza - “Biochimica clinica e biologia molecolare
clinica”.
 Scuola di Specializzazione in Neurochirurgia - “Biochimica clinica e biologia molecolare clinica ”.
 Scuola di Specializzazione in Ematologia - “Biochimica clinica e biologia molecolare clinica ”.
 Scuola di Specializzazione in Geriatria - “Biochimica clinica e biologia molecolare clinica ”.
 Scuola di Specializzazione in Malattie dell'Apparato Cardiovascolare - “Malattie dell'apparato
cardiovascolare 1”.
Docenze e partecipazione a Collegi di Dottorato







Partecipazione al Collegio: [SOG0340119]. Ateneo prop onente: Università degli Studi di VERONA. Titolo:
"BIOSCIENZE" [DOT0340119]. Anno accademico di inizio: 2006 - Ciclo: XXII - Durata: 3 anni.
Partecipazione al Collegio: [SOG0340119]. Ateneo proponente: Università degli Studi di VERONA. Titolo:
"BIOSCIENZE" [DOT0340119]. Anno accademico di inizio: 2007 - Ciclo: XXIII - Durata: 3 anni.
"BIOSCIENZE" [DOT0340119]. Anno accademico di inizio: 2008 - Ciclo: XXIV - Durata: 3 anni.
"BIOSCIENZE" [DOT0340119]. Anno accademico di inizio: 2009 - Ciclo: XXV - Durata: 3 anni.
Partecipazione al Collegio: [DOT1321593]. Ate neo proponente: Università degli Studi di PARMA. Titolo:
"MEDICINA MOLECOLARE". Anno accademico di inizio: 2014 - Ciclo: XXX - Durata: 3 anni.
Partecipazione al Collegio: [DOT1321593]. Ateneo proponente: Università degli Studi di PARMA. Titolo:
"MEDICINA MOLECOLARE". Anno accademico di inizio: 2015 - Ciclo: XXXI - Durata: 3 anni.
Partecipazione al Collegio: [DOT 1340724]. Ateneo proponente: Università degli Studi di VERONA. Titolo:
“SCIENZE APPLICATE DELLA VITA E DELLA SALUTE ”. Anno accademico di inizio: 2016 - Ciclo: XXXII - Durata:
3 anni.
Partecipazione a Consigli di CDL e commissioni di esami di Profitto






Componente del Consiglio CDL in Tecnico di laboratorio Biomedico della Facoltà di Medicina e Chirurgia
dell’Università degli Studi di Verona nel periodo di didattica sopra citato
Componente del Consiglio CDLS in Medicina e Chirurgia della Facoltà di Medicina e Chirurgia dell’ Università
degli Studi di Verona nel periodo di didattica sopra citato
Componente del Consiglio CDL in Tecnico di laboratorio Biome dico dell’Università degli Studi di Parma nel
periodo di didattica sopra citato
Componente del Consiglio delle Scuole di Specializzazione dell’ Università degli Studi di Verona e
dell’Università degli Studi di Parma nel periodo di didattica sopra citato
Componente delle commissioni di esami di Profitto per gli Studenti del CDLS in Medicina e Chirurgia, CDL in
Tecniche di Laboratorio Biomedico e delle Scuole di Specializzazione , secondo quanto previsto dagli Atenei
di Verona e Parma e nell’ambito degli insegnamenti elencati in precedenza.
AA 2015/16:

Direttore della Scuola di Specializzazione in Patologia Clinica e Biochimica Clinica , Università degli
Studi di Verona.

Componente del Collegio didattico del Corso di Laurea in Tecniche di Laboratorio biomedico Medicina e Chirurgia

Componente del Collegio Didattico di Biotecnologie - Dipartimento Biotecnologie

Componente del Collegio Didattico Scienze Motorie - Dipartimento Neuroscienze, Biomedicina e
Movimento

Componente del Consiglio del Dipartimento di Neuroscienze,
Dipartimento Neuroscienze, Biomedicina e Movimento
Biomedicina
e
Movimento
-
Attività di tutoraggio
Dall’a.a. 2001 al 209 ha esercitato regolare attività di tutoraggio presso l’ Università degli studi di Verona:

Tutoraggio degli specializzandi della Scuola di Specializzazione Biochimica Clinica, partecipando alla
redazione delle tesi di specializzazione ed alle commissioni di Esami e Specializzazione;

Tutoraggio degli studenti del CDLS in Medicina e Chirurgia.

Tutoraggio degli studenti del CDL in Tecniche di Laboratorio Biomedico, partecipando alla redazione delle
tesi di laure ed alle commissioni di Esami e Specializzazione
Dall’a.a. 2009 ad oggi ha esercitato regolare attività di tutoraggio presso l’ Università degli studi di Parma:

Tutoraggio degli specializzandi della Scuola di Specializzazione Biochimica Clinica, partecipando alla
redazione delle tesi di specializzazione ed alle commissioni di Esami e Specializzazione.

Tutoraggio degli studenti del CDL in Tecniche di Laboratorio Biomedico, parte cipando alla redazione delle
tesi di laure ed alle commissioni di Esami e Specializzazione.
Altre attività Accademiche

Dal 20 al 21 maggio 2003 è componente della Commissione Elettorale Centrale per l'elezione del Rettore
dell'Università degli Studi di Verona per il quadriennio accademico 2003-2007.

Dall’anno Accademico settembre 2003 al 2009 è membro della Commissione Giudicatrice incaricata di
provvedere alla valutazione delle prove per l'ammissione degli studenti ai Corsi di Laurea delle professioni
sanitarie della Facoltà di Medicina e Chirurgia dell'Università degli Studi di Verona.

Dall'anno Accademico 2006-2007 al 2009 è membro della Commissione Ricerca e Sviluppo della Facoltà di
Medicina e Chirurgia dell’Università degli Studi di Verona.

Dall’anno 2010 al 20015 è membro del Board della Ricerca dell’Azienda Ospedaliero -Universitaria di Parma.

Dall’anno 2015 è membro del Collegio dei Professori Ordinari di Biochimica Clinica e Biologia Molecolare
Clinica (BIO/12).

Dall’anno 2016 è membro del Direttivo del Collegio dei Professori Ordinari di Biochimica Clinica e Biologia
Molecolare Clinica (BIO/12), con delega al Nord Italia e membro della Commissione per i “Problemi
Assistenziali ed i rapporti con le Professioni” .

Nell’Anno 2016 è Membro e Segretario della Commissione nazionale per l’Abilitazione Scientifica Nazionale
(ASN), Settore concorsuale 05/E3 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICA .
Attività Scientifica
I principali filoni di ricerca sono:

Dal 1988 al 1996 compie ricerche sul metaboli smo ossidativo e sulle risposte funzionali dei neutrofili umani.

Dal 1988 ad oggi compie ricerche analitiche e cliniche rivolte alla valutazione di nuove tecniche e metodi
di laboratorio nell'ambito della diagnostica biochimica, ematologica e coagulativa.

Dal 1994 ad oggi compie ricerche sui fattori di rischio per le malattie cardiovascolari e dei biomarcatori per
la diagnosi e la stratificazione del rischio.

Dal 1995 ad oggi si occupa di biochimica clinica ed ematologia dello sport e del problema dei supplementi
nutrizionali e del doping, in particolare del ruolo dei test di Laboratorio per l'identificazione dell'illecito
sportivo.

Dal 1997 ad oggi compie ricerche sulle indagini di laboratorio per la valutazione del rischio emorragico e
tromboembolico.

Dal 1998 ad oggi compie studi sulla variabilità extra-analitica del dato di laboratorio, con particolare
interesse per l’incertezza nella fase preanalitica.

Dal 1998 ad oggi è riferimento internazionale per la validazione di nuove strumentazioni e/o tecniche
analitiche e/o metodiche diagnostiche commerciali.

Dal 2005 ad oggi compie studi sulla identificazione, validazione ed applicazione clinica di nuovi
biomarcatori.
Progetti di ricerca finanziati
1.
Progetto “Identificazione della variazione dei principali par ametri ematochimici in una popolazione di
atleti”. Università degli Studi di Verona. Anno 2004. P.I. - Progetto autofinanziato.
2.
Progetto “Diagnostica delle Connettiviti”. Finanziato dalla Regione Emilia-Romagna nell’ambito dei
Progetti di Modernizzazione della Regione. Anno 2009. P.I.
3.
Progetto “Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its
progression to disability and general consequences to health and well -being - The FRAILOMIC Initiative”.
Finanziato con 15.251.106,94 Euro dall’Unione Europea nell’ambito del “ European Union′s Seventh
Framework Programme (FP7/2007-2013), grant agreement n° 305483, FRAILOMIC Project”. Anno 2012,
durata 5 anni. Inserito in tutti i Work Package come Leader determinazione biomarcatori.
4.
Progetto “A tailored approach to the immune monitoring and clinical management of viral and
autoimmune disease”. Progetto di ricerca Regione-Università - Area 1 Ricerca Innovativa, finanziato dalla
Regione Emilia-Romagna. Anno 2013. Responsabile (P.I.) del Work Package 4, “Early identification of
patients at risk of developing severe and degenerative pathologies: primari biliary cirrhosis” .
5.
Progetto “Studio prospettico controllato per identificare biomarcatori coinvolti nella transazione da mal
di schiena acuto a persistente/cronico – Pain-OMICS”. Finanziato dall’Unione Europea nell’ambito del
“European Union′s Seventh Framework Programme ( FP7-HEALTH-2013), grant agreement n° 602736, Pain OMICS Project”. Anno 2013, durata 5 anni. Collaborative Center - Determinazione biomarcatori.
6.
Progetto “Health risks associated with prolonged travel in athletes ”. Applied Sports Science Research
Grant. Finanziato da Exercise & Sports Science Australia (ESSA). Anno 2015. A.I. del progetto.
7.
Studio multicentrico “Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in
Patients with Venous Thromboembolism in Europe ” - ETNA-VTE-EUROPE/DSE-EDO-05-14-EU.
ClinicalTrials.gov Identifier: NCT02943993. Anno 2016. Studio finanziato da Daiichi Sankyo Europe GmbH.
Responsabile di un dei centri arruolati.
Progetti di ricerca sottomessi (in valutazione)
1.
Progetto ““OMIC” approach might help to predict short -term and long-term postoperative breast and
colorectal cancer outcome: from pain to cancer recurrence [GIV E HOPE CANCER]”. Sottomesso come
“European Commission - ERC Consolidator Grant 2015”. Anno 2015. Responsabile di Work Package.
Progetti di ricerca sottomessi ma non finanziati
1.
Progetto “Usefulness of non-invasive test Gastropanel in order to improve the P rotonic Pomp Inhibitors
(PPIs) administration appropriateness in elderly population in Parma area ”. Sottomesso come “Progetto
Ordinario di Ricerca Finalizzata” promosso dal Ministero della Salute. Anno 2014. Responsabile di Work
Package. Punteggio 10.5/10.0.
2.
Progetto: “Standardization of Preanalytical Procedures for in vitro diagnostic studies in Personalized
Medicine - PREPMED”. Sottomesso in valutazione nell’ambito della Call Horizon 2020 SC1 -HCO-02-2016.
Leader di Work Package (WP3) e partecipante ad altri cinque Work Package (WP2, WP4 e WP5, WP6 e WP7) Punteggio 10.5/10.0.
Premi e riconoscimenti
1.
Nel marzo 1993 a Marbella (Spagna) una Giuria internazionale di esperti conferisce al team formato da
Roberto Facchinetti, Orazio Ruzzenente, Giovanni Poli, G iuseppe Lippi, Giuseppe Bellisola e Gian Cesare
Guidi il primo premio del “Second International Beckman Award” per una ricerca originale sulla
lipoproteina(a) dal titolo “Purified Lipoprotein(a) based on affinity for Lysine and effects on in vitro
fibrinolysis”.
2.
Nel maggio 1994 la Giuria del 44° Congresso Nazionale della Società Italiana di Patologia Clinica, Rimini 24 27 maggio 1994, gli conferisce il premio Instrumentation Laboratory per la ricerca originale “ Diagnosi di
emoglobinopatie in LPLC.” (Lippi G, Ruzzenente O, Poli G, Manzato F, Guidi G) per il valido contributo nel
campo della identificazione e diagnosi delle diverse forme di emoglobinopatie.
3.
Nel giugno 1995 una Giuria internazionale di esperti gli conferisce a Cagliari il secondo premio del “Th ird
International Beckman Award” per una ricerca originale sulla lipoproteina(a) dal titolo “ Effects of
Lipoprotein(a) on platelet aggregation. ” (Lippi G, Lo Cascio C, Ruzzenente O, Guidi G).
4.
Nell’ottobre del 1996 la Giuria del 10° Congresso Nazionale dell a Società Italiana di Medicina di Laboratorio,
Verona 5-7 dicembre 1996, gli conferisce un premio per la ricerca originale “ Evidence that apolipoprotein B
immunoassays include lipoprotein(a) ” (Guidi G, Ruzzenente O, Lippi G).
5.
Nel 2012 riceve il Premio Aziendale dal Direttore Generale dell’Azienda Ospedaliero -Universitaria di Parma,
per le azioni intraprese per perseguire e migliorare l’appropriatezza delle richieste di esami di laboratorio.
6.
Nel 2012 riceve l’Eberhard F. Mammen “Most Popular Article Award” per l’articolo scientifico “Moderate
Red Wine Consumption and Cardiovascular Disease Risk: Beyond the French Paradox”, di Lippi G, Franchini
M, Favaloro EJ, Targher G, pubblicato in Seminars in Thrombosis and Hemostasis.
7.
Nel 2013 riceve l’Honorary Membership per meriti scientifici alla Croatian Society of Medical Biochemistry
and Laboratory Medicine.
8.
Nel 2013 riceve l’Eberhard F. Mammen “Most Popular Article Award” per l’articolo scientifico “Obstructive
Sleep Apnea Syndrome and Cardiovascular Diseases”, di Fava C, Montagnana M, Favaloro EJ, Guidi GC, Lippi
G, pubblicato in Seminars in Thrombosis and Hemostasis.
9.
Nel 2014 riceve il Management Sciences and Patient Safety Award per meriti scientifici dall’American
Association of Clinical Chemistry (AACC).
10. Nel 2015 riceve l’Outstanding Speaker Award dall’American Association of Clinical Chemistry (AACC) .
11. Nel 2015 riceve la Chiave della Biochimica Clinica, come premio per l’attitività scientifica ed il support o
alla Società Italiana di Biochimica Clinica e Medicina di Laboratorio (SIBioC).
12. Nel 2016 riceve l’Eberhard F. Mammen “Most Popular Article Award” per l’articolo scientifico “ECigarettes and Cardiovascular Risk: Beyond Science and Mysticism ”, di Lippi G, Favaloro EJ, Meschi T,
Mattiuzzi C, Borghi L, Cervellin G, pubblicato in Seminars in Thrombosis and Hemostasis.
13. Nel 2016 riceve la Chiave della Biochimica Clinica, come premio per l’attitività scientifica ed il supporto
alla Società Italiana di Biochimica Clinica e Medicina di Laboratorio (SIBioC).
14. Nel 2017, la rivista Clinica Chemistry gli dedica una foto sulla copertina del numero di Febbraio.
Sintesi della produzione scientifica al 25 febbraio 2017

1344 pubblicazioni in extenso su riviste censite da PubMed/Medline, ISI Web of Science e Scopus, di cui
748 come primo Autore (56%), 111 come secondo Autore (8%), 55 come penultimo Autore (4%) e 341 come
ultimo Autore (25%).


Impact Factor totale: 4642.3

Impact Factor medio per pubblicazione : 3.5 (ISI Web of Science)

H-Index: 69 (Google Scholar); 53 (Scopus); 50 (ISI Web of Science)

CItazioni: 25753 (Google Scholar); 17195 (Scopus ID:23989140600); 15589 (ISI Web of Science)

i10-index (articoli con >10 citazioni) : 611 (Google Scholar)
49 pubblicazioni in extenso su riviste internazionali non censite, di cui 42 (86%) come primo, secondo o
ultimo Autore.

27 pubblicazioni in extenso su riviste nazionali non censite.

4 monografie e 20 capitoli in monografie nazionali ed internazionali.

39 commentaries / rapid responses / e-letters / newslewtters su riviste indicizzate, censite da Current
Contents, tutte come primo, secondo o ultimo Autore (più 12 recensioni o traduzioni).

216 poster o abstract (92 a meeting internazionali, 124 a meeting nazionali)

219 relazioni su invito o seminari d’aggiornamento scientifico, di cui 51 a meeting internazionali.
170
160
150
P ub. P ubM ed/ISI/Sco pus
P ub. Intern/No n indiciz.
M o no grafie/Capito li
P ub. Nazio nali/No n indiciz.
E-Letters/Recensio ni
Relazio ni
140
130
120
110
100
90
80
70
60
50
40
30
20
10
in press
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
0
Sintesi delle pubblicazioni scientifiche al 25 febbraio 2017
Rivista
Acad Emerg Med
Accred Qual Assur
IF 2015
n
IF tot
Clin Physiol Funct Imaging
2.537
1
2.537
Clin Ter
1.052
1.010
Acta Biomed
1.869
1
1.869
J Med Biochem
0.742
15
11.130
1
0.000
J Nephrol
1.352
1
1.352
1
1.052
J Nutr Health Aging
3.199
1
3.199
J Occup Med Toxicol
1.486
1
1.486
1
1.010
Clin Transl Sci
10
0.000
Clinics
1.328
1
1.328
Acta Cardiol
0.600
2
1.200
CMAJ - Can Med Assoc J
6.724
7
47.068
J Pediatr
3.890
1
3.890
Acta Haematol
1.053
1
1.053
CNS Neurol Disord Drug Targets
2.188
1
2.188
J Physiol
4.731
1
4.731
Adv Clin Chem
2.295
11
25.245
Crit Care
4.950
1
4.950
J Sci Med Sport
3.756
1
3.756
Adv Hematol
1
0.000
Crit Rev Clin Lab Sci
4.167
10
41.670
J Sport Health Sci
1.685
1
1.685
Adv Orthop
1
0.000
Crit Rev Oncol Hematol
5.039
2
10.078
J Sports Med Phys Fitness
1.111
2
2.222
4.201
Curr Pharm Des
3.052
2
6.104
J Sports Sci
2.142
2
4.284
2.374
1
2.374
J Strength Cond Res
1.978
4
7.912
J Surg Res
2.198
1
2.198
Age Ageing
4.201
1
Aging Clin Exp Res
1.368
1
1.368
Curr Vasc Pharmacol
Altern Ther Health Med
1.329
1
1.329
Diabet Med
3.152
3
9.456
Am Heart J
4.332
2
8.664
Diabetes Care
8.934
6
53.604
J Thorac Dis
1.649
1
1.649
Am J Cardiol
3.154
9
28.386
Diabetes Res Clin Pract
3.045
4
12.180
J Thromb Haemost
5.565
3
16.695
Am J Clin Pathol
2.278
4
9.112
Diabetologia
6.206
2
12.412
J Thromb Thrombolysis
1.884
25
47.100
Am J Emerg Med
1.504
7
10.528
Diagnosis
J Transl Med
3.694
1
10.383
Drug Test Anal
J Vet Diagn Invest
1.196
1
1.196
Am J Gastroenterol
10.383
1
2.859
6
0.000
4
11.436
3
0.000
JAMA
37.684
2
75.368
3.694
Am J Hematol
5.000
3
15.000
Emerg Care J
Am J Kidney Dis
6.269
2
12.538
Endocr Res
1.476
1
1.476
JAMA Intern Med
14.000
2
28.000
Am J Med
5.610
4
22.440
Epidemiol Prev
0.924
1
0.924
Kardiol Pol
0.878
3
2.634
Am J Med Sci
1.575
1
1.575
Eur Geriatr Med
1.326
3
3.978
Kidney Int
7.683
1
7.683
Am J Prev Med
4.465
1
4.465
Eur Heart J
15.064
1
15.064
Lab Hematol
3
0.000
Am J Respir Cell Mol Biol
4.082
1
4.082
Eur J Appl Physiol
2.328
8
18.624
Lab Medicine
0.561
9
5.049
Am J Rhinol Allergy
1.960
1
1.960
Eur J Clin Invest
2.687
3
8.061
Lancet Haematol
4.889
2
9.778
2.710
1
2.710
Leuk Lymphoma
3.093
1
3.093
Anaesthesia
3.794
2
7.588
Eur J Clin Pharmacol
Anal Bioanal Chem
3.125
1
3.125
Eur J Endocrinol
3.892
1
3.892
Lipids Health Dis
2.137
1
2.137
Angiology
2.931
1
2.931
Eur J Haematol
2.544
1
2.544
Liver Int
4.470
1
4.470
Ann Clin Biochem
2.119
7
14.833
Eur J Intern Med
2.591
20
51.820
Meat Sci
2.801
1
2.801
Ann Clin Lab Sci
0.846
1
0.846
6
0.000
Med Lab
0.104
2
0.208
Ann Hematol
3.022
4
12.088
Eur Urol
14.976
1
14.976
Med Sci Monit
1.405
1
1.405
Ann Intern Med
16.440
1
16.440
Europace
4.021
1
4.021
Med Sci Sport Exer
4.041
1
4.041
1.870
Expert Opin Biol Ther
3.438
1
3.438
MedGenMed
2
0.000
Expert Opin Drug Saf
2.896
1
2.896
Medicine (Baltimore)
1
1.206
2
0.000
3
3.708
1
0.000
1
2.841
3
0.000
1
3.530
Ann Lab Med
1.870
1
Eur J Lab Med
Ann Med
3.763
9
33.867
Ann Oncol
9.269
1
9.269
Expert Opin Orphan Drugs
0.464
1
0.464
Minerva Ginecol
1
0.000
Expert Rev Hematol
2.439
4
9.756
Minerva Med
1
0.658
Expert Rev Proteomics
3.465
1
3.465
Minerva Medicoleg
29
0.000
FEBS J
4.237
1
4.237
Mini-Rev Med Chem
1
1.910
Fertil Steril
4.426
1
4.426
MLO Med Lab Obs
84.000
G Ital Nefrol
1
0.000
Mol Med
1
3.096
Muscles Ligaments Tendons J
1
0.000
N Engl J Med
N Z J Med Lab Sci
Ann Stomatol (Roma)
Ann Thorac Cardiovasc Surg
0.658
Ann Transl Med
Appl Physiol Nutr Metab
Arch Intern Med
1.910
14.000
6
1.236
2.841
3.530
Arch Med Res
2.219
1
2.219
Gerontology
Arch Med Sci
1.812
1
1.812
Giorn It Allergol Immunol Clin
Arch Pathol Lab Med
2.631
11
28.941
Gynecol Endocrinol
1.413
1
1.413
2
0.000
Arq Bras Cardiol
1.194
1
1.194
Haematologica
6.671
17
113.407
Nat Rev Cardiol
10.533
2
21.066
Arthritis Rheum
8.955
1
8.955
Haemophilia
2.673
7
18.711
Nephrol Dial Transplant
4.085
2
8.170
Artif Intell Med
2.142
1
2.142
Hematology
1.385
1
1.385
Neurol Sci
1.783
1
1
0.000
Hepatol Int
1.125
1
1.125
Neurology
8.166
1
8.166
5.985
1
5.985
Nutr Metab Cardiovasc Dis
3.390
4
13.560
Asian J Sports Med
3.096
1.206
59.558
1
0.000
13
774.254
1.783
Atherosclerosis
3.942
5
19.710
Hum Mol Genet
Autoimmun Rev
8.490
2
16.980
Hypertension
6.249
1
6.249
Obesity (Silver Spring)
3.614
3
10.842
Bioanalysis
2.813
1
2.813
Immunol Res
2.934
1
2.934
Obstet Gynecol
5.656
1
5.656
Biochem Med (Zagreb)
3.051
35
106.785
Indian Heart J
1
0.000
Ox Med Cell Longevity
4.667
2
9.334
Biochim Clin
22
0.000
Indian J Chest Dis Allied Sci
1
0.000
Pathology
2.968
1
2.968
Biologics
1
0.000
Indian J Clin Biochem
1
0.000
Pediatr Blood Cancer
2.634
2
5.268
1
2.179
Indian J Med Res
1.446
1
1.446
Pediatr Diabetes
3.488
1
3.488
2.160
1
2.160
Pediatr Hematol Oncol
1.090
1
1.090
Pediatr Neurol
1.866
1
1.866
5.196
1
5.196
3
0.000
Biomark Med
2.179
Biomed Pharmacother
2.326
1
2.326
Infus Ther Transfus Med
Biomed Res Int
2.134
1
2.134
Int J Cardiol
4.638
38
176.244
Biopreserv Biobank
1.804
1
1.804
Int J Clin Lab Res
2.854
3
8.562
Pediatrics
BJOG
4.039
1
4.039
Int J Clin Pract
2.226
1
2.226
Perfor Enhan Health
Blood
11.841
3
35.523
Int J Dermatol
1.415
1
1.415
Perspect Public Health
0.987
1
0.987
Blood Coagul Fibrinolysis
1.242
45
55.890
Int J Food Sci Nutr
1.451
2
2.902
Phys Sportsmed
1.144
1
1.144
Blood Transfus
1.514
23
34.822
Int J Gynaecol Obstet
1.674
1
1.674
Plos One
3.057
3
9.171
2.371
Int J Gynecol Cancer
2.116
1
2.116
Pol Arch Med Wewn
2.054
3
6.162
2.229
1
2.229
Pract Lab Med
2
0.000
BMC Geriatr
2.371
1
BMC Med
8.005
1
8.005
Int J Infect Dis
Bone Marrow Transplant
3.636
1
3.636
Int J Lab Hematol
2.401
24
57.624
1
0.000
Int J Mol Sci
3.257
1
3.257
Int J Sports Med
2.528
14
35.392
1
0.000
Br Hom J
Br J Biomed Sci
1.245
5
6.225
Br J Cancer
5.569
3
16.707
Brit J Dermatol
4.317
1
4.317
Br J Sports Med
6.724
13
87.412
Int J Wine Res
1
1.570
Q J Med
2.824
2
5.648
Radiology
6.798
1
6.798
Recenti Prog Med
12
0.000
Rev Bras Hematol Hemoter
2
0.000
2.387
1
2.387
Intern Emerg Med
2.340
7
16.380
2
3.404
0.832
3
2.496
RIMeL/IJLM
21
0.000
1.526
1
1.526
Riv Med Lab/JLM
4
0.000
1
0.000
Scand J Clin Lab Invest
1.471
13
19.123
1
0.879
Scand J Infect Dis
1.366
1
1.366
1
0.000
Scand J Sports Med Sci
3.025
2
6.050
Semin Thromb Hemost
3.505
94
329.470
Brit Med Bull
2.921
3
8.763
Can J Cardiol
3.112
2
6.224
Intern Med J
Can J Emerg Med
1.106
1
1.106
Iran J Pathol
Cancer
5.649
1
5.649
Isr Med Assoc J
Cancer Prev Res
3.887
1
3.887
ISRN Hematol
Cancer Treat Rev
7.983
2
15.966
Cardiovasc Toxicol
2.063
1
Cell Biochem Funct
2.016
2
Cell Stress Chaperones
2.583
1
Chest
5.940
Circulation
Circ Cardiovasc Interv
0.879
Rheumatol Int
1.702
J Agric Food Chem
2.857
1
2.857
2.063
J Am Coll Cardiol
17.759
4
71.036
Signa Vitae
0.154
2
0.308
4.032
J Am Soc Nephrol
8.491
1
8.491
Sports Med
5.579
3
16.737
2.583
J Antimicrob Chemother
4.919
1
4.919
Stroke
5.787
1
5.787
1
5.940
J Appl Biomed
1.509
1
1.509
Surgery
3.309
1
3.309
17.047
4
68.188
J Appl Physiol
3.004
2
6.008
Swiss Med Wkly
1.549
1
1.549
5.706
1
5.706
J Cardiovasc Med
1.658
1
1.658
Transfus Apher Sci
0.963
2
1.926
1
0.000
J Cell Mol Med
4.938
2
9.876
Transfusion
3.042
1
3.042
2
3.946
J Chromatogr B
2.687
1
2.687
Transplant Proc
0.867
1
1
0.000
Trends Mol Med
9.292
1
9.292
Trends Pharmacol Sci
11.840
3
35.520
5.255
10
52.550
Clin Adv Hematol Oncol
1.973
J Clin Immunoassay
Clin Biochem
2.382
43
102.426
Clin Cardiol
2.431
1
2.431
Clin Chem
7.457
12
Clin Chem Lab Med
3.017
180
Clin Chim Acta
2.799
54
151.146
Clin Drug Investig
1.806
1
1.806
J Diabetes Sci Technol
Clin Endocrinol
3.487
1
3.487
J Electrocardiol
1.290
5.708
J Emerg Med
1.048
0.872
Clin Exp Med
1.570
Int Orthop
Intern Med
Clin Appl Thromb Hemost
Prim Care Diabetes
2.854
2
J Clin Lab Anal
1.549
12
18.588
89.484
J Clin Rheumatol
1.245
1
1.245
Thromb Haemost
543.060
J Clin Pharm Ther
1.833
1
1.833
Thromb J
J Diabetes
2.500
1
2.500
Thromb Res
1
0.000
1
1.290
4
4.192
1
Clin J Am Soc Nephrol
4.657
2
9.314
J Emerg Nurs
Clin J Sport Med
2.308
4
9.232
J Epidemiol Global Health
Clin Lab
0.936
26
24.336
Clin Lab Med
1.690
1
Clin Obstet Gynecol
1.616
Clin Pharmacol Ther
7.268
0.867
4
0.000
2.320
16
37.120
Transl Res
4.557
1
4.557
Trends Endocrinol Metab
8.964
1
8.964
Urology
2.187
1
2.187
0.872
Wild Environ Med
1.163
1
1.163
3
0.000
World J Emerg Med
1.583
1
1.583
2.787
1
2.787
1344
4642.3
J Eval Clin Pract
1.053
2
2.106
World J Gastroenterol
1.690
J Immunol Methods
1.858
1
1.858
Totale
1
1.616
J Lab Autom
1.297
10
12.970
1
7.268
J Lab Clin Med
4.557
1
4.557
Title chan ges: Arch Intern Med, n ow JAMA Intern Med; B r H om J, noe
Hom eop athy; Infus Th er Trans fus M ed, now Transf us Med Hem oth; Int
J Clin Lab Res, now Clin Exp Med; J Lab Clin Med, now Trans lation al
Research; Bi omed Res Int, formerl y Jou rnal Of Biom edicine And
Biotechnol ogy
Pubblicazioni in extenso su riviste scientifiche indicizzate da PubMed, ISI e Scopus
1.
Advantages of a new anticoagulant in routine hematology on the Counter S -Plus STKR analayzer. Lippi U,
Schinella M, Modena N, Nicoli M, Lippi G. Am J Clin Pathol 1990:93;760-4.
2.
EDTA - induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated
complete blood count. Lippi U, Schinella M, Nicoli M, Modena N, Lippi G. Haematologica 1990;75:38-41.
3.
Homologous priming in chemotactic peptide -stimulated neutrophils. Bellavite P, Chirumbolo S, Lippi G, Guzzo
P, Santonastaso C. Cell Biochem Funct 1993;11:93-100.
4.
Dual effects of formylpeptides on the adhesion of endotoxin - primed human neutrophils. Bellavite P,
Chirumbolo S, Lippi G, Andrioli G, Bonazzi L, Ferro I. Cell Biochem Funct 1993;11:231-9.
5.
Instrumental reports and effect of anticoagulants in a case of neutrophil agglutination in vitro. Galifi M,
Schinella M, Nicoli M, Lippi G. Haematologica 1993:78:364-70.
6.
Effects of homeopathic preparations of organic acids and minerals on the oxidative metabolism of human
neutrophils. Chirumbolo S, Signorini A, Bianchi I, Lippi G, Bellavite P. Br Hom J 1993;82:237-44.
7.
Latex immunonephelometry for lipopoprotein(a) assay. Lippi G, Ruzzenente O, Facchinetti R, Poli G, Schiesari
F, Guidi G. Eur J Lab Med 1994;2:23-8.
8.
A simple assessment of human neutrophil adhesiveness. Lippi U, Schinella M, Nicoli M, Bellavite P, Lippi G. Int
J Clin Lab Res 1994;24:41-4.
9.
High light scatter by neutrophils in the Bayer -Technicon H*2 analyzer: A screening test of morphologically
defective responsiveness to in vitro chemotactic stimulation. Lippi U, Bellavite P, Schinella M, Nicoli M, Lippi
G. Eur J Clin Chem Clin Biochem 1994;32:11-7.
10.
Assessment of neutrophil aggregation by Coulter STKR and STKS haematological analyser. Lippi U, Bellavite P,
Schinella M, Nicoli M, Lippi G. Clin Lab Haematol 1994;16:43-55.
11.
Semi-quantitative latex method for lipoprotein(a) assay. Lippi G, Ruzzenente O, Facchinetti R, Guidi G. Clin
Chim Acta 1994;229:147-51.
12.
Detection of deactivated neutrophils by a widely use d hematological analyzer. Lippi U, Schinella M, Nicoli M,
Lippi G. Eur J Lab Med 1995;3:151-3.
13.
Changes in several neutrophil functions in basketball players before, during and after the sports season.
Benoni G, Bellavite P, Adami A, Chirumbolo S, Lippi G, Brocco G, Giulini GM, Cuzzolin L. Int J Sports Med
1995;16:34-7.
14.
Effect of pyridoxal 5’-phosphate on human neutrophil aggregation in vitro. Schinella M, Nicoli M, Lippi G,
Chirumbolo S. Int J Clin Lab Res 1995;25:99-103.
15.
Lipoprotein(a) immunoassays: compar ison between a semi-quantitative latex method and two monoclonal
enzyme immunoassays. Marcovina SM, Lippi G, Guidi G. Int J Clin Lab Res 1995;25:201-4.
16.
Effect of acute exercise on some haematological parameters and neutrophil functions in active and inacti ve
subjects. Benoni G, Bellavite P, Adami A, Chirumbolo S, Lippi G, Brocco G, Cuzzolin L. Eur J Appl Physiol
1995;70:187-91.
17.
Effects of anticoagulants on lipoprotein(a) measurements with four commercial assays . Lippi G, Giampaolo L,
Guidi G. Eur J Clin Chem Clin Biochem 1996;34:251-5.
18.
Platelet count in EDTA-dependent pseudothrombocytopenia. Lippi G, Guidi G, Nicoli M. Eur J Haematol
1996;56:112-3.
19.
A simple and rapid procedure for the purification of lipoprotein(a). Lippi G, Lo Cascio C, Ruzzenente O, Poli G,
Brentegani C, Guidi G. J Chromatogr B 1996;268:225-31.
20.
Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level.
Marcovina SM, Lippi G, Bagatell CJ, Bremner WJ. Atherosclerosis 1996;122:89-95.
21.
Significant reduction of the bias among commercial immunoassays for lipoprotein(a) after use of a uniform
calibrator. Lippi G, Lo Cascio C, Ruzzenente O, Brentegani C, Guidi G. Clin Chim Acta 1996;256:125-34.
22.
Lipoprotein(a): When lack of standardization means misclassi fication. Lippi G, Brentegani C, Guidi G. Eur J Lab
Med 1997;5:70-7.
23.
Clinical performance of the new Roche Cobas Vega haematological analyzer. Lippi G, Nicoli M, Modena N, Guidi
G. Eur J Clin Chem Clin Biochem 1997;2:105-10.
24.
Paradoxical behaviour of lyophilised commercial control materials for CK and CK -MB assays after
reconstitution at either 4°C or 24°C. Lippi G, Brentegani C, Cocco C, Lo Cascio C, Guidi G. Clin Chim Acta
1997;261:167-73.
25.
Evaluation of five new liquid stable applications on the Roche Coba s Integra. Lippi G, Brentegani C, Mazzi C,
Recchi C, Ruzzenente O, Guidi G. Eur J Clin Chem Clin Biochem 1997;35:877-80.
26.
Acute effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with
postmenopausal osteoporosis. Lippi G, Braga V, Adami S, Guidi G. Scand J Clin Lab Invest 1997;57:507-12.
27.
Evidence that lipoprotein(a) is not an adhesive and proaggregating molecule for platelets in vitro . Lippi G,
Guidi G, Lo Cascio C, Lussignoli S, Andrioli G, Bellavite P. Eur J Lab Med 1998;6:24-8.
28.
Lipoprotein(a) and ischemic cerebrovascular disease. Lippi G, Guidi G. Ann Clin Biochem 1998;35:327-9.
29.
Standardization and clinical management of lipoprotein(a) measurements. Lippi G, Guidi G. Clin Chem Lab Med
1998;36:5-16.
30.
Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates induced acute phase response. Lippi G, Braga V, Adami S, Guidi G. Clin Chim Acta 1998;271:79-87.
31.
Effect of pyridoxal 5’-phosphate on human neutrophil respiratory burst and adhesion on serum coated
microplates. Lippi G, Chirumbolo S, Guidi G. Biomed Pharmacother 1998;52:157-61.
32.
The usefulness of lipids, lipoprotein(a) and fibrinogen measurements in identifying subjects at risk of
occlusive complications following vascular and endovascular surgery. Lippi G, Veraldi GF, Dorucci V, Dusi R,
Ruzzenente O, Brentegani C, Guidi G, Cordiano C . Scand J Clin Lab Invest 1998;58:1-8.
33.
Evaluation of the analytical performances of a new fully automated commercial immunonephelometri c assay
for lipoprotein(a). Lippi G, Ruzzenente O, Brentegani C, Pierotti A, Guidi G . Clin Chem Lab Med 1998;36:719-23.
34.
Plasma D-Dimer in the diagnosis of deep vein thrombosis. Lippi G, Mengoni A, Manzato F. JAMA 1998;280:18289.
35.
Evaluation of the APTT sensitivity to heparin of five commercial reagents: implications for therapeutic
monitoring. Manzato F, Mengoni A, Grilenzoni A, Lippi G. Clin Chem Lab Med 1998;36:975-80.
36.
Accurate platelet count avoiding platelet clumping. Lippi G, Facchinetti R. Lab Hematol 1998;4:225-6.
37.
Sensitivity of two commercial reagents for prothrombin time and activated partial thromboplastin time to
isolate coagulation factor deficiencies. Lippi G, Mengoni A, Manzato F. Eur J Lab Med 1999;7:61-5.
38.
An automated method based on plasma t hiocyanate determination for the identification of exposure to
tobacco smoke. Brocco G, Rossato B, Fraccaroli M, Lippi G. Eur J Lab Med 1999;7:106-10.
39.
Biochemical risk factors and patient’s outcome: the case of lipoprotein(a). Lippi G, Guidi G. Clin Chim Acta
1999;280:59-71.
40.
Reticulocyte analysis on sodium citrate -anticoagulated samples. Lippi G, Nicoli M, Solero P. Lab Hematol
1999;5:67-9.
41.
Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study. Lippi G,
Bassi A, Brocco G, Manzato F, Marini M, Guidi G. Haematologica 1999;84:726-9.
42.
A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the successful
treatment of acquired hemophilia A with high-titer inhibitor. Gandini G, Franchini M, Manzato F, Lippi G, Aprili
G. Haematologica 1999;84:1054.
43.
Relationship between venous thromboembolism and lipid or lipoprotein disorders. Lippi G, Brocco G, Manzato
F, Guidi G. Thromb Res 1999;95:353-4.
44.
Doping e sport. Lippi G, Guidi G. Minerva Med 1999;90:345-57.
45.
Lipoprotein(a): from ancestral benefit to modern pathogen. Lippi G, Guidi G. Q J Med 2000;93:75-84.
46.
Further evidences of pyridoxal phosphate antiaggregant effect on platelets in vitro. Lippi G, Lippi U,
Facchinetti R, Guidi G. Lab Hematol 2000;6:79-81.
47.
Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI
deficiency. Franchini M, de Gironcoli M, Lippi G, Manzato F, Aprili G, Gandini G. Haematologica 2000;85:106-7.
48.
Laboratory screening for erythropoietin abuse in sport: an emerging challenge. Lippi G, Guidi G. Clin Chem
Lab Med 2000;38:1-7.
49.
Emofilia A acquisita: epidemiologia, diagnosi e trattamento . Gandini G, Franchini M, Manzato F, Lippi G, de
Gironcoli M, Piccoli P, Aprili G. Recenti Prog Med 2000; 91:251-5.
50.
From idiopathic thrombosis to screening for thrombophilia: Still an unsolved enigma. Lippi G. Riv Med
Lab/JLM 2000;1:5-9.
51.
…relationship between dislipidemia and thrombosis yet unproven. Lippi G, Guidi G. Blood Coagul Fibrinolysis
2001;12:81-3.
52.
Influence of the ABO blood type on the platelet function analyzer PFA -100. Lippi G, Franchini M, Brocco G,
Manzato F. Thromb Haemost 2001;85:369-70.
53.
Preoperative screening: the rationale of measuring APTT in risk assessment . Lippi G, Franchini M, Brazzarola
P, Manzato F. Haematologica 2001;86:328.
54.
Clinical efficiency of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a
patient with high inhibitor titer. Franchini M, Capra F, Capelli C, de Maria E, Lippi G, Gandini G. Haematologica
2001;86:E12.
55.
Cardiovascular risk factors in patients with chronic renal failure maintained on hemodialysis or continuos
ambulatory peritoneal dialysis. Lippi G, Tessitore N, Gammaro L, Rugiu C, Maschio G, Guidi G. Thromb Res
2001;101:517-9.
56.
Establishment of reference values for the PFA-100 platelet function analyzer in pediatrics. Lippi G, Manzato
F, Franchini M, Brocco G, Florenziani G, Guidi G. Clin Exp Med 2001;1:70-71.
57.
The role of iron status markers in predicting response to intravenous iron i n haemodialysis patients on
maintenance erythropoietin. Tessitore N, Solero P, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco
G, Restivo G, Bernich P, Lupo A, Maschio G. Nephrol Dial Transplant 2001;16:1416-23.
58.
Severe preeclampsia in antithrombin III deficiency without previous history of thromboembolism. Gammaro L,
Lippi G, Bottini E, Valenti G, Manzato F, Tessitore N, Maschio G. J Nephrol 2001;14:312-5.
59.
Association of phlebotomy and subcutaneous bolus injection of deferoxamine for the treatmen t of anemic
patients with iron overload. Franchini M, Gandini G, Girelli D, Lippi G, de Gironcoli M, Aprili G. Haematologica
2001;86:873-4.
60.
The natural history of chronic hepatitis C in a cohort of HIV -negative Italian patients with hereditary bleeding
disorders. Franchini M, Rossetti G, Tagliaferri A, Capra F, de Maria E, Pattacini C, Lippi G, Lo Cascio G, de
Gironcoli M, Gandini G. Blood 2001;98:1836-41.
61.
Biochemical risk factors for cardiovascular disease in an aged male population. Emphasis on emerging
vascular pathogens. Lippi G, Arosio E, Prior M, Guidi G. Angiology 2001;10:681-7.
62.
Laboratory screening for abnormalities of primary hemostasis. What's next? Lippi G, Franchini M. Clin Chem
2001;11:2071.
63.
Variation of plasma D-dimer following surgery: implications for prediction of postoperative venous
thromboembolism. Lippi G, Veraldi GF, Fraccaroli M, Manzato F, Cordiano C, Guidi G. Clin Exp Med 2001;1:161-4.
64.
Critical parameters in transfusion medicine. Franchini M, Lippi G. Riv Med Lab/JLM 2001;2:5-11.
65.
Prothrombotic effects and clinical implications of third generation oral contraceptives use. Lippi G, Manzato
F, Brocco G, Franchini M, Guidi G. Blood Coagul Fibrinolysis 2002;13:69-72.
66.
Hematocrit measurement and antidoping policies. Lippi G, Franchini M, Guidi G. Clin Lab Haematol 2002;24:656.
67.
Le nuove frontiere del doping ematico. Lippi G, Franchini M. Recenti Prog Med 2002;93:1-8.
68.
Stratification and management of the cardiovascular risk: beyond conventional parameters. Lippi G, Guidi G.
CMAJ – Can Med Assoc J 2002;166:710.
69.
Efficacy of desmopressin as surgical prophylaxis in patients with coagulation disorders associated with
thyroid disease undergoing thyroid surgery . Franchini M, De Gironcoli M, Lippi G, Manzato F, Brazzarola P,
Bottura D, Aprili G, Gandini G. Haemophilia 2002;8:142-4.
70.
Evaluation of the PFA-100 System as monitoring of desmopressin therapy in patients with type 1 von
Willebrand disease. Franchini M, Gandini G, Manzato F, Lippi G. Haematologica 2002;87:670.
71.
Frequency of adverse events during blood apheresis donations: a single-center study. Franchini M, Gandini G,
Gandini AR, Crocco I, de Gironcoli M, Bertuzzo D, Giuffrida AC, Lippi G, Vassanelli A, Bressan F, Aprili G. Infus
Ther Transfus Med 2002;29:200-5.
72.
Cytomegalovirus infection in patient s undergoing autologous peripheral blood stem cell transplantation.
Franchini M, Pizzighella S, Vassanelli A, Rocca P, Meneghini V, Veneri D, Lippi G, Benedetti F. Int J Infect Dis
2002;6:83-4.
73.
Relationship between regular aerobic physical exercise and in flammatory markers. Lippi G, Bassi A, Guidi G,
Zatti M. Am J Cardiol 2002;90:820.
74.
Relationship between hematocrit, primary hemostasis and cardiovascular disease in athletes. Lippi G, Manzato
F, Franchini M, Guidi G. Am Heart J 2002;144:E14.
75.
Menorrhagia and inherited disorders of coagulation. Franchini M, Capra F, Lippi G, Aprili G, Gandini G. Minerva
Ginecol 2002;54:453-60.
76.
Biochemical parameters for monitoring of erythropoietin. Lippi G. Riv Med Lab/JLM 2002;3(2 Suppl.1):84-6.
77.
Lipoprotein(a): an emerging cardiovascular risk Factor. Lippi G, Guidi G. Crit Rev Clin Lab Sci 2003;40:1-42.
78.
Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate -P®) in preventing bleeding
during surgery or invasive procedures in patients with von Willebran d disease. Franchini M, Rossetti G,
Tagliaferri A, Pattacini C, Pozzoli D, Lippi G, Manzato F, Bertuzzo D, Gandini G. Haematologica 2003;88:1279-83.
79.
New scenarios in antidoping research. Lippi G, Guidi G. Clin Chem 2003;49:2106-7.
80.
Lipoprotein(a): atherogenesis linked to thrombosis and inflammation at last? Lippi G, Guidi G. Am J Kidney Dis
2003;42:1326.
81.
The Oral Glucose Tolerance Test between clinical practice and scientific evidences. Andreani P, Mosca A,
Testa R, Massi Benedetti M, Borsotti M, Carta M, Ce rotti F, Dorizzi R, Ferrai G, Graziani M, La Polla A, Lippi G,
Maccaroni I, Marra M, Migali M, Paleari R, Palleschi G, Peirone C, Quercioli M, Tocchini M, Tomassoni ML. Riv Med
Lab/JLM 2004;5:121-7.
82.
Metabolic risks of completing Giro, Tour, and Vuelta in t he same season. Lippi G, Guidi G. Br J Sports Med
2004;38:103.
83.
Athletes genotyping: ethical and legal issues. Lippi G, Solero PG, Guidi G. Int J Sports Med 2004;25:159.
84.
Hepatitis C in hemophiliacs. Franchini M, Capra F, Veneri D, Lo Cascio G, de Maria E, M anzato F, Lippi G,
Gandini G. Recenti Prog Med 2004;95:30-4.
85.
Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? Lippi
G. Franchini M, Guidi G. Haematologica 2004;89:ELT05.
86.
Clinical use of erythropoietin. Franchini M, Gandini G, Lippi G, De Gironcoli M, Cantini M, Aprili G. Recenti Prog
Med 2004;95:129-36.
87.
Mandatory wear of helmets for elite cyclists: new perspectives in prevention of head injuries. Lippi G,
Mattiuzzi C. Br J Sports Med 2004;38:364.
88.
Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes
versus healthy controls. Lippi G, Brocco G, Franchini M, Schena F, Guidi G. Clin Chem Lab Med 2004;42:644-7.
89.
Prevention of doping in sports: epidemiological is sues and ethical implications. Lippi G, Mattiuzzi C, Guidi G.
Epidemiol Prev 2004;28:178-83.
90.
Gene manipulation and improvement of athletic performances: new strategies in blood doping. Lippi G, Guidi
G. Br J Sports Med 2004;38:641.
91.
Effect of specimen collection on routine coagulation assays and d-dimer measurement. Lippi G, Guidi GC. Clin
Chem 2004;50:2150-2.
92.
AP1800 H C D : towards automation of the CLA assay. Ruzzenente O, Lippi G, Dima F, Bertasini A, Guidi GC. Giorn It
Allergol Immunol Clin 2004;14:165-71.
93.
High prevalence of acquired von Willebrand’s syndrome in patients with thyroid diseases undergoing thyroid
surgery. Franchini M, Zugni C, Veneri D, Gandini G, Lippi G, Manzato F, Brazzarola P. Haematologica
2004;89:1341-6.
94.
Lipids and cardiovascular risks. Lippi G. RIMeL/IJLM 2005;1:14-19.
95.
Variability of coagulation testing between two separate laboratories: Implications for diagnosis and therapeutic monitoring.
Lippi G, Giavarina D, Carta MR, Poli G, Montagnana M, Salvagno GL, Soffiati G, Guidi GC. RIMeL/IJLM 2005;1:183-5.
96.
The measurement of ischemia modified albumin in clinical laboratories: Where do we stand? Lippi G,
Montagnana M, Guidi GC. J Clin Immunoassay 2005;28:207-15.
97.
Total and free PSA serum concentrations are not influenced by extensive physical e xercise and bicycle riding.
Lippi G, Corgnati A, Salvagno G, Schena F, Franchini M, Guidi G. Int J Sports Med 2005; 26:79-81.
98.
No influence of a butterfly device on routine coagulation assays and d -dimer measurement. Lippi G, Salvagno
GL, Guidi GC. J Thromb Haemost 2005;3:389-91.
99.
Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels.
Franchini M, Veneri D, Lippi G. Thromb Haemost 2005;93:392-3.
100.
Preanalytical variability in laboratory testing: the influence of the blood drawing technique. Lippi G, Salvagno
GL, Brocco G, Guidi GC. Clin Chem Lab Med 2005;43:319-25.
101.
Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. Franchini M, Girelli D, Olivieri O,
Bozzini C, Guiotto G, Zardini G, Lippi G, Manzato F, Gandin G. Haematologica 2005;90:ECR16.
102.
New perspectives in the diagnostic approach to the acute coronary syndrome. Montagnana M, Lippi G, Guidi
GC. Recenti Prog Med 2005 96:171-7.
103.
Influence of two different buffered sodium citrate concentrati ons on coagulation testing. Lippi G, Salvagno
GL, Montagnana M, Guidi GC. Blood Coagul Fibrinolysis 2005;16:381-3.
104.
Haematological testing and antidoping policies. Lippi G, Franchini M, Guidi GC. Int J Sports Med 2005;26:508-9.
105.
High-workload endurance training may increase the serum ischemia modified albumin concentrations. Lippi G,
Brocco G, Salvagno GL, Montagnana M, Dima F, Guidi GC. Clin Chem Lab Med 2005;43:741–4.
106.
Effective measures to improve driver’s safety. Lippi G, Guidi GC. Br J Sports Med 2005;39:686.
107.
Influence of short-term venous stasis on clinical chemistry testing. Lippi G, Salvagno GL, Montagnana M, Guidi
GC. Clin Chem Lab Med 2005;43:869-75.
108.
Short term venous stasis influences routine coagulation testing. Lippi G, Salvagno GL, Montagnana M, Guidi GC.
Blood Coagul Fibrinolysis 2005;16:453-8.
109.
Serum ferritin as a marker of potential biochemical iron overload in athletes. Lippi G, Schena F, Franchini M,
Salvagno GL, Guidi GC. Clin J Sport Med 2005;15:356-8.
110.
Thromboprophylaxis in stroke patients. Lippi G, Guidi GC. Stroke 2005;36:2067-8.
111.
Chronic influence of vigorous aerobic training on hemostasis. Lippi G, Salvagno GL, Montagana M, Guidi GC.
112.
Other advantages to aerobic exercise. Lippi G, Salvagno GL, Guidi GC. CMAJ – Can Med Assoc J 2005;173:1066.
113.
Are thrombotic complications in von Willebrand disease patients expression of a multifactorial disease?
Franchini M, Salvagno GL, Manzato F, Lippi G. Haematologica 2005;90 Suppl:ECR34.
114.
Cobalt chloride administration in athletes: a new perspective in blood doping? Lippi G, Franchini M, Guidi GC.
Br J Sports Med 2005;39:872-3.
115.
Predicting cardiac outcomes. Lippi G, Montagnana M, Guidi GC. CMAJ – Can Med Assoc J 2005;173:1206-7.
116.
Stability of blood cell counts, hematologi c parameters and reticulocytes indexes on the Advia A120
hematologic analyzer. Lippi G, Salvagno GL, Solero GP, Franchini M, Guidi GC. J Lab Clin Med 2005;146:333-40.
117.
Lo screening preoperatorio di laboratorio. Lippi G, Montagnana M, Mattiuzzi C, Franchini M, Alberti V, Guidi GC.
Minerva Med 2005;96:397-407.
118.
Preanalytical variability. Lippi G, Bassi A, Guidi GC. RIMeL/IJLM 2006;2:24-31.
119.
Recommendation for the execution of the oral glucose tolerance test for the diagnosis of diabetes mellitus.
Andreani P, Caldini A, Carta MR, Cerotti F, Falorni A, Ferrai G, Ghiara F, Giordani E, Graziani M, Lapolla A, Lippi
G, Lo Cascio C, Maccaroni I, Malloggi L, Marra M, Massi -Benedetti M, Migali E, Montagnana M, Musso M, Paleari R,
Pegoretti G, Tomassoni ML, Testa R, Mosca A, per il Gruppo di Studio Intersocietario Diabete Mellito. Biochim Clin
2006;30:482-6; RIMeL/IJLM 2006;2:331-4.
120.
Plasma D-dimer concentration in patients with systemic sclerosis. Lippi G, Volpe A, Caramaschi P, Salvagno GL,
Montagnana M, Guidi GC. Thromb J 2006;4:2.
121.
Laboratory quality improvement by implementation of phlebotomy guidelines. Lippi G, Mattiuzzi C, Guidi GC.
MLO Med Lab Obs 2006;38:6-7.
122.
Interference of blood cell lysis on routine coagulation testing. Lippi G, Montagnana M, Salvagno GL, Guidi GC .
Arch Pathol Lab Med 2006 130:181-4.
123.
Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Lippi G, Caramaschi P, Montagnana M,
Salvagno GL, Volpe A, Guidi GC. Clin Chim Acta 2006;364:345-8.
124.
Ischemia Modified Albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease.
Montagnana M, Lippi G, Fava C, Minuz P, Lechi Santonastaso C, Arosio E, Guidi GC. Clin Chem Lab Med
2006;44:207-12.
125.
Recent acquisitions in the pathophysiology, diagnosis and
coagulation. Franchini M, Manzato F, Lippi G. Thromb J 2006;4:4.
126.
Influence of centrifuge temperature on routine coagulation testing. Lippi G, Salvagno GL, Montagnana M, Poli
G, Guidi GC. Clin Chem 2006;52:537-8.
127.
Influence of hemolysis on routine clinical chemistry testing. Lippi G, Salvagno GL, Montagnana M, Brocco G,
Guidi GC. Clin Chem Lab Med 2006;44:311-6.
128.
Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Lippi
G, Montagnana M, Guidi GC. Int J Cardiol 2006;108:410-1.
129.
Comparison of the lipid profile and lipoprotein[a] between sedentary and highly trained subjects. Lippi G,
Schena F, Salvagno GL, Montagnana M, Balestrieri F, Guidi GC. Clin Chem Lab Med 2006;44:322-6.
130.
Inherited thrombophilia. Franchini M, Veneri D, Salvagno GL, Manzato F, Lippi G. Crit Rev Clin Lab Sci
2006;43:249-90.
131.
Influence of warfarin therapy on activated factor VII clotting activity. Lippi G, Montagnana M, Salvagno GL,
Poli G, Franchini M, Guidi GC. Blood Coagul Fibrinolysis 2006;17:221-4.
132.
Preanalytical variability: the dark side of the moon in laboratory testing. Lippi G, Guidi GC, Mattiuzzi C,
Plebani M. Clin Chem Lab Med 2006;44:358-65.
133.
Influence of physical exercise and relationship with biochemical variables of NT -pro-brain natriuretic peptide
and ischemia modified albumin. Lippi G, Salvagno GL, Montagnana M, Schena F, Balestrieri F, Guidi GC. Clin
Chim Acta 2006;367:175-80.
treatment
of
disseminate d
intravascular
134.
Plasma D-dimer variation following elective orthopedic surgery. Lippi G, Montagnana M, Regis D, Viola G, Guidi
GC. Blood Coagul Fibrinolysis 2006;17:87-8.
135.
Drugs and competitive sports. Lippi G, Guidi GC. Clin J Sport Med 2006;16:181.
136.
D-dimer concentration is not influenced by previous physical activity. Lippi G, Schena F, Salvagno GL,
Montagnana M, Guidi GC. Thromb Res 2006;117:731-2.
137.
Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. Lippi G,
Montagnana M, Salvagno GL, Guidi GC. Can J Emerg Med 2006;8:27-31.
138.
Efficacy of desmopressin in preventing hemor rhagic complications in a patient with Marfan syndrome
undergoing cardiac surgery. Franchini M, Lippi G, Veneri D. Blood Coagul Fibrinolysis 2006;17:325-6.
139.
High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebr and
disease. Franchini M, Veneri D, Poli G, Manzato F, Salvagno GL, Lippi G. Am J Hematol 2006;81:465-7.
140.
The influence of the tourniquet time on hematological testing for antidoping purposes. Lippi G, Salvagno GL,
Solero GP, Guidi GC. Int J Sports Med 2006;27:359-62.
141.
Biochemistry, physiology and complications of blood doping: facts and speculation. Lippi G, Franchini M,
Salvagno GL, Guidi GC. Crit Rev Clin Lab Sci 2006;43:349-91.
142.
Preanalytic errors tracking in a laboratory medicine department. Results of a one-year experience. Lippi G,
Bassi A, Brocco G, Montagnana M, Salvagno GL, Guidi GC. Clin Chem 2006;52:1142-3.
143.
Relationship between serum creatinine values and body mass index in elite athletes of different sports. Banfi
G, Del Fabbro M, Lippi G. Br J Sports Med 2006;40:675-8.
144.
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients
with mild/moderate haemophilia A. Franchini M, Girelli D, Olivieri O, Castaman G, Lippi G, Poli G, Salvagno GL,
Tagariello G, Giuffrida A, De Gironcoli M, Morfini M, Berntorp E, Gandini G. Haemophilia 2006;12:448-51.
145.
Nonsteroidal anti-inflammatory drugs in athletes. First do not harm. Lippi G, Franchini M, Guidi GC. Br J Sports
Med 2006;40:661-2.
146.
Phlebotomy issues and quality improvement in results of laboratory testing. Lippi G, Salvagno GL, Montagnana
M, Franchini M, Guidi GC. Clin Lab 2006;52:217-30.
147.
Laboratory Medicine in the 2000s: programmed death or rebirth? Guidi GC, Lippi G. Clin Chem Lab Med
2006;44:913-7.
148.
Blood doping by cobalt. Should we measure cobalt in athletes? Lippi G, Franchini M, Guidi GC. J Occup Med
Toxicol 2006;1:18.
149.
The efficacy of rituximab in the treatment of inhibitor -associated hemostatic disorders. Franchini M, Veneri D,
Lippi G, Stenner R. Thromb Haemost 2006;96:119-25.
150.
Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry
testing. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Clin Chem Lab Med 2006;44:1009-14.
151.
Inhibitors in mild/moderate hemophilia A: an update. Franchini M, Salvagno GL, Lippi G. Thromb Haemost
2006;96:113-8.
152.
Comparison of platelet function between sedentary individuals and competitive athletes at rest. Lippi G,
Montagnana M, Salvagno GL, Franchini M, Guidi GC. Thromb J 2006;4:10.
153.
Quality and reliability of routine coagulation testing. Can we trust that sample? Lippi G, Franchini M,
Montagnana M, Salvagno GL, Poli P, Guidi GC. Blood Coagul Fibrinolysis 2006;17:513-9.
154.
Reliability of the Thrombin Generation Assay on frozen - thawed platelet rich plasma. Lippi G, Salvagno GL,
Montagnana M, Guidi GC. Clin Chem 2006;52:1827-8.
155.
The skilled phlebotomist. Lippi G, Salvagno GL, Montagnana M, Guidi GC. Arch Pathol Lab Med 2006;130:1260-1.
156.
Low levels of activated factor VII in systemic scle rosis. Volpe A, Salvagno GL, Lippi G, Caramaschi P,
Montagnana M, Canestrini S, Carletto A, Bambara LM, Biasi D, Guidi GC. J Thromb Thrombolysis 2006;22:133-8.
157.
Health benefits of physical activity. Lippi G, Schena F, Guidi GC. CMAJ - Can Med Assoc J 2006;175:776.
158.
Influence of the needle bore size on platelet count and routine coagulation testing. Lippi G, Salvagno GL,
Montagnana M, Poli G, Guidi GC. Blood Coagul Fibrinolysis 2006;17:557-61.
159.
Managing transferability of laboratory data. Guidi GC, Lippi G, Solero GP, Poli G, Plebani M. Clin Chim Acta
2006;374:57-62.
160.
Preanalytic indicators of laboratory performances and quality improvement of laboratory testing. Lippi G,
Guidi GC. Clin Lab 2006;52:457-62.
161.
Evaluation of four portable self-monitoring blood glucose meters. Lippi G, Salvagno GL, Guidi GC, Negri M,
Rizzotti P. Ann Clin Biochem 2006;43:408-13.
162.
Venous stasis and routine hematologic testing. Lippi G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Clin
Lab Haematol 2006:28:332-7.
163.
Evaluation of cardiac involvement following major orthopedic surgery. Montagnana M, Lippi G, Regis D, Fava C,
Viola G, Bartolozzi P, Guidi GC. Clin Chem Lab Med 2006;44:1340-6.
164.
Readers' Response and Author's Reply to "Laboratory Results That Should Be Ignored". Lippi G, Guidi GC,
Elston DM. MedGenMed 2006;8:38.
165.
Von Willebrand factor and thrombosis. Franchini M, Lippi G. Ann Hematol 2006;85:415-23.
166.
Thyroid status in patients with Systemic Sclerosis. Lippi G, Caramaschi P, Montagnana M, Salvagno GL, Volpe A,
Guidi GC. J Clin Rheumatol 2006;12:322-4.
167.
Blood transfusions in athletes. Old dogmas, new tricks. Lippi G, Banfi G. Clin Chem Lab Med 2006;44:1395-402.
168.
The use of recombinant activated factor VII in congenital and acquired von Willebrand disease. Franchini M,
Veneri D, Lippi G. Blood Coagul Fibrinolysis 2006;17:615-9.
169.
National survey on the pre-analytical variability in a representative cohort of Italian laboratories. Lippi G,
Montagnana M, Giavarina D. Clin Chem Lab Med 2006:44;1491-4.
170.
Legal regulation and medico-forensic aspects of the current anti-doping legislation. Lippi G, Mattiuzzi C, Guidi
GC. Minerva Medicoleg 2006;126:383-9.
171.
Inherited factor XI deficiency: a concise review. Franchini M, Veneri D, Lippi G. Hematology 2006;11:307-9.
172.
Evaluation of cardiac laboratory marke rs in patients with systemic sclerosis. Montagnana M, Lippi G, Volpe A,
Salvagno GL, Biasi D, Caramaschi P, Guidi GC. Clin Biochem 2006;39:913-7.
173.
Determination of Ischemia Modified Albumin in emergency medicine. Lippi G, Montagnana M, Guidi GC.
RIMeL/IJLM 2007;3:88-93.
174.
Recommendations for detection and management of unsuitable samples in clinical laboratories. Lippi G, Banfi
G, Buttarello M, Cerotti F, Daves M, Dolci A, Caputo M, Giavarina D, Montagnana M, Miconi V, Milanesi B, Mosca A,
Morandini M, Salvagno GL. Biochim Clin 2007;31:216-24; RIMeL/IJLM 2007;3:124-34.
175.
The management of patients with congenital von Willebrand disease during surgery or other invasive
procedures: Focus on antihemophilic factor/von Willebrand factor complex. Franchini M, Lippi G. Biologics
2007;1:285-9.
176.
Diagnostic approach to the inherited bleeding disorders. Lippi G, Franchini M, Guidi GC. Clin Chem Lab Med
2007;45:2-12.
177.
Recent acquisitions in acquired and congenital von Willebrand disorders. Franchini M, Lippi G. Clin Chim Acta
2007;377:62-9.
178.
Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation.
Salvagno GL, Astermark J, Ekman M, Franchini M, Guidi GC, Lippi G, Poli G, Berntorp E. Haemophilia 2007;13:516.
179.
The use of recombinant activated factor VII in obstetrical and gynaecological haemorrhage. Franchini M, Lippi
G, Franchi M. BJOG 2007;114:8-15.
180.
Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte platelet aggregates. Lippi G, Montagnana M, Salvagno GL, Cicorella N, Minuz P, Lechi C, Guidi GC. Int J Cardiol
2007;115:101-2.
181.
Standardization of ischemia modified albumin testing: adjustment for serum albumin. Lippi G, Montagnana M,
Salvagno GL, Guidi GC. Clin Chem Lab Med 2007;45:261-2.
182.
Multiple biomarkers for the prediction of first major cardiovascular events and death: considerable costs and
limited benefits. Lippi G, Salvagno GL, Targher G, Guidi GC. MedGenMed 2007;9:34.
183.
Inflammation and hemostasis: a bidirectional interactio n. Franchini M, Veneri D, Lippi G. Clin Lab 2007;53:6368.
184.
The role of von Willebrand factor in hemorrhagic and thrombotic disorders. Franchini M, Lippi G. Crit Rev Clin
Lab Sci 2007;44:115-49.
185.
Lipoprotein(a), thrombophilia and venous thrombosis. Lippi G, Targher G, Franchini M. Acta Haematol
2007;117:246-7.
186.
Lipoprotein(a), athero-thrombosis and longevity. A historical paradox finally elucidated? Lippi G, Franchini M,
Guidi GC. Haematologica 2007;92:e48.
187.
Drug-induced anti-factor VIII antibodies: A systemat ic review. Franchini M, Capra F, Nicolini N, Veneri D,
Manzato F, Baudo F, Lippi G. Med Sci Monit 2007;13:RA55-61.
188.
Antagonists of activated factor X and thrombin: innovative antithrombotic agents. Franchini M, Lippi G. Curr
Vasc Pharmacol 2007;5:121-8.
189.
Lipid and lipoprotein profile in physiological pregnancy. Lippi G, Albero A, Montagnana M, Salvagno GL,
Scevarolli S, Franchi M, Guidi GC. Clin Lab 2007;53:173-7.
190.
Plasma PAI-1 levels are increased in patients with non-alcoholic steatohepatitis. Targher G, Bertolini L, Scala
L, Zenari L, Lippi G, Franchini M, Arcaro G. Diabetes Care 2007;30:e31-2.
191.
Is the activated partial thromboplastin time suitable to screen for von Willebrand Factor deficiencies? Lippi
G, Franchini M, Poli G, Salvagno GL, Montagnana M, Guidi GC. Blood Coagul Fibrinolysis 2007;18:361-4.
192.
The role of Ethylene Diamine Tetraacetic Acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Banfi
G, Salvagno GL, Lippi G. Clin Chem Lab Med 2007;45:565-76.
193.
The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
Lippi G, Franchini M, Targher G, Poli P, Guidi GC. Clin Chim Acta 2007;381:167-70.
194.
The International Cycling Union unveils new anti-doping program. How much is enough? Lippi G. Int J Sports
Med 2007;28:446-7.
195.
Alanine aminotransferase as an independent predictor of incident nonalcoholic fatty liver disease. Targher G,
Franchini M, Guidi GC, Muggeo M, Lippi G. Clin Chem 2007;53:1159.
196.
The growing impact of publications in hemostasis and thrombosis j ournals. Lippi G, Franchini M. Thromb
Haemost 2007;97:1049-50.
197.
How many troponins should we measure to get a clinically significant result? Lippi G, Salvagno GL, Montagnana
M, Guidi GC. Q J Med 2007;100:389-90.
198.
Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et
al. Targher G, Bertolini L, Zoppini G, Lippi G, Zenari L. Diabetes Care 2007;30:e51.
199.
Measurement of Elecsys NT-proBNP in serum, K2 EDTA and heparin plasma. Lippi G, Salvagno GL, Montagnana
M, Guidi GC. Clin Biochem 2007;40:747-8.
200.
Ginkgo biloba, inflammation and lipoprotein(a). Lippi G, Targher G, Guidi GC. Atherosclerosis 2007;195:417-8.
201.
Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy. Lippi G, Targher G,
Franchini M. Thromb Haemost 2007;97:1059-60.
202.
Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. Franchini M, Montagnana M, Targher G,
Manzato F, Lippi G. J Thromb Thrombolysis 2007;24:29-38.
203.
Increased D-dimer value and occult cancer in the absence of detectable thrombosis. Lippi G, Franchini M,
Biasiutti C, Dellagiacoma G, Salvagno GL, Guidi GC. Haematologica 2007;92:e053.
204.
New strategies for noninvasive screening and prenatal diagnosis: the cell -free fetal DNA in maternal blood.
Montagnana M, Lippi G, Guidi GC. Minerva Ginecol 2007;59:331-41.
205.
Risk management in the preanalytical phase of laboratory testing. Lippi G, Guidi GC. Clin Chem Lab Med
2007;45:720-7.
206.
Recommendations for detection and management of unsuitable samples in clinical laboratories. Lippi G, Banfi
G, Buttarello M, Cerotti F, Daves M, Dolci A, Caputo M, Giavarina D, Montagnana M, Miconi V, Milanesi B, Mosca A,
Morandini M, Salvagno GL. Clin Chem Lab Med 2007;45:728-36.
207.
Influence of the centrifuge time of primary plasma tu bes on routine coagulation testing. Lippi G, Salvagno GL,
Montagnana M, Manzato F, Guidi GC. Blood Coagul Fibrinolysis 2007;18:525-8.
208.
One hundred years of laboratory testing and patient safety. Lippi G, Guidi GC, Plebani M. Clin Chem Lab Med
2007;45:797-8.
209.
Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with
inhibitors. Franchini M, Zaffanello M, Veneri D, Lippi G. Pediatr Blood Cancer 2007;49:6-10.
210.
Influence of primary sample mixing on routine coagulation testing. Lippi G, Salvagno GL, Montagnana M, Guidi
211.
Measurement of beta-CTX in lithium heparin plasma. Lippi G, Brocco G, Dima F, Guidi GC. Clin Lab
2007;53:453-4.
212.
The paradox in translational medicine. Lippi G, Plebani M, Guidi GC. Clin Chem 2007;53:1553.
213.
Genetic analysis to prevent warfarin complications. Lippi G, Salvagno GL, Guidi GC. CMAJ - Can Med Assoc J
2007;177:377.
214.
Appropriateness of theophylline plasma levels. Lippi G, Salvagno GL, Brocco G, Guidi GC. Arch Pathol Lab Med
2007;131:1166.
215.
Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with
disseminated intravascular coagulation: a systematic review. Franchini M, Manzato F, Salvagno GL, Lippi G.
216.
Relationship between mean platelet volume and biochemical components of the metabolic syndrome. Lippi G,
Salvagno GL, Targher G, Guidi GC. Clin Drug Investig 2007;27:731-2.
217.
Preparation of a quality sample: effect of centrif ugation time on stat clinical chemistry testing. Lippi G,
Salvagno GL, Montagnana M, Guidi GC. Lab Medicine 2007;38:172-6.
218.
Genetic factors for warfarin dose prediction. Lippi G, Salvagno GL, Guidi GC. Clin Chem 2007:53:1721-2.
219.
Influence of the sample matrix on the stability of beta-CTX at room temperature for 24 and 48 hours. Lippi G,
Brocco G, Salvagno GL, Montagnana M, Guidi GC, Schmidt -Gayk H. Clin Lab 2007;53:455-9.
220.
Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population. Lippi G,
Targher G, Montagnana M, Salvagno GL, Guidi GC. Clin Chim Acta 2007;384:163-6.
221.
Chronic influence of demanding physical exercise on venous blood -gas status. Lippi G, Schena F, Franchini M,
Guidi GC. J Sci Med Sport 2007;10:288-90.
222.
Monitoring glycaemic control: is there evidence for an appropriate use of routine measurement of glycated
haemoglobin? Salvagno GL, Lippi G, Targher G, Montagnana M, Guidi GC. Clin Chem Lab Med 2007;45:1065-7.
223.
Relationhip between Lipopriotein(a) and fasting pl asma glucose in the general population. Lippi G, Targher G,
Salvagno GL, Montagnana M, Guidi GC. Eur J Clin Invest 2007;37:826-7.
224.
Effect of serum gamma-glutamyltransferase and obesity on the risk of dyslipidemia and poor glycemic control
in type 2 diabetic patients. Cross-sectional findings from the Verona Diabetes Study. Targher G, Zoppini G,
Lippi G, Guidi GC, Muggeo M. Clin Chem 2007;53:1867-9.
225.
Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur. Lippi G, Fortunato
A, Salvagno GL, Montagnana M, Soffiati G, Guidi GC. J Clin Lab Anal 2007;21:293-7.
226.
The cost-benefit ratio of screening pregnant women for thrombophilia. Salvagno GL, Lippi G, Franchini M,
Targher G, Montagnana M, Franchi M, Guidi GC. Blood Transfus 2007;5:189-203.
227.
Relationship between ABO blood groups and von Willebrand factor levels: from biology to clinical
implications. Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Thromb J 2007;5:14.
228.
Influence of haemodialysis on the NT-proBNP plasma concentration. Lippi G, Tessitore N, Salvagno GL,
Montagnana M, Lupo A, Guidi GC. Clin Chem Lab Med 2007;45:1414-5.
229.
Relationship between {gamma}-Glutamyltransferase, Fasting Plasma Glucose, and Triglycerides in the General
Population. Lippi G, Targher G, Guidi GC. Clin Chem 2007;53:1866-7.
230.
Relationship between lipoprotein(a) and thyroid status in the general population. Lippi G, Targher G,
Montagnana M, Salvagno GL, Guidi GL. Arch Med Res 2007;38:905-6.
231.
Has homocysteine shrunk? Lippi G, Targher G, Franchini M, Guidi GC. Clin Chem Lab Med 2007;45:1419-20.
232.
National survey on critical values reporting in a cohort of Italian laboratories. Lippi G, Giavarina D,
Montagnana M, Salvagno GL, Cappelletti P, Plebani M, Guidi GC. Clin Chem Lab Med 2007;45:1411-3.
233.
Acquired von Willebrand syndrome: an update. Franchini M, Lippi G. Am J Hematol 2007;82:368-75.
234.
Lipoprotein[a] and cancer: antineoplastic effect besides its cardiovascular potency. Lippi G, Franchini M,
Salvagno GL, Guidi GC. Cancer Treat Rev 2007;33:427-36.
235.
Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and
autoantibody patterns in systemic sclerosis. Montagnana M, Volpe A, Lippi G, Caramaschi P, Salvagno GL, Biasi
D, Bambara LM, Guidi GC. Clin Biochem 2007;40:837-42.
236.
The potential role of recombinant activated FVII in the management of critical oncohematological bleeding: a
systematic review. Franchini M, Lippi G. Bone Marrow Transplant 2007;39:729-35.
237.
Routine coagulation tests in newborn and young infants. Lippi G, Salvagno GL, Rugolotto S, Chiaffoni GP,
Padovani EM, Franchini M, Guidi GC. J Thromb Thrombolysis 2007;24:153-5.
238.
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular
events in type 2 diabetic patients. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G.
Diabetes Care 2007;30:2119-21.
239.
The role of iron in diabetes and its complications: reponse to swaminathan et al. Targher G, Franchini M,
Montagnana M, Lippi G. Diabetes Care 2007;30:e132.
240.
Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community -dwelling
older adults: response to reis et al. Lippi G, Montagnana M, Targher G, Guidi GC. Diabetes Care 2007;30:e135.
241.
Vitamin D3 deficiency among Italian childre n. Lippi G, Montagnana M, Targher G. CMAJ - Can Med Assoc J
2007;177:1529-30.
242.
Prohibition of artificial hypoxic environments in sports: health risks beside ethics. Lippi G, Franchini M, Guidi
GC. Appl Physiol Nutr Metab 2007;32:1206-7.
243.
Serum ferritin levels correlate with haemoglobin concentration: a report on 589 outpatients from a single
centre. Franchini M, Salvagno GL, Montagnana M, Lippi G. Blood Transfus 2007;5:244-5.
244.
Evaluation of different mixing procedures for K2 EDTA primary samples on hematologic al testing. Lippi G,
Salvagno GL, Montagnana M, Banfi G, Guidi GC. Lab Medicine 2007;38:723-5.
245.
Improving appropriateness of Prostate -Specific Antigen screening. Lippi G, Montagnana M, Guidi GC. Arch
Intern Med 2007;167:2529-30.
246.
Appropriateness of serum digoxin levels. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Eur J Clin
Pharmacol 2007;63:1201-2.
247.
Coagulation testing in pediatrics: the young are not just miniature adults. Lippi G, Franchini M, Montagnana M,
Guidi GC. Semin Thromb Hemost 2007;33:816-20.
248.
Evolution of technical regulations and drivers’ safety in top class motor sports. Lippi G, Salvagno GL, Franchini
M, Guidi GC. Br J Sports Med 2007;41:922-5.
249.
Prevalence and type of preanalytical errors on inpatient samples referred for complete blo od count. Lippi G,
Bassi A, Solero GP, Salvagno GL, Guidi GC. Clin Lab 2007;53:555-6.
250.
Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other
diseases. Franchini M, Montagnana M, Targher G, Lippi G. Semin Thromb Hemost 2007;33:787-97.
251.
Genomics and proteomics in venous thromboembolism: building a bridge towards a rational personalized
medicine framework. Lippi G, Franchini M, Montagnana M, Guidi GC. Semin Thromb Hemost 2007;33:759-70.
252.
Tour de chaos. Lippi G, Franchini M, Guidi GC. Br J Sports Med 2007;41:625-6.
253.
Analytical performances of the D-dimer assay for the Immulite 2000 automated immunoassay analyzer. Lippi
G, Salvagno GL, Rossi L, Montagnana M, Franchini M, Guidi GC. Int J Lab Hematol 2007;29:415-20.
254.
Prophylaxis in von Willebrand disease. Franchini M, Targher G, Lippi G. Ann Hematol 2007;86:699-704.
255.
Influence of haemodialysis on lipoprotein(a), high sensitivity -C Reactive Protein, apolipoprotein A and B.
Lippi G, Tessitore N, Salvagno GL, Bedogna V, B assi A, Montagnana M, Lupo A, Guidi GC. Clin Biochem
2007;40:1336-8.
256.
Recommendations for detection and management of critical values in clinical laboratories. Lippi G, Caputo M,
Banfi G, Buttarello M, Cerotti F, Daves M, Dolci A, Montagnana M, Mosca A, Mic oni V, Milanesi B, Morandini M,
Piva E, Salvagno GL, Giavarina D, per il Gruppo di Studio Intersocietario SIBioC -SIMeL-CISMEL sulla variabilità
extra-analitica del dato di laboratorio. Biochim Clin 2008;32:209-16; RIMeL/IJLM 2008;4:28-35.
257.
Governance of preanalytical variability and error detection. Lippi G. J Med Biochem 2008;27:337-8.
258.
Recommendations for collection of venous blood. Lippi G, Caputo M, Banfi G, Buttarello M, Cerotti F, Daves M,
Dolci A, Montagnana M, Miconi V, Milanesi B, Morandini M, Piva E, Salvagno GL, Giavarina D, per il Gruppo di
Studio Intersocietario SIBioC-SIMeL-CISMEL sulla variabilità extra-analitica del dato di laboratorio. Biochim Clin
2008;32:569-77; RIMeL/IJLM 2008;4:249-58.
259.
The growing trend of scientific interest in sports s cience research. Lippi G, Guidi GC, Nevill A, Boreham C. J
Sports Sci 2008;26:1-2.
260.
Laboratory errors and Medicare's new reimbursement rule. Lippi G, Guidi GC. Lab Medicine 2008;39:5-6.
261.
Influence of sampling time and ultrafiltration coefficient of the dialy sis membrane on cardiac troponin I and
T. Lippi G, Tessitore N, Montagnana M, Salvagno GL, Lupo A, Guidi GC. Arch Pathol Lab Med 2008;132:72-6.
262.
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic
patients. Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G. Diabet Med
2008;25:45-50.
263.
Glycaemic control in athletes. Lippi G, Montagnana M, Salvagno GL, Franchini M, Guidi GC. Int J Sports Med
2008;29:7-10.
264.
Inherited platelet disorders. Franchini M, Lippi G, Veneri D, Targher G, Zaffanello M, Guidi GC. Clin Chim Acta
2008;387:1-8.
265.
Effect of hemodialysis on traditional and innovative cardiac markers. Montagnana M, Lippi G, Tessitore N,
Salvagno GL, Targher G, Gelati M, Lupo A, G uidi GC. J Clin Lab Anal 2008;22:59-65.
266.
New strategies for doping control. Lippi G, Banfi G, Franchini M, Guidi GC. J Sports Sci 2008;26:441-5.
267.
Genomics and sports: building a bridge toward a rational and personalized training framework. Lippi G. Int J
Sports Med 2008;29:264-5.
268.
Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens. Lippi G. Clin
Chem Lab Med 2008;46:426.
269.
Abolishing the law of gravity. Lippi G. CMAJ - Can Med Assoc J 2008;178:598.
270.
Relationship between Von Willebrand factor, cholesterol and triglycerides in non -diabetic subjects. Lippi G,
Targher G, Franchini M, Salvagno GL, Montagnana M, Guidi GC. Nutr Metab Cardiovasc Dis 2008;8:E3-4.
271.
Relationship between serum vitamin D and inflammatory markers in the general population: Comment on the
article by Patel et al. Lippi G, Montagnana M, Targher G, Guidi GC. Arthritis Rheum 2008;58:913-4.
272.
Should women with abnormal serum thyroid stimulating hormone undergo screening for anemia? Lippi G,
Montagnana M, Salvagno GL, Guidi GC. Arch Pathol Lab Med 2008;132:321-2.
273.
Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory. Salvagno GL,
Lippi G, Bassi A, Poli G, Guidi GC. J Eval Clin Pract 2008;14:351-3.
274.
Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood
pressure. Fava C, Montagnana M, Rosberg L, Burri P, Almgren P, Jonsson A, Wanby P, Lippi G, Minuz P, Hulthen
LU, Aurell M, Melander O. Hum Mol Genet 2008;17:413-8.
275.
N-Terminal proB-type natriuretic peptide (NT-proBNP) concentrations in elite rugby players at rest and after
active and passive recovery following strenuous training sessions. Banfi G, D'Eril GM, Barassi A, Lippi G. Clin
Chem Lab Med 2008;46:247-9.
276.
Wisdom of theragnostics, other changes. Lippi G. MLO Med Lab Obs 2008;40:6.
277.
Serum pro-inflammatory cytokines in physiologic and preeclamptic pregancies. Montagnana M, Lippi G, Albiero
A, Salvagno GL, Franchi M, Guidi GC. Gynecol Endocrinol 2008;24:113-6.
278.
Clinical, laboratory and therapeutic aspects of platelet -type von Willebrand Disease. Franchini M, Montagnana
M, Lippi G. Int J Lab Hematol 2008;30:91-4.
279.
The erythrocyte mean corpuscular volume is associated with serum levels of thyroid stimulating hormone in
women. Montagnana M, Lippi G, Franchini M, Guidi GC. Am J Hematol 2008;83:258.
280.
Pistorius ineligible for the Olympic Games: the right decision. Lippi G, Mattiuzzi C. Br J Sports Med
2008;42:160-1.
281.
The appropriateness of colorectal cancer screening by faecal occult bloo d tests. Lippi G, Brocco G, Guidi GC.
Am J Gastroenterol 2008;103:800-1.
282.
Comparison of creatinine-based estimations of glomerular filtration rate in endurance athletes at rest. Lippi
G, Banfi G, Luca Salvagno G, Montagnana M, Franchini M, Cesare Guidi G . Clin Chem Lab Med 2008;46:235-9.
283.
Switch off the light on cycling, switch off the light on doping. Lippi G, Franchini M, Guidi GC. Br J Sports Med
2008;42:162.
284.
D-dimer testing in pregnancy: clinically useful, but at what cost? Lippi G, Montagnana M. Ann Intern Med
2008;148:484.
285.
N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH. Simeoni S, Lippi G, Puccetti A,
Montagnana M, Tinazzi E, Prati D, Corrocher R, Lunardi C. Rheumatol Int 2008;28:657-60.
286.
The power of negative thinking. Lippi G, Guidi GC. Am J Emerg Med 2008;26:373-4.
287.
Cardiac troponins in pediatric myocarditis. Lippi G, Salvagno GL, Guidi GC. Pediatrics 2008;121:864.
288.
Iron and thrombosis. Franchini M, Targher G, Montagnana M, Lippi G. Ann Hematol 2008;87:167-73.
289.
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected
outpatients. Targher G, Montagnana M, Salvagno GL, Mughetti P, Zoppini G, Muggeo M, Lippi G. Clin Endocrinol
2008;68:481-4.
290.
Is estimated glomerular filtration rate suitabl e for stratification of chronic kidney disease? Lippi G, Salvagno
GL, Guidi GC. Scand J Clin Lab Invest 2008;68:254-5.
291.
A critical review on the use of recombinant factor VIIa in life -threatening obstetric postpartum hemorrhage.
Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G. Semin Thromb Hemost 2008;34:104-12.
292.
Plasma gamma-glutamyl transferase activity predicts homocysteine concentration in a large cohort of
unselected outpatients. Lippi G, Salvagno GL, Targher M, Montagnana M, Guid i GC. Intern Med 2008;47:705-7.
293.
Quality improvement in laboratory medicine. Focus on extra -analytical issues. Lippi G, Fostini R, Guidi GC.
Clin Lab Med 2008;28:285-94.
294.
Metformin for the treatment of the polycystic ovary syndrome. Targher G, Lippi G, Moghetti P. N Engl J Med
2008;358:1867.
295.
Dishomogeneous separation of citrated plasma in primary collection tubes for routine coagulation testing.
Lippi G, Salvagno GL, Bassi A, Montagnana M, Poli G, Guidi GC. Blood Coagul Fibrinolysis 2008;19:330-2.
296.
Glomerular filtration rate in endurance athletes. Lippi G, Banfi G, Salvagno GL, Franchini M, Guidi GC. Clin J
Sport Med 2008;18:286-88.
297.
Relationship between thyroid status and renal function in a general population of unselected outpatients.
Lippi G, Montagnana M, Targher G, Salvagno GL, Guidi GC. Clin Biochem 2008;41:625-7.
298.
Comment on effects of microwave cooking conditions on bioactive compounds present in broccoli
inflorescences. Lippi G, Salvagno GL, Montagnana M, Guidi GC. J Agric Food Chem 2008;56:2296.
299.
The paradoxical relationship between serum uric acid and cardiovascular disease. Lippi G, Montagnana M,
Franchini M, Favaloro EJ, Targher G. Clin Chim Acta 2008;392:1-7.
300.
Plasma D-dimer in the diagnosis of acute aortic dissection. Salvagno GL, Targher G, Franchini M, Lippi G. Eur
Heart J 2008;29:1207.
301.
Comparison of two methods for the calculation of estimated glomerular filtration rate. Lippi G, Montagnana M,
Banfi G, Guidi GC. Lab Medicine 2008;39:35-7.
302.
Sudden cardiac death: prevalence, pathogenesis and prevention . Montagnana M, Lippi G, Franchini M, Targher
G, Guidi GC. Ann Med 2008;40:360-75.
303.
Endometriosis and oxidative stress-serum markers? Montagnana M, Lippi G, Albiero A, Franchi M, Guidi CG.
Fertil Steril 2008;89:1282-3.
304.
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney
disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Targher G, Bertolini L, Rodella
S, Zoppini G, Lippi G, Day C, Muggeo M. Diabetologia 2008;51:444-50.
305.
Acute variation of osteocalcin and parathyroid hormone in athletes after running a half -marathon. Lippi G,
Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Clin Chem 2008;6:1093-5.
306.
Cardiovascular events during World Cup Soccer. Lippi G, Targher G. N Engl J Med 2008;358:2408.
307.
Distribution of creatine kinase in the general population: implications for statin therapy. Lippi G, Banfi G. Am
Heart J 2008;155:e51.
308.
The genetic basis of human athletic performance. Why are psychological components so often overl ooked?
Lippi G, Favaloro EJ, Guidi GC. J Physiol 2008;586:3017.
309.
Cardiac biomarkers in pulmonary embolism. Lippi G, Favaloro EJ. Thromb Haemost 2008;99:1134-6.
310.
Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Lippi G,
Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, Vassault AJ, Plebani M. Clin Chem Lab Med 2008;46:764-72.
311.
Natriuretic peptides for assessing the prognosis of acute pulmonary embolism. Lippi G, Targher G, Goldhaber
SZ. Chest 2008;133:1531-2.
312.
Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta -analysis.
Franchini M, Mengoli C, Veneri D, Mazzi R, Lippi G, Cruciali M. J Antimicrob Chemother 2008 61:1191-1200.
313.
Relationship between serum testosterone and ca rdiovascular risk profile in the general population.
Montagnana M, Lippi G. Arch Intern Med 2008;168:1350.
314.
Comment to: Recombinant erythropoietin found in seized blood bags from sportsmen. Haematologica
2008;93:313–4. Lippi G, Franchini M, Kayser B. Haematologica 2008;93:e55.
315.
Role of biochemical risk factor and markers for the risk of atherosclerosis. Montagnana M, Lippi G, Salvagno
GL, Franchini M, Targher G, Guidi GC. Recenti Prog Med 2008;99:215-22.
316.
Glucose challenge test does not predict gestational dia betes mellitus. Montagnana M, Lippi G, Targher G, Fava
C, Guidi GC. Intern Med 2008;47:1171-4.
317.
The potential contribution of laboratory biomarkers to the diagnosis of pulmonary embolism. Lippi G,
Montagnana M, Guidi GC. Am J Emerg Med 2008;26:624-5.
318.
The use of recombinant factor VIIa in liver diseases. Franchini M, Montagnana M, Targher G, Zaffanello M, Lippi
G. Blood Coagul Fibrinolysis 2008;19:341-8.
319.
Standards of practice and uniformity in references style. Salvagno GL, Lippi G, Montagnana M, Guidi GC. Clin
Chem Lab Med 2008;46:437-8.
320.
Pharmacy-based laboratory services: risk, opportunity or both? Lippi G, Siest G, Plebani M. Clin Chem Lab Med
2008;46:435-6.
321.
Prevalence of folic acid and vitamin B12 deficiencies in patients with thyroid disorders. Lippi G, Montagnana
M, Targher G, Salvagno GL, Guidi GC. Am J Med Sci 2008;336:50-2.
322.
Procalcitonin values in preeclamptic women are related to severity of disease. Montagnana M, Lippi G, Albero
A, Scevarolli S, Salvagno GL, Franchi M, Cesare Guidi G. Clin Chem Lab Med 2008;46:1050-1.
323.
Doping in competition or doping in sport? Lippi G, Franchini M, Guidi GC. Brit Med Bull 2008;86:95-107.
324.
Acquired factor VIII inhibitors. Franchini M, Lippi G. Blood 2008;112:250-5.
325.
Acute kidney injury: time to shift from creatinine to th e estimated glomerular filtration rate? Lippi G, Guidi
GC. Crit Care 2008;12:423.
326.
Sudden cardiac death in young athletes. Montagnana M, Lippi G, Franchini M, Banfi G, Guidi GC. Intern Med
2008;47:1373-8.
327.
Increased risk of CKD among type 2 diabetics with no nalcoholic fatty liver disease. Targher G, Chonchol M,
Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M. J Am Soc Nephrol 2008;19:1564-70.
328.
Acquired factor VIII inhibitors in oncohematology: a systematic review. Franchini M, Targher G, Manzato F,
Lippi G. Crit Rev Oncol Hematol 2008:66:194-9.
329.
Appropriateness of statistical analysis for evaluating results of lipoprotein(a) testing. Lippi G, Guidi GC. Int J
Dermatol 2008;47:973.
330.
The V433M variant of the CYP4F2 is associated with isch emia stroke in male Swedes beyond its effect on
blood pressure. Fava C, Montagnana M, Almgren P, Rosberg L, Lippi G, Hedblad B, Engström G, Berglund G, Minuz
P, Melander O. Hypertension 2008;52:373-80.
331.
High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al. Lippi G, Targher G,
Montagnana M, Salvagno GL, Guidi GC. Diabetes Care 2008;31:e68.
332.
Estimation of glomerular filtration rate by the modification of diet in renal disease (MDRD) equation in
patients with sickle cell disease. Lippi G, De Franceschi L, Salvagno GL, Montagnana M, Guidi GC. Clin Chem Lab
Med 2008;46:1200-1.
333.
Non-homogeneous separation of triglycerides, gamma -glutamyltransferase, C-reactive protein and lactate
dehydrogenase after centrifugation of lithium-heparin tubes. Salvagno GL, Lippi G, Montagnana M, Brocco G,
Guidi GC. Clin Chem Lab Med 2008;46:1180-2.
334.
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Targher G, Bertolini L,
Rodella S, Lippi G, Franchini M, Zoppini G, Mugg eo M, Day CP. Obesity (Silver Spring) 2008;16:1394-9.
335.
Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected
myocardial ischemia. Lippi G, Filippozzi G, Montagnana M, Salvagno GL, Guidi GC. J Thromb Thrombolysis
2008;25:247-50.
336.
Relationship between hypomagnesemia and glucose homeostasis. Montagnana M, Lippi G, Targher G, Salvagno
GL, Guidi GC. Clin Lab 2008;54:169-72.
337.
Undergraduate education in Laboratory Medicine. Guidi GC, Lippi G. Clin Chim Acta 2008;393:9-12.
338.
The holistic approach to teach laboratory medicine. Guidi GC, Lippi G, Plebani M. Clin Chim Acta 2008;393:513.
339.
No correlation between lipoprotein(a) and biochemical markers of renal function in the general population.
Lippi G, Salvagno GL, Montagnana M, Targher G, Franchini M, Guidi GC. Arch Pathol Lab Med 2008;132:1436-8.
340.
Salbutamol in athletes. Lippi G, Franchini M, Favaloro EJ, Guidi GC. Clin J Sport Med 2008;18:469.
341.
Point-of-care testing for measuring hemoglobin A1c: is it really worthwhile? Lippi G, Montagnana M, Targher G.
Am J Clin Pathol 2008;130:646.
342.
Updates on improvement of human athletic performance: focus on world records in athletics. Lippi G, Banfi
G, Favaloro EJ, Rittweger J, Maffulli N. Brit Med Bull 2008;87:7-15.
343.
Acute influence of aerobic physical exercise on procalcitonin. Lippi G, Schena F, Montagnana M, Salvagno GL,
Guidi GC. Eur J Clin Invest 2008;38:784-5.
344.
Reference ranges and diagnostic thresholds of laboratory markers of cardiac damage and dysfunction in a
population of apparently healthy black Africans. Montagnana M, Lippi G, Salvagno GL, Guidi GC. Clin Chem Lab
Med 2008;46:714-6.
345.
Separation of hemoglobin HbE and HbA2 by the fully -automated, high pressure liquid chromatography Tosoh
HLC-723 G7 analyzer. Lippi G, Carta MR, Salvagno GL, Bellorio F, Montagnana M, Soffiati G, Guidi GC. Int J Lab
Hematol 2008;30:432-6.
346.
The metabolic syndrome and the risk of arterial and venous thrombosis. Franchini M, Targher G, Montagnana
M, Lippi G. Thromb Res 2008;122:727-35.
347.
Sputum eosinophils for screening athletes presenting with anti-asthmatic therapeutic use exemption. Lippi G,
Banfi G, Guidi G. Med Sci Sport Exer 2008;40:1707.
348.
The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban
based sample of middle aged Swedes. Montagnana M, Fava C, Nilsson PM, Engström G, Hedblad B, Lippi G, Minuz
P, Berglund G, Melander O. Diabet Med 2008;25:902-8.
349.
Influence of a half-marathon run on NT-proBNP and troponin T. Lippi G, Schena F, Salvagno GL, Montagnana M,
Gelati M, Tarperi C, Banfi G, Guidi GC. Clin Lab 2008;54:251-4.
350.
Creatinine values during a competitive season in elite athletes involved in different sport disciplines. Banfi
G, Del Fabbro M, Lippi G. J Sports Med Phys Fitness 2008 48:479-82.
351.
Influence of stable, long-term treatment with phenobarbital on the activity of serum alanine
aminotransferase and gamma-glutamyltransferase. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Br J Biomed
Sci 2008;65:132-5.
352.
Rivaroxaban for thromboprophylaxis. Lippi G, Franchini M, Targher G. N Engl J Med 2008;359:2174.
353.
Aspirin 'responsiveness', 'non-responsiveness' or 'resistance': a putative role for von Willebrand factor?
Kilanowska J, Favaloro EJ, Lippi G. Blood Coagul Fibrinolysis 2008;19:823-4.
354.
Performance of the automated and rapid HemosIL D-Dimer HS on the ACL TOP analyzer. Salvagno GL, Lippi G,
Montagnana M, Poli G, Giavarina D, Manzato G, Guidi GC. Blood Coagul Fibrinolysis 2008;19:817-821.
355.
Frequency and type of preanalytical errors in a laboratory medicine department i n India. Lippi G, Rattan A.
Clin Chem Lab Med 2008;46:1657-9.
356.
Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Chonchol M, Lippi G,
Salvagno G, Zoppini G, Muggeo M, Targher G. Clin J Am Soc Nephrol 2008;3:1296-300.
357.
Laboratory diagnostics in thrombosis and hemostasis: the past, the present, and the future. Favaloro EJ, Lippi
G, Franchini M. Semin Thromb Hemost 2008;34:579-84.
358.
Activated partial thromboplastin time: new tricks for an old dogma. Lippi G, Favaloro EJ. Semin Thromb
Hemost 2008;34:604-11.
359.
Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Favaloro EJ,
Lippi G, Adcock DM. Semin Thromb Hemost 2008;34:612-34.
360.
Relationship between soluble CD40 ligand and gamma -glutamyltransferase concentrations in non-drinking,
young Type 1 diabetic individuals. Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M. Diabet Med
2008;25:1283-8.
361.
Comments on Delanghe and Joyner's Editorial "Testing for recombinant human erythropoietin". Lippi G, Banfi
G, Mørkeberg J, Belhage B, Damsgaard R, Skibeli V. J Appl Physiol 2008;105:1990-1.
362.
Comments on Lundby et al.'s "Testing for recombinant human erythropoietin in urine: problems associated
with current anti-doping testing". Lippi G, Jelkmann WE, Salvagno GL, Guidi GC, Valeri CR, Ragno G, Kayser B,
Lasne F, Schumacher YO, Pottgiesser T, Mørkeberg J, Belhage B, Damsgaard R, Skibeli V, Saugy M, Robinson N,
Lamon S, Schänzer W, Geyer H. J Appl Physiol 2008;105:1992-6.
363.
Immune tolerance with rituximab in cong enital haemophilia with inhibitors: a systematic literature review
based on individual patients’ analysis. Massimo M, Mengoli C, Lippi G, Targher G, Montagnana M, Salvagno GL,
Zaffanello M, Cruciani M. Haemophilia 2008;14:903-12.
364.
Detection of duplicates and redundancies. A major responsibility of peer-reviewers? Lippi G, Favaloro EJ. Clin
Chem Lab Med 2008;46:1796-7.
365.
Arm blood pressure index and lipoprotein(a) in renal transplant recipients. Lippi G, Franchini M, Targher G.
Transplant Proc 2008;40:3499.
366.
Pathogenesis of venous thromboembolism: When the cup runneth over. Lippi G, Franchini M. Semin Thromb
Hemost 2008;34:747-61.
367.
Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT. Lippi G, Franchini
M, Salvagno GL, Montagnana M, Guidi GC. J Thromb Thrombolysis 2008;26:103-5.
368.
Correlation between von Willebrand Factor Antigen, von Willebrand Factor ristocetin cofactor activity and
Factor VIII activity in plasma. Lippi G, Franchini M, Salvagno GL, Montagnana M, Poli G, Guidi GC. J Thromb
Thrombolysis 2008;26:150-3.
369.
Relationship between uric acid, hyperglycemia and hypertriglyceridemia in the general population. Lippi G,
Montagnana M, Targher G, Salvagno GL, Guidi GC. Biochem Med (Zagreb) 2008;18:37-41.
370.
Association of inflammation with anemia in patients with chronic kidney disease not requiring chronic
dialysis. Chonchol M, Lippi G, Montagnana M, Muggeo M, Targher G. Nephrol Dial Transplant 2008;23:2879-83.
371.
A half-marathon run does not acutely influence lipoprotein(a). Lippi G, Schena F, Salvagno GL, Montagnana M,
Guidi GC. Nutr Metab Cardiovasc Dis 2008;18:e37-8.
372.
Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Franchini M, Targher G, Montagnana M,
Lippi G. Clin Chim Acta 2008;395:14-8.
373.
Acute variation of biochemical markers of muscle damage following a 21 -km, half-marathon run. Lippi G,
Schena F, Salvagno GL, Montagnana M, Gelati M, Tarperi C, Banfi G, Guidi GC. Scand J Clin Lab Invest
2008;68:667-72.
374.
Air pollution and sports performance in Beijing. Lippi G, Guidi GC, Maffulli N. Int J Sports Med 2008;29:696-8.
375.
Help me, Doctor! My D-dimer is raised. Lippi G, Franchini M, Targher G, Favaloro EJ. Ann Med 2008;40:594-605.
376.
Uric acid concentration in patient with acute coronary syndrome. Lippi G, Montagnana M, Franchini M, Guidi
GC, Targher G. Intern Emerg Med 2008;3:409-11.
377.
Acute variation of estimated glomerular filtration rate following a half -marathon run. Lippi G, Schena F,
Salvagno GL, Tarperi C, Montagnana M, Gelati M, Banfi G, Guidi GC. Int J Sports Med 2008;29:948-51.
378.
Relationship between red blood cell distribution width and kidney function tests in a large cohort of
unselected outpatients. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Scand J Clin Lab
Invest 2008;68:745-8.
379.
Influence of acute physical exercise on emerging muscular biomarkers. Lippi G, Schena F, Montagnana M,
Salvagno GL, Guidi GC. Clin Chem Lab Med 2008;46:1313-8.
380.
Detecting of chronic kidney disease in older people by the MDRD and MCQ formulas. Lippi G, Targher G,
Salvagno GL, Montagnana M, Guidi GC. Age Ageing 2008;37:722.
381.
The effect of iron depletion on chronic hepatitis C virus infection. Franchini M, Targher G, Capra F,
Montagnana M, Lippi G. Hepatol Int 2008;2:335-40.
382.
Air pollution and coagulation testing: a new sou rce of biological variability? Lippi G, Favaloro EJ, Franchini M,
Guidi GC. Thromb Res 2008;123:50-4.
383.
Hyperuricaemia is associated with increased C -reactive protein concentrations in a large cohort of unselected
outpatients. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Nutr Metab Cardiovasc Dis 2008;18:e41-2.
384.
Recommendations for the management, the evaluation and the use of glucometers in the extrahospital
setting. Montagnana M, Caputo M, Giavarina D, Testa R, Mosca A, Lippi G. RIMeL/IJLM 2009;5:253-63; Biochim
Clin 2009;33:262-70.
385.
Procalcitonin concentrations in bacteremia. Schinella M, Lippi G, Curci V, Gualdi P, Collini L, Mattarei M.
RIMeL/IJLM 2009;5:38-43.
386.
Preanalytical variability of coagulation testing. Lippi G, Salvagno G, Adcock DM, Franchini M, Favaloro EJ.
RIMeL/IJLM 2009;5:91-8.
387.
Epidemiological association between fasting plasma glucose and shortened APTT. Lippi G, Franchini M, Targher
G, Montagnana M, Salvagno GL, Guidi GC, Favaloro EJ. Clin Biochem 2009;42:118-120.
388.
Will "personalized medicine" need personalized laboratory approach? Guidi GC, Lippi G. Clin Chim Acta
2009;400:25-29.
389.
Continuous glucose monitoring and type 1 diabetes. Montagnana M, Lippi G, Guidi GC. N Engl J Med
2009;360:190.
390.
Ischaemia-modified albumin in ischemic disorders. Lippi G, Montagnana M. Ann Thorac Cardiovasc Surg
2009;15:347.
391.
Thrombin generation assay: a useful routine check -up tool in the management of patients with hemophilia?
Salvagno GL, Astermark J, Lippi G, Ekman M, Franchini M, Guidi GC, Berntorp E. Haemophilia 2009;15:290-6.
392.
Laboratory diagnostics and therapy in thrombosis and hemostasis: from bench to bedside. Lippi G, Favaloro
EJ, Franchini M. Semin Thromb Hemost 2009;35:3-8.
393.
Milestones and perspectives in coagulation and hemostasis. Lippi G, Favaloro EJ, Franchini M, Guidi GC. Semin
Thromb Hemost 2009;35:9-22.
394.
Circadian variation within hemostasis: An underrecognized link between biology and disease? Montagnana M,
Salvagno GL, Lippi G. Semin Thromb Hemost 2009;35:23-33.
395.
Extracorporeal immunoadsorption for the treatment of coagulation inhibitors. Franchini M, Sassi M, Dell’Anna
P, Manzato F, Salvano GL, Montagnana M, Zaffanello M, Targher G, Lippi G. Semin Thromb Hemost 2009;35:76-80.
396.
Biochemical correlates of lipoprotein(a) in a general adult populati on. Possible implications for
cardiovascular risk assessment. Lippi G, Targher G, Franchini M, Guidi GC. J Thromb Thrombolysis 2009;27:44-7.
397.
Inherited and acquired risk factors for arterial ischemic stroke in childhood. Lippi G, Franchini M, Montagnana
M, Salvagno GL, Targher G, Guidi GC. J Thromb Thrombolysis 2009;27:239-48.
398.
Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and preeclamptic pregnancy.
Montagnana M, Lippi G, Albiero A, Scevarolli S, Salvagno GL, Franchi M, Guidi G C. J Clin Lab Anal 2009;23:88-92.
399.
Serum creatinine concentration and creatinine-based estimation of glomerular filtration rate in athletes.
Banfi G, Del Fabbro M, Lippi G. Sports Med 2009;39:331-7.
400.
The impact factor and journals in laboratory medicine. Lippi G, Favaloro EJ, Guidi GC. Clin Lab 2009;55:49-52.
401.
Response to "NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men”. Targher
G, Lippi G, Muggeo M. Obesity (Silver Spring) 2009;17:627.
402.
Vitamin B12, folate, and anemia in old age. Lippi G, Montagnana M, Targher G, Guidi GC. Arch Intern Med
2009;169:716.
403.
Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part I. Franchini M, Lippi G,
Favaloro EJ. Semin Thromb Hemost 2009;35:257-9.
404.
Biological influence of physical exercise on hemostasis. Lippi G, Maffulli N. Semin Thromb Hemost 2009;35:26976.
405.
Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of
inherited thrombophilia. Franchini M, Montagnana M, Targher G, Veneri D, Zaffanello M, Salvagno GL, Manzato F,
Lippi G. Semin Thromb Hemost 2009;35:307-12.
406.
Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Lippi G, Montagnana
M, Favaloro EJ, Franchini M. Semin Thromb Hemost 2009;35:325-36.
407.
Pharmacogenetics of vitamin K antagonists: useful or hype? Lippi G, Franchini M, Favaloro EJ. Clin Chem Lab
Med 2009;47:503-15.
408.
The clinical dilemma of positive results of high -sensitive troponin assays. Lippi G, Montagnana M, Guidi GC. Am
J Cardiol 2009;103:1332.
409.
Together we care: new challenges for global haemophilia treatment centers. Franchini M, Lippi G. Indian J
Med Res 2009;129:345-7.
410.
Migraine, valproic acid and lipoprotein(a). Lippi G, Targher G, Franchini M. Pediatr Neurol 2009;41:78.
411.
HER2: closing the gap between laboratory testing and clinical practice. Plebani M, Lippi G. Am J Clin Pathol
2009;131:897-8.
412.
Event reporting in laboratory medicine. Is there something we are missing? Lippi G, Mattiuzzi C, Plebani M.
MLO Med Lab Obs 2009;41:23.
413.
Bilirubin concentration and cardiovascular risk profile. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi
GC. Liver Int 2009;29:315-6.
414.
Relationship between activated partial thromboplastin time, heparin and potassium levels. Lippi G, Franchini
M, Guidi GC, Favaloro EJ. Diabetes Res Clin Pract 2009;83:e33-4.
415.
Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of
unselected outpatients. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Arch Pathol Lab
Med 2009;133;628-32.
416.
Relationship between serum bilirubin and kidney function in nondiabetic and diabetic individuals. Targher G,
Zoppini G, Guidi GC, Lippi G. Kidney Int 2009;75:863.
417.
Risks and benefits of replacing conventional plasma lipids with apolipoprotein measurement. Lippi G, Targher
G, Guidi GC. Acta Cardiol 2009;64:413-4.
418.
Hemolysis index: quality indicator or criterion for sample rejection? Plebani M, Lippi G. Clin Chem Lab Med
2009;47:899-902.
419.
Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Lippi G, Salvagno GL,
Blanckaert N, Giavarina D, Green S, Kitchen S, Palicka V, Vassalut AJ, Plebani M. Clin Chem Lab Med 2009;47:9349.
420.
Clinical usefulness of measuring red blood cell distribution width on a dmission in patients with acute
coronary syndromes. Lippi G, Filippozzi L, Montagnana M, Salvagno GL, Franchini M, Guidi GC, Targher G. Clin
Chem Lab Med 2009;47:353-7.
421.
Increased mean platelet volume in patients with acute coronary syndromes. Lippi G, Filippozzi L, Salvagno GL,
Montagnana M, Franchini M, Guidi GC, Targher G. Arch Pathol Lab Med 2009;133:1441-3.
422.
Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer.
Montagnana M, Minicozzi AM, Salvagno GL, D anese E, Cordiano C, de Manzoni G, Guidi GC, Lippi G. Clin Lab
2009;55:187-92.
423.
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass. Montagnana M, Lippi G,
Ruzzenente O, Bresciani V, Danese E, Scevarolli S, Salvagno GL, Giud ici S, Franchi M, Guidi GC. J Clin Lab Anal
2009;23:331-5.
424.
Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part II. Lippi G, Franchini M,
425.
Unsuspected triggers of venous thromboemboli sm - Trivial or not so trivial? Lippi G, Franchini M, Favaloro EJ.
Semin Thromb Hemost 2009;35:597-604.
426.
The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in
moderating thrombosis and cancer spread. Franchini M, Montagnana M, Favaloro EJ, Lippi G. Semin Thromb
Hemost 2009;35:644-53.
427.
Prostate-Specific Antigen, prostate cancer, and disorders of hemostasis. Lippi G, Plebani M, Franchini F, Guidi
GC, Favaloro EJ. Semin Thromb Hemost 2009;35:654-64.
428.
Laboratory investigation of thrombophilia: the Good, the Bad, and the Ugly. Favaloro EJ, McDonald D, Lippi G.
429.
Informatics aids to reduce failure rates in notification of abnormal outpatient test results. Lippi G, Plebani M.
Arch Intern Med 2009;169:1815.
430.
Influence of age and gender variations on glomerular filtration rate estimated by the MCQE formula. Lippi G,
Tessitore N, Montagnana M, Bedogna V, Salvagno GL, Targher G, Lupo A, Guidi GC. Biochem Med (Zagreb)
2009;19:81-6.
431.
The missing link between genotype, phenotype and clinics. Lippi G, Favaloro EJ. Biochem Med (Zagreb)
2009;19:137-45.
432.
Serum prolactin in professional soccer players. Lippi G, De Vita F, Salvagno GL, Montagnana M, Targher G, Guidi
GC. Biochem Med (Zagreb) 2009;19:177-81.
433.
The Impact Factor for evaluating scientists: the good, the bad and the ugly. Lippi G. Clin Chem Lab Med
2009;47:1585-6.
434.
Relation of serum gamma-glutamyltransferase with atherogenic dyslipidemia and glycemic control in type 2
diabetes. Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M. Obesity (Silver Spring) 2009 17:370-4.
435.
Biomarkers of myocardial infarction in patients undergoing gastrointestinal cancer surgery. Lippi G, Salvagno
GL, Minicozzi AM, Montagnana M, Cordiano C, De Manzoni G, Guidi GC . Lab Medicine 2009 40:91-5.
436.
Eosinophilia and first-line coagulation testing. Lippi G, Montagnana M, Salvagno GL, Franchini M, Targher G,
Guidi GC. J Thromb Thrombolysis 2009;28:90-3.
437.
The red blood cell distribution width is associated with serum levels of thyroid stimulating hormone in the
general population. Montagnana M, Lippi G, Targher G, Salvagno GL, Guidi GC. Int J Lab Hematol 2009;31:581-2.
438.
Analytical comparison of AxSYM, HemosIL DD HS and Innovance D -dimer immunoassays with the Vidas Ddimer. Salvagno GL, Lippi G, Manzato F, Giavarina D, Montagnana M, Poli G, Guidi GC. Int J Lab Hematol
2009;31:475-7.
439.
Cardiac troponin T during sickle cell crisis. Lippi G, De Franceschi L, Luca Salvagno G, Pavan C, Montagnana M,
Cesare Guidi G. Int J Cardiol 2009;136:357-8.
440.
Dark chocolate: consumption for pleasure or therapy? Lippi G, Franchini M, Montagnana M, Favaloro EJ, Guidi
GC, Targher G. J Thromb Thrombolysis 2009;28:482-8.
441.
Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a g eneral population of
unselected outpatients. Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, Favaloro EJ. J
Thromb Thrombolysis 2009;28:362-5.
442.
Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery : when is it
necessary? Franchini M, Targher G, Montagnana M, Lippi G. J Thromb Thrombolysis 2009;28:215-9.
443.
Thromboprophylaxis for cancer patients. Lippi G, Montagnana M, Salvagno GL. Thromb Res 2009; 124:236.
444.
Causes, consequences, detection and prevention of identification errors in laboratory diagnostics. Lippi G,
Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, Vassault AJ, Mattiuzzi C, Plebani M. Clin Chem Lab Med
2009;47:143-53.
445.
Epidemiological association between C-reactive protein and prostate specific antigen. Lippi G, Montagnana M,
Guidi GC. Cancer 2009;115:132.
446.
Overview on self-monitoring of blood glucose. Montagnana M, Caputo M, Giavarina D, Lippi G. Clin Chim Acta
2009;402:7-13.
447.
D-dimer measurement and laboratory feedback. Lippi G, Favaloro EJ. J Emerg Med 2009;37:82-3.
448.
Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients.
Lippi G, Montagnana M, Salvagno GL, Targher G, Guidi GC. Diabetes Res Clin Pract 2009; 84:e3-5.
449.
Hemophilia and cancer: a new challenge for hemophilia centers. Franchini M, Lippi G, Montagnana M, Targher
G, Zaffanello M, Salvagno GL, Rivolta GF, Di Perna C, Tagliaferro A. Cancer Treat Rev 2009; 35:374-7.
450.
Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients
with type 2 diabetes. Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M. Nutr Metab Cardiovasc
Dis 2009;19:580-6.
451.
Measurement of morning saliva cortisol in athletes. Lippi G, De Vita F, Salvagno GL, Gelat i M, Montagnana M,
Guidi GC. Clin Biochem 2009;42:904-6.
452.
Lipoprotein(a) in late onset neonatal sepsis. Lippi G. Scand J Infect Dis 2009;41:383.
453.
Gene therapy for hemophilia A. Friend or foe? Lippi G, Franchini M, Saenko E. Blood Coagul Fibrinolysis
2009;20:395-9.
454.
Governance of preanalytical variability: travelling the right path to the bright side of the moon? Lippi G. Clin
Chim Acta 2009;404:32-6.
455.
Anaphylaxis in patients with congenital bleeding disorders and inhibitors. Franchini M, Lippi G, Montagnana M,
Targher G, Zaffanello M, Salvagno GL, Rivolta GF, Di Perna C, Tagliaferri A. Blood Coagul Fibrinolysis
2009;20:225-9.
456.
Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to
the bedside. Lippi G, Franchini M, Favaloro EJ. Clin Chim Acta 2009;405:8-16.
457.
Survey on the prevalence of hemolytic specimens in an Academic Hospital according to collection facility:
Opportunities for quality improvement. Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Clin Chem Lab Med
2009;47:616-8.
458.
Procalcitonin values after dialysis is closely related to type of dialysis membrane. Montagnana M, Lippi G,
Tessitore N, Salvagno GL, Danese E, Targher G, Lupo A, Guidi GC. Scand J Clin Invest 2009; 69:703-7.
459.
The International Anti-Doping System: why it might not work. Lippi G, Banfi G, Franchini M. Clin Chim Acta
2009;408:141-2.
460.
Usefulness of serum HE4 in endometriotic cysts. Montagnana M, Lippi G, Danese E, Guidi GC, Franchi M. Br J
Cancer 2009;101:548.
461.
Relationship between albuminuria and he moglobin level. Lippi G, Guidi GC, Targher G. Diabetes Res Clin Pract
2009;86:e62-3.
462.
Recent improvements in the clinical treatment of coagulation factor inhibitors. Franchini M, Lippi G. Semin
463.
Prophylaxis in congenital hemophilia with inhibitors: The role of recombinant activated factor VII. Franchini
M, Manzato F, Salvagno GL, Montagnana M, Zaffanello M, Lippi G. Semin Thromb Hemost 2009;35:814-19.
464.
The use of desmopressin in congenital factor XI deficiency: a systematic review . Franchini M, Manzato F, Lippi
G. Ann Hematol 2009;88:931-5.
465.
Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Lippi G,
Targher G, Franchini M, Plebani. Clin Chem Lab Med 2009;47:1183-94.
466.
Development and implementation of an automatic system for verification, validation and delivery of
laboratory test results. Guidi GC, Poli G, Bassi A, Giobelli L, Benetollo PP, Lippi G. Clin Chem Lab Med
2009;47:1355-60.
467.
One-stage clotting versus chromogenic assays for asses sing recombinant Factor VIII: two faces of a
haemostasis coin. Lippi G, Franchini M, Favaloro EJ. Blood Coagul Fibrinolysis 2009;20:1-3.
468.
Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease
not requiring chronic dialysis. Targher G, Chonchol M, Zoppini G, Salvagno G, Pichiri I, Franchini M, Lippi G. Clin
Chem Lab Med 2009;47:1367-71.
469.
Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
Salvagno GL, Lippi G, Montagnana M, Franchini M, Poli G, Guidi GC. Int J Lab Hematol 2009;31:462-7.
470.
In reply. Lippi G. Arch Pathol Lab Med 2009;133:1188-9.
471.
Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult
population. Findings from the National Health and Nutrition Examination Survey 2001 -2006. Targher G,
Bosworth C, Kendrick J, Smits G, Lippi G, Chonchol M. Clin Chem Lab Med 2009;47:1055-62.
472.
Mouse recombinant protein C variants with enhanced membrane affinity and hyper -anticoagulant activity in
mouse plasma. Krisinger MJ, Guo LJ, Salvagno GL, Guidi GC, Lippi G, Dahlbäck B. FEBS J 2009;276:6586-602.
473.
Are hemophiliacs protected against cancer development? Prospective controlled studies are needed.
Franchini M, Lippi G. J Cell Mol Med 2009;13:1185.
474.
The importance of incident reporting in laboratory diagnostics. Lippi G, Plebani M. Scand J Clin Lab Invest
2009;69:811-3.
475.
Prostate specific antigen-based screening for prostate cancer in the third millennium: useful or hype? Lippi
G, Montagnana M, Guidi GC, Plebani M. Ann Med 2009;41:480-9.
476.
Application of MLPA (Multiplex Ligation -Dependent Probe Amplification) for the screening of subtelomeric
rearrangements in children with mental retardation. Danese E, Bernardi F, Meneghelli E, Darra F, Zoccante L,
Montagnana M, Lippi G, Guidi GC. RIMeL/IJLM 2010;6:13-9.
477.
Red wine and cardiovascular health: the “French paradox” revisited. Lippi G, Franchini M, Guidi GC. Int J
Wine Res 2010;2:1–7.
478.
Free DNA quantification by real-time polymerase chain reaction (PCR) in serum of patients with polyps and
colorectal cancer. Danese E, Montagnana M, Minicozzi AM, De Matteis G, Salvagno GL, Cordiano C, Lippi G, Guidi
GC. Biochim Clin 2010;34:194-8.
479.
Coagulopathies and Thrombosis: Usual and Unusual Causes and Associations, Part III. Favaloro EJ. Lippi G,
Franchini M. Semin Thromb Hemost 2010;36:1-5.
480.
Influenza and cardiovascular disease: does Swine -Origin, 2009 H1N1 Flu Virus represent a risk factor, an
acute trigger, or both? Lippi G, Franchini M, Favaloro EJ. Semin Thromb Hemost 2010;36:49-58.
481.
Thyroid-associated autoimmune coagulation disorders. Franchini M, Lippi G, Manzato F, Vescovi PP. J Thromb
482.
Hemophilia, cancer and cardiovascular disease. Franchini M, Favaloro EJF, Lippi G. Blood Coagul Fibrinolysis
2010;21:1-2.
483.
To Err is Human. To misdiagnose might be deadly. Plebani M, Lippi G. Clin Biochem 2010;43:1-3.
484.
Intermittent hypoxic training: doping or what? Lippi G, Franchini M. Eur J Appl Physiol 2010;108:411-2.
485.
Glanzmann thrombasthenia: an update. Franchini M, Favaloro EJF, Lippi G. Clin Chim Acta 2010;411:1-6.
486.
Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype? Lippi G, Plebani M. Clin Chem
Lab Med 2010;48:1-5.
487.
Determinants of anemia in the very elderl y: a major contribution from impaired renal function? Lippi G,
Franchini M, Salvagno GL, Montagnana M, Targher G, Guidi GC. Blood Transfus 2010;8:44-8.
488.
Red Blood Cell-Mimicking synthetic biomaterial particles: the new frontier of blood doping? Lippi G, Franchini
M, Banfi G. Int J Sports Med 2010;31:75-6.
489.
Moderate red wine consumption and cardiovascular disease risk: Beyond the ‘‘French Paradox’’. Lippi G,
Franchini M, Favaloro EJ, Targher G. Semin Thromb Hemost 2010;36:59-70.
490.
The use of recombinant activated FVII in postpartum hemorrhage. Franchini M, Franchi M, Bergamini V,
Montagnana M, Salvagno GL, Targher G, Lippi G. Clin Obstet Gynecol 2010;53:219-27.
491.
Total quality in laboratory diagnostics. It’s time to think outside the box. Lippi G, Simundic AM. Biochem Med
(Zagreb) 2010;20:5-8.
492.
Development of a preanalytical errors recording software. Lippi G, Bonelli P, Rossi R, Bardi M, Aloe R, Caleffi
A, Bonilauri E. Biochem Med (Zagreb) 2010;20:90-5.
493.
Analytical variability in athletes haematological testing. Banfi G, Drago L, Lippi G. Int J Sports Med
2010;31:218.
494.
Vaccination, squalene and anti-squalene antibodies: facts or fiction? Lippi G, Targher G, Franchini M: Eur J
Intern Med 2010;21:70-73.
495.
Platelet inhibition with cangrelor. Lippi G, Franchini M, Favaloro EJ. N Engl J Med 2010;362:1049.
496.
Highly sensitive cardiac troponin T is not increased by strenuous eccentric exercise. Lippi G, Guidi GC,
Salvagno GL, Impellizzeri F, Schena F. Am J Cardiol 2010;105:1043-4.
497.
Sensitive cardiac troponin T assay. Lippi G, Cervellin G, Plebani M. N Engl J Med 2010;363:1242.
498.
Etiology and diagnosis of acquired von Willebrand syndrome. Franchini M, Lippi G, Favaloro EJ. Clin Adv
Hematol Oncol 2010;8:20-4.
499.
Proteomic analysis of venous thromboembolism. Lippi G, Favaloro EJ, Plebani M. Expert Rev Proteomics
2010:7:275-82.
500.
Genetics and sports. Lippi G, Longo UG, Maffulli N. Brit Med Bull 2010;93:27-47.
501.
Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Lippi G, Favaloro EJ.
Neurology 2010;74:1477.
502.
Laboratory medicine and natural disasters: are we ready for the challenge? Lippi G, Favaloro EJ, Plebani M.
503.
Factor V Leiden and hemophilia. Franchini M, Lippi G. Thromb Res 2010;125:119-23.
504.
Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Lippi G, Targher G. Clin Chem Lab Med
2010;48:609-14.
505.
Quality issues in laboratory haemostasis. Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES,
Srivastava A. Haemophilia 2010; 16(Suppl. 5):93–9.
506.
Quality in laboratory diagnostics: from theory to practice. Lippi G, Plebani M, Simundic AM. Biochem Med
(Zagreb) 2010;20:126–30.
507.
Overview on patient safety in healthcare and laboratory diagnostics. Lippi G, Simundic AM, Mattiuzzi C.
Biochem Med (Zagreb) 2010;20:131–43.
508.
Hemolysis detection and management of hemolyzed specimens. Simundic AM, Topic E, Nikolac N, Lippi G.
Biochem Med (Zagreb) 2010;20:154-9.
509.
Quality in the extra-analytical phases of urinalysis. Caleffi A, Manoni F, Alessio MG, Ottomano C, Lippi G.
Biochem Med (Zagreb) 2010;20:179–83.
510.
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. Lippi G, Mattiuzzi C, Targher G.
N Engl J Med 2010;362:2030.
511.
Biochemical markers of muscular damage. Brancaccio P, Lippi G, Maffulli N. Clin Chem Lab Med 2010;48:757-67.
512.
Serum bilirubin levels and cardiovascular disease risk - A Janus bifrons? Franchini M, Targher G, Lippi G. Adv
Clin Chem 2010;50:47-63.
513.
Recombinants in Thrombosis and Hemostasis: From Basic Research to Clinical Therapy. Lippi G, Favaloro EJ.
514.
Recombinant Factor VIII Concentrates. Franchini F, Lippi G. Semin Thromb Hemost 2010;36:493-7.
515.
Thrombotic Complications of Erythropoiesis-Stimulating Agents. Lippi G, Franchini F, Favaloro EJ. Semin
516.
Recombinant Platelet Factor 4: A Therapeutic, Anti -Neoplastic Chimera? Lippi G, Favaloro EJ. Semin Thromb
Hemost 2010;36:558-69.
517.
Prevalence of hypokalemia: the experience of a large Academic Hospital. Lippi G, Favaloro EJ, Montagnana M,
Guidi GC. Intern Med J 2010;40:315-6.
518.
Shortened activated partial thromboplastin time: causes and management. Lippi G, Salvagno GL, Ippolito L,
Franchini M, Favaloro EJ. Blood Coagul Fibrinolysis 2010;21:459-63.
519.
Disseminated intravascular coagulation in burn injury. Lippi G. Ippolito L, Cervellin G. Semin Thromb Hemost
2010;36:429-36.
520.
Disseminated intravascular coagulation in trauma injuries. Lippi G, Cervellin G. Semin Thromb Hemost
2010;36:378-87.
521.
Influence of a light meal on routine haematological tests. Lippi G, Lima-Oliveira G, Salvagno GL, Montagnana M,
Gelati M, Picheth G, Duarte AJ, Franchini M, Guidi GC. Blood Transfus 2010;8:94-9.
522.
Recombinant Activated Factor VII: Mechanisms of Action and Current Indications. Franchini M, Lippi G. Semin
523.
Serum uric acid in top-level alpine skiers over four consecutive competitive seasons. Lombardi G, Colombini
A, Ricci C, Freschi M, Lippi G, Banfi G. Clin Chim Acta 2010;411:645-8.
524.
Prothrombin complex concentrates: an update. Franchini M, Lippi G. Blood Transfus 2010;8:149-54.
525.
The unusual case of a spurious, transfusion -acquired haemoglobin S. Lippi G, Mercadanti M, Caleffi A,
Franchini M. Blood Transfus 2010;8:199-202.
526.
The “Obamanomics”: a revolution in laboratory diagnostics. Lippi G, Plebani M. Clin Chem Lab Med
2010:48:741-3.
527.
Laboratory testing in pharmacies. Lippi G, Plebani M, Favaloro EJ, Trenti T. Clin Chem Lab Med 2010;48:943-53.
528.
Acute variation of leucocytes counts following a half -marathon run. Lippi G, Banfi G, Montagnana M, Salvagno
GL, Schena F, Guidi GC. Int J Lab Hematol 2010;32:117-21.
529.
Improving the post-analytical phase. Plebani M, Lippi G. Clin Chem Lab Med. 2010;8:435-6.
530.
Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect
type of sample. Lippi G, Salvagno GL, Adcock DM, Gelati M, Guidi GC, Favaloro EJ. Int J Lab Hematol
2010;32:132-8.
531.
Relationship between 24-hour air pollution, emergency department admission and diagnosis of acute
coronary syndrome. Lippi G, Franchini M, Montagnana M, Filippozzi L, Favaloro EJ, Guidi GC. J Thromb
532.
The role of ethnicity, age and gender in venous thromboembolism. Montagnana M, Favaloro EJ, Franchini M,
Guidi GC, Lippi G. J Thromb Thrombolysis 2010;29:489-96.
533.
Sample stability for the measurement of hemoglobin A1c. Mercadanti M, Caleffi A, Targher G, Lippi G. Diabetes
Res Clin Pract 2010;90:e13-4.
534.
Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Cervellin G, Comelli I,
Lippi G. Clin Chem Lab Med 2010;48:749-56.
535.
A world apart: Inaccuracies of laboratory methodologies in antidoping testing. Banfi G, Lombardi G, Colombini
A, Lippi G. Clin Chim Acta 2010;411:1003-8.
536.
Cocaine in acute myocardial infarction. Lippi G, Plebani M, Cervellin G. Adv Clin Chem 2010;51:53-70.
537.
Is it laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed.
Plebani M, Lippi G. Clin Biochem 2010;43:939-41.
538.
Preanalytical variability: the dark side of the moon in blood doping screening. Lippi G, Banfi G, Maffulli N. Eur
J Appl Physiol 2010;109-1003-5.
539.
Frequency and type of newly diagnosed haemoglobin variants in Northern Italy. Lippi G, Montagnana M, Danese
E, Salvagno GL, Bellorio F, Franchini M, Guidi GC. Blood Transfus 2010;8:307-8.
540.
Discard tubes are sometimes necessary when drawing samples for hemostasis. Favaloro EJ, Lippi G. Am J Clin
Pathol 2010;134:851.
541.
Hyponatremia and pseudohyponatremia: first, do not to harm. Lippi G, Aloe R. Am J Med 2010;123:e17.
542.
Notification of abnormal and critical va lues: the road ahead. Piva E, Lippi G, Plebani M. Am J Med
2010;123:e19.
543.
Darwinian evolution or regression? The fate of laboratory professionals. Plebani M, Lippi G. Clin Chem Lab Med
2010 2010;48:1367-8.
544.
The use of desmopressin in mild hemophilia A. Franchini M, Zaffanello M, Lippi G. Blood Coagul Fibrinolysis
2010;21:615-9.
545.
Recombinant Factor VIII Concentrates. Franchini M, Lippi G. Semin Thromb Hemost 2010;36:930-2.
546.
Direct LDL-cholesterol measurement: not ready for the prime time? Lippi G, Montagnana M, Guidi GC. Int J
Cardiol 2010;145:86-7.
547.
Lipoprotein(a) and ageing. Lippi G, Targher G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Clin Lab
2010;56:463-6.
548.
Hemostatic abnormalities in endocrine and metabolic disorders. Franchini M, Lippi G, Manzato F, Vescovi PP,
Targher G. Eur J Endocrinol 2010;162:439-51.
549.
Mild hemophilia A. Franchini M, Favaloro EJ, Lippi G. J Thromb Haemost 2010;8:421-32.
550.
Laboratory reporting of hemostasis assays: the final post -analytical opportunity to reduce errors of clinical
diagnosis in hemostasis? Favaloro EJ, Lippi G. Clin Chem Lab Med 2010;48:309-21.
551.
Bone metabolism markers in sports medicine. Banfi G, Lombardi G, Colombini A, Lippi G. Sports Med
2010;40:697-714.
552.
Non-alcoholic fatty liver disease is independently associated w ith an increased prevalence of chronic kidney
disease and retinopathy in type 1 diabetic patients. Targher G, Bertolini L, Chonchol M, Zoppini G, Rodella S,
Lippi G, Zenari L, Bonora E. Diabetologia 2010;53:1341-8.
553.
NT-proBNP concentrations in mountain marathoners. Banfi G, Lippi G, Susta D, Barassi A, D'Eril GM, Dogliotti G,
Corsi M. J Strength Cond Res 2010;24:1369-72.
554.
Exercise-related increase of cardiac troponin release in sports: An apparent paradox finally elucidated? Lippi
G, Banfi G. Clin Chim Acta 2010;411:610-1.
555.
Problems in laboratory testing – Haemophilia and beyond. Favaloro
2010;8:1119-20.
556.
Hepcidin and iron metabolism: from laboratory to clinical implications. Franchini M, Montagnana M, Lippi G.
Clin Chim Acta 2010;411:1565-9.
557.
Laboratory "incidentalomas": Facts or fiction? Lippi G, Plebani M. Eur J Intern Med 2010;21:572.
558.
Coagulation update: What’s new in hemostasis testing? Favaloro EJ, Lippi G. Thromb Res 2010; 127 (Suppl. 2):
S31–S34.
559.
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2
diabetic patients. Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, Pichiri I, Lippi G, Muggeo M, Bonora E.
Atherosclerosis 2010;210:575-80.
560.
Autologous platelet-rich plasma: a revolution in soft tissue sports injury management? Mei-Dan O, Lippi G,
Sánchez M, Andia I, Maffulli N. Phys Sportsmed 2010;38:127-35.
561.
Human epydidimis protein 4 (HE4): could it be useful in the diagnosis of vulvar cancer? Montagnana M, Lippi
G, Danese E, Ruzzenente O, Franchi M, Guidi GC. Clin Lab 2010;56:601-2.
562.
Contemporary platelet function testing. Favaloro EJ, Lippi G, Franchini M. Clin Chem Lab Med 2010;48:579-98.
563.
The clinical role of high-sensitive troponin assays: update, interpretation, and perspe ctives. Lippi G,
Cervellin G. Recenti Prog Med 2010;101:423-8.
564.
Epidemiological association between uric acid concentration in plasma, lipoprotein(a) and the traditional
lipid profile. Lippi G, Montagnana M, Luca Salvagno G, Targher G, Cesare Guidi G. Clin Cardiol 2010;33:E76-80.
565.
Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future. Lippi G,
Cervellin G, Franchini M, Favaloro EJ. J Thromb Thrombolysis 2010;30:459-71.
566.
Kinetics of highly sensitive troponin I and T after eccentric exercise. Lippi G, Impellizzeri F, Salvagno GL, Mion
M, Zaninotto M, Cervellin G, Guidi GC, Schena F, Plebani M. Clin Chem Lab Med 2010;48:1677-9.
567.
Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps an d
colorectal cancers. Danese E, Montagnana M, Minicozzi AM, De Matteis G, Scudo G, Salvagno GL, Cordiano C,
Lippi G, Guidi GC. Clin Chem Lab Med 2010;48:1665-8.
568.
Relationship between kidney function and liver histology in subjects with nonalcoholic steatohe patitis.
Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Clin J Am Soc Nephrol 2010;5:2166-71.
569.
C reactive protein and venous thromboembolism: causal or casual association? Lippi G, Favaloro EJ,
Montagnana M, Franchini M. Clin Chem Lab Med 2010;48:1693-701.
570.
Focused factories and boutique laboratories. The truth might lie in between. Plebani M, Lippi G. Clin Biochem
2010;43:1484-5.
571.
Acquired hemophilia in pediatrics: A systematic review. Franchini M, Zaffanello M, Lippi G. Pediatr Blood
Cancer 2010;55:606-11.
572.
Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A. A critical literature
review. Franchini M, Lippi G. Thromb Haemost 2010;104:931-40.
573.
Interferences in red blood cell counting in urinalysis using e vacuated tubes. Caleffi A, Russo R, Lippi G. Clin
Chem Lab Med 2010;48:1681-2.
574.
Pathogenesis, laboratory and clinical characteristics of Helicobacter pylori -associated immune
thrombocytopenic purpura. Franchini M, Plebani M, Montagnana M, Veneri D, Lippi G. Adv Clin Chem
2010;52:131-44.
575.
Procalcitonin as a Marker for Postoperative Complications. Reply. Montagnana M, Lippi G. Clin Lab 2010;56:
154‐55.
576.
Chemical, morphological and microbiological urine examination: Proposal of guidelines for preanalytical
standardization. Manoni F, Caleffi A, Gessoni G, Alessio MG, Lippi G, Valverde S, Ottomano C, Silvestri MG,
Cappelletti P, Ercolin M, Schinella M, Saccani G. Biochim Clin 2011;35:131-9; RIMeL/IJLM 2011;7:25–35.
577.
Consensus SIBioC-SIMeL recommendations for the identification and management of haemolysed specimens
and implementation of the haemolysis index . Lippi G, Caputo M, Banfi G, Daves M, Dolci A, Montagnana M,
Miconi V, Milanesi B, Morandini M, Piva E, Salvagno GL, Troiano T, Giavarina D, per il Gruppo di Studio
EJ, Lippi G. J Thromb Haemost
Intersocietario SIBioC-SIMeL-CISMEL sulla Variabilità Extra-Analitica del Dato di Laboratorio.
2011;7:144–55; Biochim Clin 2011;35:481-90.
RIMeL/IJLM
578.
The "risk of ovarian malignancy algorithm" for estimating the risk of epithelial ovarian cancer in women
presenting with pelvic mass. Montagnana M, Danese E, Ruzzenente O, Giudici S, Gelati M, Salvagno GL, Franchi
M, Lippi G, Guidi GC. Biochim Clin 2011;35:30-5.
579.
Tranexamic acid and the risk of thrombosis in women with heavy menstrual bleeding. Lippi G, Cervellin G,
Franchini M. Obstet Gynecol 2011;117:176.
580.
Reduction of unsuitable specimens: a more radical and comprehensive approach is neede d. Lippi G, Plebani M.
Clin Chim Acta 2011:412:400.
581.
Letter by lippi and cervellin regarding article, "high -sensitivity troponin T concentrations in acute chest pain
patients evaluated with cardiac computed tomography". Lippi G, Cervellin G. Circulation 2011;123:e3.
582.
Detection of chronic kidney disease in hospitalized patients: is one estimating glomerular filtration rate
equation better than another? Lippi G, Franchini M, Targher G. Eur J Intern Med 2011;22:119-20.
583.
Ex-vivo red blood cells generation: a step ahead in transfusion medicine? Lippi G, Montagnana M, Franchini M.
Eur J Intern Med 2011;22:16-9.
584.
The spectrum of coagulation abnormalities in thyroid disorders. Vescovi PP, Favaloro EJ, Lippi G, Garofano M,
Montagnana M, Manzato F, Franchini M. Semin Thromb Hemost 2011;37:7-10.
585.
Home monitoring of warfarin effects. Lippi G, Franchini M. N Engl J Med 2011;364:378.
586.
Safety of recombinant activated Factor VII in randomized clinical trials. Franchini M, Targher G, Lippi G. N
Engl J Med 2011:364:575.
587.
Venous thromboembolism in chronic liver disease. Lippi G, Targher G, Favaloro EJ, Franchini M. Semin Thromb
Hemost 2011;37:66-76.
588.
Glycoprotein IIb/IIIa inbibitors: an update on mechanism of action and use of functional testing methods to
assess antiplatelet efficacy. Lippi G, Montagnana M, Danese E, Favaloro EJ, Franchini M. Biomark Med 2011;5:6370.
589.
Coagulopathies and Thrombosis: Usual and unusual causes and associations, Part IV. Lippi G, Favaloro EJ,
Franchini M. Semin Thromb Hemost 2011;37:175-80.
590.
Prevention of venous thromboembolism: focus on mechanical prophylaxis. Lippi G, Favaloro EJ, Cervellin G.
591.
Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage? Franchini M, Lippi G. Semin
592.
Obstructive sleep apnea syndrome and cardiovascular diseases. Fava C, Montagnana M, Favaloro EJ, Guidi GC,
593.
Nuclear and radiation accidents: the next and further challenge for laboratory diagnostics. Lippi G, Plebani M,
Ruffini L. Clin Chem Lab Med 2011;49:563-5.
594.
Cardiac troponins and physical exercise. It's time to make a point. Lippi G, Cervellin G, Plebani M. Biochem
Med (Zagreb) 2011;21: 55-64.
595.
Laboratory testing and/or monitoring of the new oral antico agulants/antithrombotics: For and against?
Favaloro EJ, Lippi G. Clin Chem Lab Med 2011;49:755-7.
596.
Analytical variability in sport hematology: its importance in an antidoping setting. Banfi G, Lombardi G,
Colombini A, Lippi G. Clin Chem Lab Med 2011;49:779-82.
597.
Prevalence of hemolytic specimens referred for arterial blood gas analysis. Lippi G, Ippolito L, Fontana R. Clin
Chem Lab Med 2011;49:931-2.
598.
The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in
women presenting with pelvic mass: is it really useful? Montagnana M, Danese E, Ruzzenente O, Bresciani V,
Nuzzo T, Gelati M, Salvagno GL, Franchi M, Lippi G, Guidi GC. Clin Chem Lab Med 2011;49:521-5.
599.
Vitamin K in neonates: facts and myths. Lippi G, Franchini M. Blood Transfus 2011;9:4-9.
600.
Direct-to-consumer genomewide profiling. Plebani M, Lippi G. N Engl J Med 2011;364:2074-5.
601.
New ways to deal with known preanalytical issues: use of transilluminator instead of tourniquet for easing
vein access and eliminating stasis on clinical biochemistry. Lima-Oliveira G, Salvagno GL, Lippi G, Montagnana
M, Picheth G, Guidi GC, Scartezini M. Biochem Med (Zagreb) 2011;21:152-9.
602.
Diagnostic criteria for percutaneous coronary intervention -related myocardial infarction time for rev ision?
Lippi G, Cervellin G. J Am Coll Cardiol 2011;58:312-3
603.
High-sensitive troponin testing and the "runner's syndrome". Lippi G, Plebani M. J Emerg Med 2011;41:85-7.
604.
Prehospital qualitative troponin measurement: Is it really worthwhile and needed? Lippi G, Cervellin G. Am J
Cardiol 2011;108:475.
605.
Pathophysiology, clinics and diagnostics of non -thrombotic pulmonary embolism. Montagnana M, Cervellin G,
Franchini M, Lippi G. J Thromb Thrombolysis 2011;31:436-44.
606.
A laboratory standpoint on the role of hemoglob in A1c for the diagnosis of diabetes in childhood: more
doubts than certainties? Lippi G, Targher G. Pediatr Diabetes 2011;12:183-6.
607.
Troubleshooting anaemia in the elderly In reply. Lippi G, Franchini M. Blood Transfus 2011;9:110-1.
608.
Seasonal variations of haematological parameters in athletes. Banfi G, Lundby C, Robach P, Lippi G. Eur J Appl
Physiol 2011;111:9-16.
609.
From music-beat to heart-beat: a journey in the complex interactions between music, brain and heart.
Cervellin G, Lippi G. Eur J Intern Med 2011;22:371-4.
610.
Further advances of normalizing the Preventable Harm Index. Lippi G, Plebani M. J Pediatr 2011;158:1038.
611.
An unusual false positive case of urinary screening for buprenorphine. Lippi G, Romero A, Cervellin G,
Mercadanti M. J Clin Lab Anal 2011;25:244-5.
612.
Inherited and acquired factor V deficiency. Lippi G, Favaloro EJ, Montagnana M, Manzato F, Guidi GC, Franchini
M. Blood Coagul Fibrinolysis 2011;22:160-6.
613.
Laboratory applications for smartphones: risk or opportunity? Lippi G, Plebani M. Clin Biochem 2011;44:273-4.
614.
Cycling: to race or to live - reflections on skewed priorities? Lippi G, Sanchis-Gomar F, Favaloro EJ. Int J
Sports Med 2011;32:648-9.
615.
Normobaric hypoxia and sports: the debate continues. Lippi G, Franchini M, Banfi G. Eur J Appl Physiol
2011;111:159-60.
616.
Acquired factor V inhibitors: a systematic review. Franchini M, Lippi G. J Thromb Thrombolysis 2011;31:449-57.
617.
The measurement of cardiac troponins in patients undergoing major orthopaedic surgery. Lippi G, Cervellin G,
Plebani M. Int Orthop Int Orthop 2011;35:463-4.
618.
Pharmacogenomics of alcohol metabolism: implications for legal testing. Lippi G, Plebani M. Clin Chem Lab Med
2011;49:9-11.
619.
Translational research and sport sciences. Lippi G. Br J Sports Med 2011;45:167.
620.
Regional short-term climate variations influence on the number of visits for renal colic in a large urban
Emergency Department: results of a seven years survey. Cervellin G, Comelli I, Comelli D, Cortellini P, Lippi G,
Meschi T, Borghi L. Intern Emerg Med 2011;6:141-7.
621.
Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence,
guidelines and recommendations. Lippi G, Franchini M, Targher G. Clin Chim Acta 2011;412:797-801.
622.
Identification errors in the blood transfusion laboratory: a stil l relevant issue for patient safety. Lippi G,
Plebani M. Transfus Apher Sci 2011;44:231-3.
623.
Tomatoes, lycopene-containing foods and cancer risk. Lippi G, Targher G. Br J Cancer 2011;104:1234-5.
624.
Point-of-care testing of cardiac biomarkers against standard co re laboratory testing. Lippi G, Aloe R, Cervellin
G. Am J Emerg Med 2011;29:469-7.
625.
Letter to the Editor regarding "Rapid determination of urinary di(2 -ethylhexyl) phthalate metabolites based
on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug
testing". Banfi G, Franchini M, Lippi G. Anal Bioanal Chem 2011;401:577-8.
626.
Biochemistry and physiology of Anabolic Androgenic Steroids doping. Lippi G, Franchini M, Banfi G. Mini-Rev
Med Chem 2011;11:362-73.
627.
Blood cells characteristics as determinants of acute myocardial infarction. Cemin R, Donazzan L, Lippi G, Clari
F, Daves M. Clin Chem Lab Med 2011;49:1231-6.
628.
Laboratory diagnostics and appropriate care of people with haemophilia. Lippi G, Favaloro E. Haemophilia
2011;17:824–5.
629.
Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Lippi G,
Plebani M, Di Somma S, Cervellin G. Crit Rev Clin Lab Sci 2011;48:143-53.
630.
Acquired hemophilia A. Franchini M, Lippi G. Adv Clin Chem 2011;54:71-80.
631.
Significant variation of traditional markers of liver injury after a half -marathon run. Lippi G, Schena F,
Montagnana M, Salvagno GL, Banfi G, GuidiGC. Eur J Intern Med 2011;22:e36-8.
632.
Inflammatory biomarkers for the diagnosis, monitoring and follow -up of community-acquired pneumonia:
clinical evidence and perspectives. Lippi G, Meschi T, Cervellin G. Eur J Intern Med 2011;22:460-5.
633.
Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review.
Franchini M, Lippi G, Targher G. Clin Appl Thromb Hemost 2011;17:387-92.
634.
HE4 in ovarian cancer: from discovery to clinical application. Montagnana M, Danese E, Giudici S, Franchi M,
Guidi GC, Plebani M, Lippi G. Adv Clin Chem 2011;55:1-20.
635.
Transillumination: a new tool to elimin ate the impact of venous stasis during the procedure for the collection
of diagnostic blood specimens for routine haematological testing. Lima-Oliveira G, Lippi G, Salvagno GL,
Montagnana M, Scartezini M, Guidi GC, Picheth G. Int J Lab Hematol 2011;33:457-62.
636.
The significance of protein S-100B testing in cardiac arrest patients. Lippi G, Aloe R, Numeroso F, Cervellin G.
Clin Biochem 2011;44:567-75.
637.
The renal functional parameters during early and late recovery periods following an all -out 21-km run in
trained adolescent runners. Tian Y, Tong TK, Lippi G, Huang C, Shi Q, Nie J. Clin Chem Lab Med 2011;49:993-7.
638.
The usefulness of troponin testing in the diagnostics of non -thrombotic pulmonary embolism. Lippi G,
Montagnana M, Cervellin G. Int J Cardiol 2011;149:259-60.
639.
Elimination of the venous stasis error for routine coagulation testing by transillumination. Lima-Oliveira G,
Salvagno GL, Lippi G, Montagnana M, Scartezini M, Picheth G, Guidi GC. Clin Chim Acta 2011;412:1482-4.
640.
Preanalytical quality improvement: from dream to reality. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R,
Giavarina D, Grankvist K, Huisman W, Kouri T, Palicka V, Plebani M, Puro V, Salvagno GL, Sandberg S, Sikaris K,
Watson I, Stankovic AK, Simundic AM. Clin Chem Lab Med 2011;49:1113-26.
641.
Bayesian network approach to detect laboratory errors: focus on likelihood ratio and critical difference. Lippi
G, Guidi GC. Artif Intell Med 2011;52:193.
642.
Human Chorionic Gonadotropin in pregnancy diagnostics. Montagnana M, Trenti T, Aloe R, Cervellin G, Lippi G.
Clin Chim Acta 2011;412:1515-20
643.
Closing the brain-to-brain loop in laboratory testing. Plebani M, Lippi G. Clin Chem Lab Med 2011 49:1131-3.
644.
Re: Jean-Nicolas Cornu, Géraldine Cancel-Tassin, Valérie Ondet, et al. Olfactory Detection of Prostate Can cer
by Dogs Sniffing Urine: A Step Forward in Early Diagnosis. Eur Urol 2011;59:197-201. Lippi G. Eur Urol
2011;60:e29.
645.
Athlete’s biological passport: to test or not to test? Lippi G, Plebani M. Clin Chem Lab Med 2011;49:1393-5.
646.
Arterial thrombus formation in cardiovascular disease. Lippi G, Franchini M, Targher G. Nat Rev Cardiol
2011;8:502-12.
647.
Quality indicators for laboratory diagnostics: consensus is needed. Plebani M, Sciacovelli L, Lippi G. Ann Clin
Biochem 2011;48:479.
648.
Influence of temperature and period of freezing on the generation of hemolysate and blood cell lysate. Lippi
G, Musa R, Aloe R, Mercadanti M, Pipitone S. Clin Biochem 2011;44:1267-9.
649.
Physiological adaptations of a mature adult walking the alps. Ardigò LP, Lippi G, Salvagno GL, Schena F. Wild
Environ Med 2011;22:236-41.
650.
A journey with Euterpe. Sinfonia concertante for music, heart and brain. Cervellin G, Lippi G. Recenti Prog
Med 2011;102:352-8.
651.
Suitability of a transport box for blood samples shipment over a long period. Lippi G, Lima Oliveira G, Coutino
Nazer S, Lopes Moreira ML, Macedo Souza RF, Salvagno GL, Montagnana M, Scartezini M, Picheth G, Guidi GC. Clin
Biochem 2011;44:1028-9.
652.
The measurement of hemoglobin A2 and F in stored whole blood samples. Mercadanti M, Romero A, Lippi G.
Clin Lab 2011;57:777-80.
653.
Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens.
Lippi G, Avanzini P, Pavesi F, Bardi M, Ippolito L, Aloe R, Favaloro EJ. Biochem Med (Zagreb) 2011; 21:297–305.
654.
Evaluation of hematocrit bias on blood glucose measurement with six different portable glucose meters.
Daves M, Cemin R, Fattor B, Cosio G, Salvagno GL, Rizza F, Lippi G. Biochem Med (Zagreb) 2011;21:306–11.
655.
Comparative evaluation of Capillary Zone Electrophoresis and HPLC in the determination of Carbohydratedeficient Transferrin. Daves M, Cemin R, Floreani M, Pusceddu I, Cosio G, Lippi G. Clin Chem Lab Med
2011;49:1677-80.
656.
Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune
rheumatic disease: conclusive results. Bonaguri C, Melegari A, Ballabio A, Parmeggiani M, Russo A, Battistelli L,
Aloe R, Trenti T, Lippi G. Autoimmun Rev 2011;11:1-5.
657.
Immune tolerance induction for patients with severe hemophilia A: a cri tical literature review. Franchini M,
Lippi G. J Thromb Thrombolysis 2011;32:439-47.
658.
Stability of Haematological Parameters and Its Relevance on the Athlete's Biological Passport Model . Lombardi
G, Lanteri P, Colombini A, Lippi G, Banfi G. Sports Med 2001;41:1033-42.
659.
Antisense therapy in the treatment of hypercholesterolemia. Lippi G, Favaloro EJ. Eur J Intern Med
2011;22:541-6.
660.
p2PSA but not total and free PSA increases after myocardial infarction: results of a preliminary investigation.
Lippi G, Aloe R, Cervellin G. Int J Cardiol 2011;153:119.
661.
The health risks of acute exercise should also matter to internal medicine. Lippi G, Sanchis-Gomar F. Eur J
Intern Med 2011;22:e143.
662.
Direct-to-consumer testing: more risks than opportunities. Lippi G, Favaloro EJ, Plebani M. Int J Clin Pract
2011;65:1221-9.
663.
Coagulopathies and thrombosis: usual and unusual causes and associations. Part V. Favaloro EJ, Franchini M,
664.
Holiday thrombosis. Lippi G, Franchini M, Favaloro EJ. Semin Thromb Hemost 2011;37:869–74.
665.
Doping and thrombosis in sports. Lippi G, Banfi G. Semin Thromb Hemost 2011;37:918-28.
666.
Thrombosis and occlusion of vascular access in hemodialyzed patients. Montagnana M, Meschi T, Borghi L, Lippi
G. Semin Thromb Hemost 2011;37:946-54.
667.
Laboratory testing of anticoagulants: the present and the future. Favaloro EJ, Lippi G, Koutts J. Pathology
2011;43:682-92.
668.
Erythropoietin and myocardial infarction. Sanchis-Gomar F, Martinez-Bello VE, Lippi G. Clin Transl Sci
2011;4:478.
669.
Appropriate labelling of blood collection tubes: a step ahead towards patients safety. Lippi G, Sonntag O,
670.
Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dar k in
clinical laboratory testing? Favaloro EJ, Plebani M, Lippi G. Clin Chem Lab Med 2011;49:1965-73.
671.
Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu -TnI and overview
of the literature. Lippi G, Avanzini P, Dipalo M, Aloe R, Cervellin G. Clin Chem Lab Med 2011;49:2097-2100.
672.
Persistent HyperCKemia in Athletes. Brancaccio P, Maffulli N, Politano L, Lippi G, Limongelli FM. Muscles
Ligaments Tendons J 2011;1:31-5.
673.
Mean temperature and humidity variations, along with pa tient age, predict the number of visits for renal
colic in a large urban Emergency Department: Results of a 9 -year survey. Cervellin G, Comelli I, Comelli D,
Meschi T, Lippi G, Borghi L. J Epidemiol Global Health 2012;2:31-8.
674.
Predictable impact of routine implementation of CKD-EPI equation for estimating the glomerular filtration
rate by a simulation study. Lippi G, Meschi T, Borghi L, Targher G. RIMeL/IJLM 2012;8:107–13.
675.
Prostate-Specific Antigen (PSA) Isoform p2PSA in prostate cancer screening: systematic review of current
evidence and further perspectives. Lippi G, Aloe R, Mattiuzzi C. RIMeL/IJLM 2012;8:231-8.
676.
The concentration of plasma ethanol measured with an enzymatic assay is decreased in hemolyzed specimens.
Lippi G, Mercadanti M, Musa R, Aloe R, Ce rvellin G. Clin Chim Acta 2012;413:356-7.
677.
Front-of-package nutrition labeling and obesity implications. Sanchis-Gomar F, Lippi G. Am J Prev Med
2012;42:e1.
678.
Influence of mechanical trauma of blood and hemolysis on PFA -100 testing. Lippi G, Fontana R, Avanzini P,
Aloe R, Ippolito L, Sandei F, Favaloro EJ. Blood Coagul Fibrinolysis 2012;23:82–6.
679.
Vitamin D, thrombosis, and hemostasis: more than skin deep. Targher G, Pichiri I, Lippi G. Semin Thromb
Hemost 2012:38:114-23.
680.
Molar expression: interconverting result s of highly sensitive troponin
significance. Guidi GC, Lippi G. Clin Biochem 2012;45:183.
I and T while preserving clinical
681.
Baseline and post-exercise N-terminal pro-B-type natriuretic Peptide values are associated with body mass
index. Lippi G, Schena F, Guidi GC. Am J Cardiol 2012;109:303-4.
682.
Genetic and clinical aspects of Brugada syndrome: an update. Lippi G, Montagnana M, Meschi T, Comelli I,
Cervellin G. Adv Clin Chem 2012;56:197-208.
683.
Variation of activated partial thromboplastin time according to age and gender in a large population study:
analytical and clinical implications. Lippi G, Meschi T, Borghi L. Blood Coagul Fibrinolysis 2012;23:177-8.
684.
Optimal therapy for reduction of lipoprotein(a). Lippi G, Targher G. J Clin Pharm Ther 2012;37:1-3.
685.
Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Lippi G, Mercadanti M, Aloe R,
Targher G. Eur J Intern Med 2012;23:150-3.
686.
Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Favaloro EJ,
Adcock DM, Lippi G. Lab Medicine 2012;43:1-10.
687.
Biomedical research platforms and their influence on article submissions and journal rankings: An update.
Lippi G, Favaloro EJ, Simundic AM. Biochem Med (Zagreb) 2012,22:7-14.
688.
Non-commutability of results of highly sensitive troponin I and T immunoassays. Lippi G, Cervellin G, Aloe R,
Montagnana M, Salvagno GL, Guidi GC. Biochem Med (Zagreb) 2012;22:127–9.
689.
Random plasma glucose measurement may improve the diagnostic specificity of highly sensitive troponin in
the emergency department. Lippi G, Cervellin G, Targher G. Int J Cardiol 2012;155:172-3.
690.
Biological variation and reference change values: an essential piece of the puzzle of laboratory testing.
Plebani M, Lippi G. Clin Chem Lab Med 2012;50:189–190.
691.
Considerations for early acute myocardial infarction rule -out for emergency department chest pain patients:
the case of copeptin. Lippi G, Plebani M, Di Somma S, Monzani V, Tubaro M, Volpe M, Moscatelli P, Vernocchi A,
Cavazza M, Galvani M, Cappelletti P, Marenz i G, Ferraro S, Lombardi A, Peracino A. Clin Chem Lab Med
2012;50:243-53.
692.
Fibrinogen replacement therapy: a critical review of the literature. Franchini M, Lippi G. Blood Transfus
2012;10:23-7.
693.
Analytical performance of the new ACL AcuStar HemosIL D -Dimer. Lippi G, Ippolito L, Russello T, Ponzo V,
Salvagno GL, Guidi GC. Blood Coagul Fibrinolysis 2012;23:164-7.
694.
Laboratory diagnosis of acute pancreatitis: in search of the Holy Grail. Lippi G, Valentino M, Cervellin G. Crit
Rev Clin Lab Sci 2012;49:18-31.
695.
Better care for diabetics: e-medicine is the goal. Lippi G. Arch Intern Med 2012;172:373.
696.
Acquired inhibitors of coagulation factors: Part II. Franchini M, Lippi G, Favaloro EJ. Semin Thromb Hemost
2012:38:1-7.
697.
Higher random plasma glucose level is associated with increased plasma cardiac troponin in emergency
department patients with suspected acute coronary syndrome. Lippi G, Montagnana M, Targher G. Am J Cardiol
2012;109:775-6.
698.
Influence of in vitro hemolysis on hematological testing on Advia 2120. Lippi G, Musa R, Avanzini P, Aloe R,
Pipitone S, Sandei F. Int J Lab Hematol 2012;34:179-84.
699.
Plasticizer detection in urine samples after autologous blood transfusion. Sanchis-Gomar F, Banfi G, Lippi G.
Transfusion 2012;52:680-1.
700.
Mean platelet volume increases with aging in a large population study. Lippi G, Meschi T, Borghi L. Thromb Res
2012;129:e159-60.
701.
Telmisartan as metabolic modulator: a new perspective in sports doping? Sanchis-Gomar F, Lippi G. J Strength
Cond Res 2012;26:608-10.
702.
Hemolysis, lipaemia and icterus in specimens for arterial blood gas analysis. Salvagno GL, Lippi G, Gelati G,
Guidi GC. Clin Biochem 2012;45:372-3.
703.
The role of resistin in colorectal cancer. Danese E, Montagnana M, Minicozzi AM, Bonafini S, Ruzzenente O,
Gelati M, De Manzoni G, Lippi G, Guidi GC. Clin Chim Acta 2012;413:760-4.
704.
Biochemical and genetic markers of erectile dysfunction. Lippi G, Plebani M, Montagnana M, Cervellin G. Adv
Clin Chem 2012;57:139-62.
705.
Coagulopathies and thrombosis: usual and unusual causes and associations, Par t VI. Lippi G, Favaloro EJ.
706.
Coffee intake and cardiovascular disease: virtue does not take center stage. Montagnana M, Favaloro EJ, Lippi
707.
Hemostatic properties of the lymph: relation ships with occlusion and thrombosis. Lippi G, Favaloro EJ,
Cervellin G. Semin Thromb Hemost 2011;38:213-21.
708.
Degradation of troponin I in serum or plasma: mechanisms, analytical and clinical implications. Lippi G,
Cervellin G. Semin Thromb Hemost 2011;38:222-9.
709.
Evaluation of the analytical performances of the novel Beckman Coulter AU5800. Lippi G, Dipalo M, Musa R,
Avanzini P, Ferrarini C, Pattini A, Aloe R. Clin Biochem 2012;45:502-4.
710.
Influence of hemolysis on routine laboratory cardiac markers testing. Daves M, Salvagno GL, Cemin R, Gelati M,
Cervellin G, Guidi GC, Lippi G. Clin Lab 2012;58:333-6.
711.
Serum levels of protein S100B predict intracranial lesions in mild head injury. Cervellin G, Benatti M,
Carbucicchio A, Mattei L, Cerasti D, Aloe R, Lippi G. Clin Biochem 2012;45:408-11.
712.
Canine olfactory detection of cancer versus laboratory testing: myth or opportunity? Lippi G, Cervellin G. Clin
Chem Lab Med 2012;50;435-9.
713.
Interference studies: focus on blood cells lysate preparation and testing. Lippi G. Clin Lab 2012;58:351-5.
714.
Comparison of high sensitivity and contemporary troponin I immunoassays for the early detection of acute
myocardial infarction in the emergency department. Lippi G, Cervellin G, Robuschi E, Salvagno GL, Montagnana
M, Aloe R, Guidi GC. Ann Clin Biochem 2012;49:205-6.
715.
Primary blood tubes mixing: time for updated recommendations. Lippi G, Plebani M. Clin Chem Lab Med
2012;50:599–600.
716.
The role of red blood cells distribution width in cardiovascular and thrombotic disorders. Montagnana M,
Cervellin G, Meschi T, Lippi G. Clin Chem Lab Med 2012;50:635–41.
717.
Mid-stream versus first-voided urine collection by using automated analyzers for particle examination in
healthy subjects: an italian multicentre study. Manoni F, Gessoni G, Alessio MG, Caleffi A, Saccani G, Silvestri
MG, Poz D, Ercolin M, Tinello A, Valverde S, Ottomano G, Lippi G. Clin Chem Lab Med 2012;50:679–84.
718.
Serum concentration of neopterin on admission does not improve the diagnostic performance of highly sensitive troponin I. Montagnana M, Lippi G, Danese E, Salvagno GL, Cervellin G, Guidi GC. Clin Chem Lab Med
2012;50:747–8.
719.
Combination of copeptin and highly sensitive troponin I for diagnosing acute myocardial infarction at
emergency department admission. Lippi G, Aloe R, Dipalo M, Cervellin G. Clin Lab 2012;58:357-60.
720.
Comparison of conventional and highly-sensitive troponin I measurement in ultra -marathon runners. Lippi G,
Schena F, Salvagno GL, Tarperi C, Aloe R, Guidi GC. J Thromb Thrombolysis 2012;33:338-42.
721.
The financial crisis implications on the expected 2012 Olympics public health effect. Sanchis-Gomar F,
Martinez-Bello VE, Pareja-Galeano H, Lippi G. Perspect Public Health 2012;132:59.
722.
Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery . Sanchis-Gomar
F, Viña J, Lippi G. J Cell Mol Med 2012;16:1150-4.
723.
Neutrophil Gelatinase-Associated Lipocalin: a more specific assay is needed for diagnosing renal injury. Lippi
G, Cervellin G. Clin Chim Acta 2012;413:1160-1.
724.
Reference values and the journal: why the past is now present. Plebani M, Lippi G. Clin Chem Lab Med
2012;50:761–3.
725.
Reference change values may need some improvement but are invaluable tools in laboratory medicine. Fraser
CG, Lippi G, Plebani M. Clin Chem Lab Med 2012;50:963-4.
726.
Serum oxidant and antioxidant status in adolescents undergoing professional endurance sports training. Tong
TK, Lin H, Lippi G, Nie J, Tian Y. Ox Med Cell Longevity 2012;2012:741239.
727.
Different manufacturers of syringes: A new source of variability in blood gas, acid –base balance and related
laboratory test? Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Clin Biochem
2012;45:683–7.
728.
Anti-"negative-doping" testing: a new perspective in anti -doping research? Lippi G, Sanchis-Gomar F, Banfi G.
Eur J Appl Physiol 2012;112:2383–4.
729.
Hbmass for Anti-Doping Purposes Should be Assessed in Combination with Hemoglobin and Blood Volume.
Sanchis-Gomar F, Lippi G. Int J Sports Med 2012;33:502.
730.
Biological therapies for von Willebrand Disease. Favaloro EJ, Franchini M, Lippi G. Expert Opin Biol Ther
2012;12:551-64.
731.
Preanalytical phase – a continuous challenge for laboratory professionals. Simundic AM, Lippi G. Biochem Med
(Zagreb) 2012;22:145-9.
732.
Preanalytical management: serum vacuum tubes validation for routine clinical chemistry. Lima-Oliveira G,
Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Biochem Med (Zagreb) 2012;22:180-6.
733.
Incomplete filling of lithium heparin tubes affects the activity of creatine kinase and
glutamyltransferase. Lippi G, Avanzini P, Cosmai M, Aloe R, Ernst D. Br J Biomed Sci 2012;69:67-70.
734.
Acquired Inhibitors of Coagulation Factors: Part II. Franchini M, Lippi G, Favaloro EJ. Semin Thromb Hemost
2012;38:447-53.
735.
Spurious hemolysis does not influence the reliability of digoxi n testing on Siemens RXL MAX and Roche Cobas
e601. Lippi G, Mercadanti M, Romero A, Lipreri G, Salvagno GL, Guidi GC. Ann Clin Lab Sci 2012;42:301-5.
736.
Highly sensitive troponin immunoassays: navigating between the Scylla and Charybdis. Lippi G, Montagnana M,
Aloe R, Cervellin G. Adv Clin Chem 2012;58:1-29.
737.
Achievement of a median door-to-balloon time of less than 90 minutes by implementation of organizational
changes in the 'Emergency Department to Cath Lab' pathway. A five - year analysis. Comelli I, Vignali L, Rolli
A, Lippi G, Cervellin G. J Eval Clin Pract 2012;18:788-92.
738.
Influence of mechanical hemolysis of blood on two D -dimer immunoassays. Lippi G, Avanzini P, Zobbi V,
Ippolito L. Blood Coagul Fibrinolysis 2012;23:461-3.
739.
Influence of a regular, standardised meal on clinical chemistry analytes. Lima-Oliveira G, Salvagno GL, Lippi G,
Gelati M, Montagnana M, Danese E, Picheth G, Guidi GC. Ann Lab Med 2012;32:250-6.
740.
An unusual case of a primary blood collection tube with floating separator gel. Daves M, Lippi G, Cosio G,
Alberto R, Peer E, Dangella A, Oberhollenzer T, Cemin R. J Clin Lab Anal 2012;26:246-7.
741.
Inherited disorders of blood coagulation. Lippi G, Franchini M, Montagnana M, Favaloro EJ. Ann Med
2012;44:405-18.
742.
Serum but not urine concentration of neutrophil gelatinase-associated lipocalin is influenced by acute
leukocyte variations. Lippi G, Salvagno GL, Banfi G. Leuk Lymphoma 2012;53:1643-5.
743.
The predictive value of plasma Neutrophil Gelatinase -Associated Lipocalinon cardiovascular death and all cause mortality might be mediated by leukocytosis. Lippi G, Cervellin G. J Am Coll Cardiol 2012;60:564.
744.
Is phlebotomy part of the dark side in the clinical laboratory struggle for quality? Lima-Oliveira G, Guidi GC,
Salvagno GL, Montagnana M, Rego FGM, Lippi G, Picheth G. Lab Medicine 2012;43:172-6.
745.
EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a
clinically threatening artifact. Lippi G, Plebani M. Clin Chem Lab Med 2012;50:1281-5.
746.
Laboratory medicine and sports: between Scylla and Charybdis. Lippi G, Banfi G, Botrè F, de la Torre X, De
Vita F, Gomez-Cabrera MC, Maffulli N, Marchioro L, Pacifici R, Sanchis -Gomar F, Schena F, Plebani M. Clin Chem
Lab Med, 2012;1309-16.
gamma -
747.
A comparative study on the reliability of an automated system for the evaluation of cell-based indirect
immunofluorescence. Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G. Autoimmun Rev 2012;11:7136.
748.
Epigenetic biomarkers: a new perspective in laboratory diagnostics. García-Giménez JL, Sanchis-Gomar F, Lippi
G, Mena S, Ivars D, Gomez-Cabrera MC, Viña J, Pallardó FV. Clin Chim Acta 2012 413:1576-82.
749.
Discard tube for coagulation testing: the debate continues. Lippi G, Adcock D, Favaloro EJ. Blood Coagul
Fibrinolysis 2012;23:572-3.
750.
K3EDTA vacuum tubes validation for routine hematological testing. Lima-Oliveira G, Lippi G, Salvagno GL,
Montagnana M, Poli G, Solero GP, Picheth G, Guidi GC. ISRN Hematol, 2012;2012:875357.
751.
Irisin: a new potential hormonal target for treatment of obesity and ty pe II diabetes. Sanchis-Gomar F, Lippi
G, Mayero S, Perez-Quilis C, García-Giménez JL. J Diabetes 2012;4:196.
752.
Quality in hemostasis and thrombosis-part I. Favaloro EJ, Plebani M, Lippi G. Semin Thromb Hemost
2012;38:549-52.
753.
Patient safety and quality in laboratory and hemostasis testing: a renewed loop? Plebani M, Favaloro EJ, Lippi
754.
Quality standards for sample collection in coagulation testing. Lippi G, Salvagno GL,
Oliveira G, Guidi GC, Favaloro EJ. Semin Thromb Hemost 2012;38:565–75.
755.
Quality standards for sample processing, transportation, and storage in hemostasis testing. Adcock Funk DM,
Lippi G, Favaloro EJ. Semin Thromb Hemost 2012;38:576-85.
756.
Estimation of glomerular filtration rate in acute ki dney injury. Lippi G, Cervellin G. Clin Chim Acta
2012;404:34-5.
757.
ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Franchini M, Favaloro EJ, Targher G,
Lippi G. Crit Rev Clin Lab Sci 2012;49:137-49.
758.
Foot-strike hemolysis after a 60-km ultramarathon. Lippi G, Schena F, Salvagno GL, Aloe R, Banfi G, Guidi GC.
Blood Transfus 2012;10:377-83.
759.
Identification of spurious hemolysis in anticoagulated blood with Sysmex XE -2100 and Siemens Advia 2120.
Lippi G, Pipitone S, Gennai D, Franchini M. Clin Lab 2012;58:801-4.
760.
Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective. Lippi G, Plebani M. Clin Chem
Lab Med 2012;50:1483-7.
761.
Evaluation of NGAL Test™, a fully-automated Neutrophil gelatinase-associated lipocalin (NGAL) immun oassay
on Beckman Coulter AU 5822. Lippi G, Aloe R, Storelli A, Cervellin G, Trenti T. Clin Chem Lab Med
2012;50:1581–4.
762.
Variation of serum and urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) after strenuous physical
exercise. Lippi G, Sanchis-Gomar F, Salvagno GL, Aloe R, Schena F, Guidi GC. Clin Chem Lab Med 2012;50:1585–9.
763.
Current limitations and future perspectives of the Athlete Blood Passport. Lippi G, Plebani M, Sanchis-Gomar
F, Banfi G. Eur J App Physiol 2012;112:3693–4.
764.
Troponin I measured with a high sensitivity immunoassay is early and significantly increased after a half
marathon run. Lippi G, Schena F, Dipalo M, Montagnana M, Salvagno GL, Aloe R, Guidi GC. Scand J Clin Lab Invest
2012;72:467-70.
765.
Hemoglobin A1c and diagnosis of diabetes . Not ready for the prime time? Lippi G, Targher G. Ann Clin Biochem
2012;49:508.
766.
Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and
prolonged APTT. Lippi G, Favaloro EJ, Franchini M. J Thromb Thrombolysis 2012;34:360-6.
767.
Paradoxical thrombosis part 2: anticoagulant and antiplatelet therapy. Lippi G, Favaloro EJ, Franchini M. J
Thromb Thrombolysis 2012;34:367-73.
768.
Analytical evaluation of Sysmex UF-1000i for flow cytometric analysis of peritoneal fluid. Buoro S, Gustinetti
R, Dominoni P, Alessio MG, Filisetti P, Lucà MG, Fagioli S, Ottomano C, Lippi G. Clin Biochem 2012;45:1263-5.
769.
Pistorious at the Olympics: the saga continues. Lippi G. Brit J Sports Med 2012;46:896.
770.
The new oral anticoagulants and the future of haemostasis laboratory testing. Favaloro EJ, Lippi G. Biochem
Med (Zagreb) 2012;22:329-41.
771.
Laboratory networking and sample quality: a still relevant issue for patient safety. Lippi G, Simundic AM. Clin
Chem Lab Med 2012;50:1703-5.
772.
Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120.
Pipitone S, Pavesi F, Testa B, Bardi M, Perri GB, Gennai D, Lippi G. Clin Chem Lab Med 2012;50:1857-9.
773.
Impact of the phlebotomy training based on CLSI/NCCLS H03 -A6 – procedures for the collection of diagnostic
blood. Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Biochem Med (Zagreb)
2012;22:342-51.
774.
Standardized designation
2012;70:1095-6.
775.
Meat consumption and cancer risk: is the definition of red meat always suitable? Lippi G, Mattiuzzi C. Ann
Oncol 2012;23:2993-4.
776.
Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning. Lippi
G, Rastelli G, Meschi M, Borghi L, Cervellin G. Clin Biochem 2012;45:1278–85.
777.
The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older
persons. Maggio M, Cattabiani C, Lauretani F, Artoni A, Bandinelli S, Schiavi G, Vig nali A, Volpi R, Ceresini G,
Lippi G, Aloe R, De Vita F, Giallauria F, McDermott MM, Ferrucci L, Ceda GP. Atherosclerosis 2012;225:469-74.
778.
Phlebotomy, stat testing and laboratory organization: an intriguing relationship. Lippi G, Simundic AM, Plebani
M. Clin Chem Lab Med 2012;50:2065–8.
779.
Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? Lippi G,
Plebani M. Clin Chem Lab Med 2012;50:2075–80.
of
commercial
troponin
immunoassays.
Lippi
G,
Montagnana M, Lima-
Cervellin
G.
Kardiol
Pol
780.
The emerging role of biomarkers and bio -impedance in evaluating hydration sta tus in patients with acute
heart failure. Di Somma S, Navarin S, Giordano S, Spadini F, Lippi G, Cervellin G, Dieffenbach BV, Maisel AS. Clin
Chem Lab Med 2012;50:2093–105.
781.
Position Paper on Laboratory Testing for Patients Taking New Oral Anticoagulants. Consensus Document of
FCSA, SIMeL, SIBioC and CISMEL. Tripodi A, Di Iorio D, Lippi G, Testa S, Manotti C. Clin Chem Lab Med
2012;50:2137–40.
782.
Further insights on the relationship between bilirubin and C -reactive protein. Lippi G, Targher G. Clin Chem
Lab Med 2012;50:2229–30.
783.
Physical exercise as an epigenetic modulator. Eustress, the "positive stress" as an effector of gene
expression. Sanchis-Gomar F, Garcia-Gimenez JL, Perez-Quilis C, Gomez-Cabrera MC, Pallardo FV, Lippi G. J
Strength Cond Res 2012;26:3469-72.
784.
Identification of troponin determinants for improving its diagnostic performance in the Emergency
Department. Lippi G, Cervellin G. J Emerg Med 2012;43:e487-8.
785.
Pregnancy-associated plasma protein A (PAPP-A) for the early diagnosis of myocardial infarct ion: more doubts
than certainties. Lippi G, Mattiuzzi C, Cervellin G. Indian Heart J 2012;64:625-6.
786.
Relationship between sampling volume of primary serum tubes and spurious hemolysis. Lippi G, Musa R,
Battistelli L, Cervellin G. Clin Lab 2012;58:1187-91.
787.
Vitamin D concentration and deficiency across different ages and genders. Lippi G, Montagnana M, Meschi T,
Borghi L. Aging Clin Exp Res 2012;24:548-51.
788.
Unusual immunofluorescence pattern on HEp-2 cells. Daves M, Bonaguri C, Scala S, Cosio G, Floreali M, Pe er E,
Lippi G. RIMeL/IJLM 2012;8:54-7.
789.
Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50 -year-old journal. Lippi G,
Gillery P, Kazmierczak P, Lackner KJ, Melichar M, Siest G, Whitfield JB, Janke H, Plebani M. Clin Chem Lab Med
2013;51:5-7.
790.
Laboratory hemostasis: milestones in Clinical Chemistry and Laboratory Medicine. Lippi G, Favaloro EJ. Clin
Chem Lab Med 2013;51:91-7.
791.
Preanalytical quality improvement: in quality we trust. Lippi G, Becan-McBride K, Behúlová D, Bowen RA,
Church S, Delanghe J, Grankvist K, Kitchen S, Nybo M, Nauck M, Nikolac N, Palicka V, Plebani M, Sandberg S,
Simundic AM. Clin Chem Lab Med 2013;51:229-41.
792.
Neutrophil Gelatinase-Associated Lipocalin (NGAL), neutrophils and chronic kidney disease: which come s
first? Lippi G, Cervellin G. Am J Kidney Dis 2013;61:184.
793.
Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and
troponin for early diagnosis of acute myocardial infarction. Lippi G, Mattiuzzi C, Cervellin G. Clin Biochem
2013;46:26-30.
794.
Evaluation of white blood cell count in peritoneal fluid with five different hemocytometers. Lippi G,
Cattabiani C, Benegiamo A, Gennari D, Pavesi F, Caleffi A, Pipitone S. Clin Biochem 2013;46:173-6.
795.
Serum gamma-glutamyltransferase and alanine aminotransferase levels are correlated with hematocrit in a
general population of outpatients. Lippi G, Danese E, Montagnana M. Scand J Clin Lab Invest 2013;73:95-6.
796.
Effects of vigorous mixing of blood vacuum tubes on laboratory tes t results. Lima-Oliveira G, Lippi G, Salvagno
GL, Montagnana M, Gelati M, Volansi W, Boritiza KC, Picheth G, Guidi GC. Clin Biochem 2013;46:250-4.
797.
Letter by Lippi and Cervellin Regarding Article, "High -sensitivity Cardiac Troponin in the Distinction of Acu te
Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease". Lippi G, Cervellin G. Circulation
2013;127:e353.
798.
Assessment of neutrophil gelatinase-associated lipocalin and lactate dehydrogenase in peritoneal fluids for
the screening of bacterial peritonitis. Lippi G, Caleffi A, Pipitone P, Elia G, Ngah A, Aloe R, Avanzini P, Ferrari
C. Clin Chim Acta 2013;418:59-62.
799.
Mean platelet volume in patients with ischemic heart disease: meta -analysis of diagnostic studies. Lippi G,
Mattiuzzi C, Comelli I, Cervellin G. Blood Coagul Fibrinolysis 2013;24:216-9.
800.
Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics. Lippi G, Mattiuzzi C.
801.
Novel and Emerging Therapies: Thrombus-Targeted Fibrinolysis. Lippi G, Mattiuzzi C, Favaloro EJ. Semin
802.
Evaluation of the current prognostic role of cardiogenic syncope. Numeroso F, Mossini G, Lippi G, Cervellin G.
Intern Emerg Med 2013;8:69-73.
803.
Massive posttraumatic bleeding: epidemiol ogy, causes, clinical features and therapeutic management. Lippi
G, Favaloro EJ, Cervellin G. Semin Thromb Hemost 2013;39:83-93.
804.
Relationship between red blood cell distribution width and prognostic biomarkers in patients admitted to the
emergency department with acute infections. Lippi G, Teti L, Dipalo M, Cervellin G. Eur J Intern Med
2013;24:e15-6.
805.
Biomarkers of myocardial ischemia in the emergency room: cardiospecific troponin and beyond. Lippi G. Eur J
Intern Med 2013;24:97-9.
806.
Antiplatelet therapy in marathon runners: more harm then benefits? Lippi G, Sanchis-Gomar F, Cervellin G. Am
J Med 2013;126:e19.
807.
Improvement in sprint performance: doping or nature? Lippi G, Sanchis-Gomar F. Drug Test Anal 2013;5: 135.
808.
Evaluation of sample hemolysis in blood colle cted by S-Monovette® using vacuum or aspiration mode. Lippi G,
Avanzini P, Musa R, Sandei F, Aloe R, Cervellin G. Biochem Med (Zagreb) 2013;23:64-9.
809.
Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta -analysis. Lippi
G, Mattiuzzi C, Comelli I, Cervellin G. Biochem Med (Zagreb) 2013;23:78-82.
810.
Effects of acute exercise and allopurinol administration on soluble urokinase plasminogen activator receptor
(suPAR). Sanchis-Gomar F, Bonaguri C, Pareja-Galeano H, Gomez-Cabrera MC, Candel J, Viña J, Lippi G. Clin Lab
2013;59:207-210.
811.
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. Danese E,
Minicozzi AM, Montagnana M, De Manzoni G, Lippi G, Guidi GC. Clin Lab 2013;59:211-4.
812.
Diagnosis and management of ischemic heart disease. Lippi G, Franchini M, Cervellin G. Semin Thromb Hemost
2013;39:202-13.
813.
A case of acquired haemophilia A. Lippi G, Ippolito L. Biochim Clin 2013;37:128-30.
814.
Blood phosphorus and magnesium levels in 130 elite track an d field athletes. Malliaropoulos N, Tsitas K,
Porfiriadou A, Papalada A, Ames PR, Del Buono A, Lippi G, Maffulli N. Asian J Sports Med 2013;4:49-53.
815.
Continuous flow automation and hemolysis index: a crucial combination. Lippi G, Plebani M. J Lab Autom
2013;18:184-8.
816.
Prostate-Specific Antigen for prostate cancer screening: a different strategy should be planned. Lippi G,
Mattiuzzi C, Cervellin G. JAMA Intern Med 2013;173:392.
817.
Influence of in vitro hemolysis on nucleated red blood cells and reticulocyte count s. Lippi G, Pavesi F,
Cattabiani C, Avanzini P, Pipitone S. Int J Lab Hematol 2013;35:225-8.
818.
Geographical trend of biomedical research: analysis of a decade of publications in an "enlarged" Group of
Eight (G8). Lippi G, Mattiuzzi C. Eur J Intern Med 2013;24:e45-6.
819.
Anemia and anysocytosis in the emergency department: a cross -sectional investigation. Lippi G, Pipitone S,
Campana V, Cervellin G. J Med Biochem 2013;32:104-8.
820.
Personalized (laboratory) medicine: a bridge to the future. Plebani M, Lippi G. Clin Chem Lab Med 2013 51:7036.
821.
Preliminary evaluation of complete blood cell count on Mindray BC -6800. Lippi G, Cattabiani C, Bonomini S,
Bardi M, Pipitone S, Aversa F. Clin Chem Lab Med 2013 51:e65-7.
822.
Quality in Hemostasis and Thrombosis — Part II. Favaloro EJ, Plebani M, Lippi G. Semin Thromb Hemost
2013;39:229–32.
823.
Regulation in Hemostasis and Thrombosis: Part I —In Vitro Diagnostics. Favaloro EJ, Plebani M, Lippi G. Semin
Thromb Hemost 2013;39:235–49.
824.
Interference in Coagulation Testing: Focus on Spurious Hemo lysis, Icterus, and Lipemia. Lippi G, Plebani M,
Favaloro EJ. Semin Thromb Hemost 2013;39:258–66.
825.
The challenges of evaluating scientists by H -index and citations in different biomedical research platforms.
Lippi G, Mattiuzzi C. Clin Chim Acta 2013;421:57-8.
826.
Von Willebrand factor and cancer: a renewed interest. Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G.
Thromb Res 2013;131:290-2.
827.
Diagnostic approach to the mild head trauma of the adult in emergency medicine: between biomarkers and
imaging. Lippi G, Cervellin G. Recenti Prog Med 2013;104:120-32.
828.
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment
with infliximab. Gisondi P, Lora V, Bonauguri C, Russo, A, Lippi G, Girolomoni G. Brit J Dermatol 2013;168:74955.
829.
Prevention of hemolysis in blood samples collected from intravenous catheters. Lippi G, Avanzini P, Cervellin
G. Clin Biochem 2013;46:561-4.
830.
The role of osteoprotegerin in cardiovascular disease. Montagnana M, Lippi G, Danese E, Guidi GC. Ann Med
2013;45:254-64.
831.
Rest heart rate and mortality: more physical exercise for the rabbit? Lippi G, Sanchis-Gomar F, Cervellin G. Int
J Cardiol 2013;165:358.
832.
Ex vivo erythrocyte generation and blood doping. Lombardi G, Banfi G, Lippi G, Sanchis-Gomar F. Blood
Transfus 2013;11:161-3.
833.
Sodium citrate vacuum tubes validation: preventing preanalytical variability in routine coagulation testing.
Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Blood Coagul Fibrinolysis
2013;24:252-55.
834.
Brand of dipotassium EDTA vacuum tube as a new source of pre -analytical variability in routine haematology
testing. Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Poli G, Solero GP, Picheth G, Guidi GC. Br J
Biomed Sci 2013;70:6-9.
835.
Smoking-related mortality in the United States. Lippi G, Mattiuzzi C. N Engl J Med 2013;368:1752.
836.
Routine noninvasive testing and highly sensitive troponin immunoassays. Lippi G, Cervellin G. JAMA Intern Med
2013;173:834-5.
837.
Anemia, heart failure and exercise training. Sanchis-Gomar F, Banfi G, Pareja-Galeano H, Martinez-Bello V,
Lippi G. Int J Cardiol 2013;165:587-8.
838.
Hemoglobin point of care testing: the HemoCue® system. Sanchis-Gomar F, Cortell-Ballester J, Banfi G, Lippi
G. J Lab Autom 2013;18:198-205.
839.
Evaluation of the fully automated hematological analyzer Sysmex XE -5000 for flow cytometric analysis of
peritoneal fluid. Lippi G, Cattabiani C, Benegiamo A, Gennari D, Pavesi F, Caleffi A, Pipitone S. J Lab Autom
2013;18:240-4.
840.
Opinion Paper on innovative approach of biomar kers for infectious diseases and sepsis management in the
Emergency Department. Di Somma S, Magrini L, Travaglino F, Lalle I, Fiotti N, Cervellin G, Avanzi GC, Lupia E,
Maisel A, Hein F, Wagner F, Lippi G. Clin Chem Lab Med 2013;51:1167-75.
841.
Troponin elevation reflects myocardial injury in carbon monoxide poisoning. Montagnana M, Lippi G. Biochim
Clin 2013;37:246-9.
842.
Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: meta -analysis of available studies.
Lippi G, Mattiuzzi C, Cervellin G. Int J Cardiol 2013;167:277-8.
843.
Erythropoietin receptor (EpoR) agonism to treat a wide range of diseases. Sanchis-Gomar F, Perez-Quilis C,
Lippi G. Mol Med 2013;19:62-4.
844.
Critical review and meta-analysis of spurious hemolysis in blood samples collected from intravenous
catheters. Lippi G, Mattiuzzi C, Cervellin G. Biochem Med (Zagreb), 2013;23:193-200.
845.
Avoidance to wipe alcohol before venipuncture is not a source of spurious hemolysis. Salvagno GL, Danese E,
Lima-Oliveira G, Guidi GC, Lippi G. Biochem Med (Zagreb) 2013;23:201-5.
846.
Incorrect order of draw could be mitigate the patient safety: a phlebotomy management case report. LimaOliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Biochem Med (Zagreb) 2013;23:218-23.
847.
Highly-sensitive troponin I in patients admitted to the emergency room with acute infections. Lippi G,
Margapoti R, Aloe R, Cervellin G. Eur J Intern Med 2013;24:e57-8.
848.
Analytical evaluation of the novel Helena V8 capillary electrophoresis system. Lippi G, Battistelli L, Vernocchi
A, Mussap M. J Med Biochem 2013;32:245-9.
849.
Controlling sources of preanalytical variability in doping samples: challenges and solutions. Lippi G, Mattiuzzi
C, Banfi G. Bioanalysis 2013;5:1571-82.
850.
Hemolysis-resistant reagent: another part of the puzzle for preventing errors in laboratory testing. Plebani M,
851.
Development of a novel, hemolysis-resistant reagent for assessment of amylase in biological fluids. Ronda L,
Mozzarelli A, Aloe R, Lippi G. Clin Chem Lab Med 2013;51:1409-15.
852.
Carryover does not affect results of Beckman Coulter highly -sensitive AccuTnI assay on Access 2. Lippi G,
Avanzini P, Musa M, Aloe R, Cervellin G. Clin Chem Lab Med 2013;51:e41-3.
853.
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Lora V,
Bonaguri C, Gisondi P, Sandei F, Battistelli L, Russo A, Melegari A, Trenti T, Lippi G, Girolomoni G. Immunol Res
2013;56:382-9.
854.
Venous Thrombosis Associated with HMG-CoA Reductase Inhibitors. Lippi G, Favaloro EJ, Sanchis-Gomar F.
855.
Quality impact on diagnostic blood specimen collection using a new device to relieve venipuncture pain.
Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Indian J Clin Biochem 2013;28:235-41.
856.
Association between periodontal disease and Interleukin -1β +3953 and vitamin D receptor Taq1 genetic
polymorphisms in an Italian caucasian population. Baldini A, Nota A, Fanti E, Martelli FS, Ottomano C, Lippi G.
Ann Stomatol (Roma) 2013;4:191-5.
857.
The athlete biological passport: facts and drawbacks. Lippi G. Biochim Clin 2013;37:265-7.
858.
Evaluation of Sysmex XE-2100 for enumeration and differentiation of cellular elements in peritoneal and
pleural fluids. Buoro S, Ottomano C, Gustinetti R, Gal liani C, Lochis E, Saleri C, Dominoni P, Lippi G. Biochim
Clin 2013;37:275-8.
859.
Proposal of a checklist for venous blood collection. Lippi G, Mattiuzzi C, Banfi G, Buttarello M, Caputo M, Daves
M, Dolci A, Miconi V, Milanesi B, Montagnana M, Morandini M, Piv a E, Salvagno GL, Troiano T, Cervellin G,
Giavarina G; per il Gruppo di Studio Intersocietario SIBioC -Società Italiana di Medicina di Laboratorio (SIMeL)
Variabilità extra-analitica. Biochim Clin 2013;37:312-7 / RIMeL/IJLM 2013;9:225-31.
860.
Highly-sensitive troponin I is increased in patients with gynecological cancers. Danese E, Montagnana M,
Giudici S, Aloe R, Franchi M, Guidi GC, Lippi G. Clin Biochem 2013;46:1135-8.
861.
Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarker s. Sanchis-Gomar
F, Bonaguri C, Aloe R, Pareja-Galeano H, Martinez-Bello V, Gomez-Cabrera MC, Candel J, Viña J, Lippi G. Transl
Res 2013;162:102-9.
862.
The syndrome of the “obsessive-compulsory scientist”: a new mental disorder? Lippi G, Plebani M, Franchini
M. Clin Chem Lab Med 2013;51:1575–7.
863.
Influence of spurious hemolysis on blood gas analysis. Lippi G, Fontana R, Avanzini P, Sandei F, Ippolito L. Clin
Chem Lab Med 2013;51:1651–4.
864.
Survey of national guidelines, education and training on phlebotomy in 28 Eur opean countries: an original
report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for
the preanalytical phase (WG-PA). Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M, Kovalevskaya S, Sprongl
L, Sumarac Z, Church S. Clin Chem Lab Med 2013;51:1585-93.
865.
The role of biomarkers in diagnosing mild traumatic head injury. Lippi G, Cervellin G, Lui YW. Radiology
2013;268:611-2.
866.
Methodological notes on acquisition and use of close evacuated systems for collection, h andling and storage
of venous blood samples for laboratory diagnostics. Plebani M, Caputo M, Giavarina D, Lippi G. Biochim Clin,
2013;37:244-5.
867.
Consensus document of Italian Federation of Thrombosis Services (FCSA), Italian Society of Laboratory
Medicine (SIMeL), SIBioC e Italian Committee for Standardization of Laboratory Tests (CISMEL) on laboratory
monitoring of the therapy with novel oral anticoagulant drugs. Lippi G, Di Iorio G, Testa S, Manotti C, Tripodi
A. Biochim Clin 2013;37:301-2.
868.
Sample collection and platelet function testing: Influence of vacuum or aspiration principle on PFA -100 test
results. Lippi G, Ippolito L, Zobbi V, Sandei F, Favaloro EJ. Blood Coagul Fibrinolysis 2013;24:666-9.
869.
Choosing troponin immunoassays in a world of limited resour ces. Lippi G, Cervellin G. J Am Coll Cardiol
2013;62:647-8.
870.
Appropriate sample dilution for troponin I testing. Lippi G, Avanzini P, Aloe R, Cervellin G. Am J Emerg Med
2013;31:1278-9.
871.
Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter
methylation in colorectal cancer. Danese E, Minicozzi AM, Benati M, Montagnana M, Paviati E, Salvagno GL,
Gusella M, Pasini F, Guidi GC, Lippi G. Br J Cancer 2013;109:807-13.
872.
Serum oxidant and antioxidant status following an all -out 21-km run in adolescent runners undergoing
professional training - A one-year prospective trial. Tong TK, Kong Z, Lin H, Lippi G, Zhang H, Nie J. Int J Mol
Sci 2013;14:15167-78.
873.
Assay characteristics and diagnostic improvement from contemporary
immunoassays. Lippi G, Cervellin G. Am J Med 2013;126:e9-10.
to
high -sensitivity
troponin
I
874.
Systematical assessment of serum indices does not impair efficiency of clinical chemistry testing: a
multicenter study. Lippi G, Avanzini P, Campioli D, Da Rin G, Dipalo M, Aloe R, Giavarina D, Salvagno GL. Clin
Biochem 2013;46:1281-4.
875.
The clinical and economical burden of drawing blood through intravenous catheters. Lippi G, Bonelli P,
Cervellin G. J Emerg Nurs 2013;39:425-6.
876.
Prognostic value of the OESIL risk score in a cohort of Emergency Department patients with syncope.
Numeroso F, Mossini G, Montali F, Lippi G, Cervellin G. Minerva Med 2013;104:413-9.
877.
Proposal for the use in emergency departments of cardiac troponins measured with the latest generation
methods in patients with suspected acute coronary syndrome without persistent ST -segment elevation.
Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M, Biasucci LM, Cervellin G, Lenzi T , Lippi G,
Plebani M, Tubaro M. Clin Chem Lab Med 2013;51:1727-37.
878.
Biomarker research and leading causes of death worldwide: a rather feeble relationship. Lippi G, Plebani M.
879.
Does laboratory automation for the preanalytical phase improve data quality? Lima-Oliveira G, Lippi G,
Salvagno GL, Danese E, Montagnana M, Brocco G, Voi M, Picheth G, Guidi GC. J Lab Autom 2013;18:375-81.
880.
Technical evaluation of the novel preanalytical module on Instrumentation Laboratory ACL TOP: advancing
automation in hemostasis testing. Lippi G, Ippolito L, Favaloro EJ. J Lab Autom 2013;18:382-90.
881.
Screening for recreational drugs in sports. Balance between fair competition and private life. Lippi G,
Mattiuzzi C. Perfor Enhan Health 2013;2:72-3.
882.
Association of red blood cell distribution width with plasma lipids in a general population of unselected
outpatients. Lippi G, Sanchis-Gomar F, Danese E, Montagnana M. Kardiol Pol 2013;71:931-6.
883.
The mean platelet volume is decreased in patients with mild head trauma and brain injury. Lippi G,
Carbucicchio A, Benfatti M, Cerve llin G. Blood Coagul Fibrinolysis 2013;24:780–3.
884.
Problems and Solutions in Laboratory Testing For Hemophilia. Favaloro EJ, Meijer P, Jennings I, Sioufi J, Bonar
RA, Kitchen DP, Kershaw G, Lippi G. Semin Thromb Hemost 2013;39:816-33.
885.
Influence of Residual Platelet Count on Routine Coagulation, Factor VIII, and Factor IX Testing in Postfreeze Thaw Samples. Lippi G, Rossi R, Ippolito L, Zobbi V, Azzi D, Pipitone S, Favaloro EJ, Adcock Funk DM. Semin
886.
FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors. Franchini M, Coppola A, Tagliaferri A, Lippi G.
887.
Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects. Montagnana
M, Paleari R, Danese E, Salvagno GL, Lippi G, Guidi GC, Mosca A. Clin Chim Acta 2013;423:1-4.
888.
The concentration of highly-sensitive troponin I is increased in patients with brain injury after mild head
trauma. Lippi G, Dipalo M, Carbucicchio A, Aloe R, Benfatti M, Cervellin G. Int J Cardiol 2013;168:1617-8.
889.
Quality management of preanalytical phase: Impact of lithium heparin vacuum tubes changes on clinical
chemistry tests. Lima-Oliveira G, Salvagno GL, Lippi G, Brocco G, Voi M, Montagnana M, Picheth G, Guidi GC.
Accred Qual Assur 2013;18:429-34.
890.
Reduction of gross hemolysis in catheter-drawn blood using Greiner Holdex® tube holder. Lippi G, Avanzini P,
Aloe R, Cervellin G. Biochem Med (Zagreb) 2013;23:303-7.
891.
The effective reduction of tourniquet application time after minor modification of the CLSI H03-A6 blood
collection procedure. Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Picheth G, Guidi GC. Biochem Med
(Zagreb) 2013;23:308-15.
892.
Abdominal Mondor’s disease presenting as acute abdominal pain. Cervellin G, Creta M, Riva M, Di Comite V,
Buttarelli L, Lippi G. Acta Biomed 2013;84:155-8.
893.
Ischemia modified albumin in the era of high sensitivity troponin immunoassays: useful or hype? Lippi G
Cervellin G, Plebani M. Scand J Clin Lab Invest 2013;73:598-9.
894.
SHBG and endothelial function in older subjects. Maggio M, Cattabiani C, Lauretani F, Mantovani M, Buttò V, De
Vita F, Volpi R, Artoni A, Giallauria F, Zuliani G, Aloe R, Lippi G, Ceresini G, Cederholm T, Ceda GP, Lind L. Int J
Cardiol 2013;168:2825-30.
895.
Challenges of serial troponin testing: an unfinished symphony.
2013;168:4397.
896.
Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the
literature. Lippi G, Aloe R, Meschi T, Borghi L, Cervellin G. Clin Chim Acta 2013;426:79-84.
897.
Lipaemic donations: truth and consequences. Lippi G, Franchini M. Transfus Apher Sci 2013;49:181-4.
898.
Point of care troponin testing: rules and regulations. Lippi G, Mattiuzzi M, Cervellin G. J Electrocardiol
2013;46;727-8.
899.
False myths and legends in laboratory diagnostics. Lippi G, Plebani M. Clin Chem Lab Med 2013;51:2087-97.
900.
Intravenous iron therapy in patients with heart failure. A double -edged sword. Lippi G, Sanchis-Gomar F,
Cervellin G. Int J Cardiol 2013;168:4863.
901.
MicroRNAs for diagnosing myocardial infarction. Advantages and limitations. Lippi G, Mattiuzzi C, Cervellin G.
Int J Cardiol 2013;168:4849-50.
902.
Evaluation of diagnostic accuracy of 75th percentile threshold for a contemporary sensitive and a high sensitivity cardiac troponin I immunoassays. Lippi G, Gnocchi C, Cervellin G. Int J Cardiol 2013;168:5045-6.
903.
The order of draw: myth or science? Salvagno GL, Lima-Oliveira G, Brocco G, Danese E, Guidi GC, Lippi G. Clin
Chem Lab Med 2013;51:2281-5.
904.
Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women.
Nouvenne A, Ticinesi A, Guerra A, Allegri F, Pinelli S, Baroni P, Pedrazzoni M, Lippi G, Terranegra A, Dogliotti A,
Soldati L, Borghi L, Meschi T, Folesani G. J Transl Med 2013;11:248.
Lippi G, Cervellin G. Int J Cardiol
905.
High-sensitivity troponin T is more susceptible than high -sensitivity troponin I to impaired renal function.
Lippi G, Cervellin G. Am J Cardiol 2013;112:1985.
906.
Lack of correlation between air pollution and acute -onset atrial fibrillation. Cervellin G, Comelli I, Lippi G.
Can J Cardiol 2013;29:1743.e9.
907.
Swept away and squashed between myth based medicine and eminence based medicine. Metaphor of medical
meta-cognition. What are we doing wrong with our patient? Cervellin G, Rastelli G, Lippi G. Recenti Prog Med
2013;104:545-53.
908.
Pediatric reference values for urine particles quantification by using automated flow cytometer: results of a
multicenter study of Italian urinalysis group. Manoni F, Gessoni G, Caleffi A, Alessio MG, Rosso R, Menozzi P,
Tinello A, Valverde S, Azzarà G, Lippi G. Clin Biochem 2013;46:1820-4.
909.
Self-monitoring of blood glucose in diabetic patients. Montagnana M, Lippi G. RIMeL/IJLM 2013;9:195-204.
910.
Blood sample contamination by glucose -containing solutions: effects and identification. Lippi G, Avanzini P,
Sandei F, Aloe R, Cervellin G. Br J Biomed Sci 2013;70:180-3.
911.
Article downloads and citations: is there any relationship? Lippi G, Favaloro EJ. Clin Chim Acta 2013;415:195.
912.
Accidental mushroom poisoning mimicking stroke. A case report and liter ature review. Comelli I, Lippi G, De
Blasio A, Cervellin G. Acta Biomed 2013;84:229-33.
913.
Pharmacotherapy of von Willebrand disease. Franchini M, Lippi G. Expert Opin Orphan Drugs 2013;1:481-9.
914.
The ten commandments of laboratory testing for emergency physici ans. Lippi G, Cervellin G, Plebani M. Clin
Chem Lab Med 2014;52:183-7.
915.
Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not . Lippi G,
Cervellin G. Clin Chem Lab Med 2014;52:205-12.
916.
The concentration of high-sensitivity troponin I, galectin-3 and NT-ProBNP substantially increase after a 60km ultramarathon. Salvagno G, Schena F, Gelati M, Danese E, Cervellin G, Guidi GC, Lippi G. Clin Chem Lab Med
2014;52:267-72.
917.
A short story on how the H-index may change the fate of scientists and scientific publishing. Lippi G, Borghi L.
Clin Chem Lab Med 2014;52:e1-3.
918.
Reference range of hemolysis index in serum and lithium -heparin plasma measured with two analytical
platforms in a population of unselected outpatients. Lippi G, Giavarina D, Gelati M, Salvagno GL. Clin Chim
Acta 2014;429:143-6.
919.
Causes of elevated D-dimer in patients admitted to a large urban emergency department. Lippi G, Bonfanti L,
Saccenti C, Cervellin G. Eur J Intern Med 2014;25:45-8.
920.
Thyroid hormone levels are associated with anisocytosis in a cohort of euthyroid older outpatients. Lippi G,
Danese E, Montagnana M. Eur J Intern Med 2014;25:e4-5.
921.
Prevalence and cost of hemolyzed samples in a large urban emergency department. Lippi G, Bonelli P,
Cervellin G. Int J Lab Hematol 2014;36:e24–6.
922.
Gender's equality in evaluation of urine particles: Results of a multicenter study of the Italian Urinalysis
Group. Manoni F, Gessoni G, Alessio MG, Caleffi A, Saccani G, Epifani MG, Tinello A, Zorzan T, Valverde S, Caputo
M, Lippi G. Clin Chim Acta 2014;427:1-5.
923.
Relationship between serum galectin -3 values and demographical or biochemical variables in patients without
acute coronary syndrome. Lippi G, Salvagno GL, Bonfanti L, Cervellin G. Int J Cardiol 2014;171:270-1.
924.
A new device to relieve venipuncture pain can affect haematology test results. Lima-Oliveira G, Lippi G,
Salvagno GL, Campelo MD, Tajra KS, Gomes FD, Valentim CD, Romano SJ, Picheth G, Guidi GC. Blood Transfus
2014;12 Suppl 1:s6-10.
925.
Advancements in laboratory diagnostics: an invaluable tool for assessing quality of blood transfusions. Lippi
G, Franchini M. Blood Transfus 2014;12 Suppl 1: s73-4.
926.
Erythropoietin and the heart: physiological effects and the therapeutic perspective. Sanchis-Gomar F, GarciaGimenez JL, Pareja-Galeano H, Romagnoli M, Perez-Quilis G, Lippi G. Int J Cardiol 2014;171:116-25.
927.
Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers. Lippi
G, Cervellin G. Crit Rev Clin Lab Sci 2014;51:13-29.
928.
Point of care testing: evolving scenarios and innovative perspectives. Plebani M, Lippi G. Clin Chem Lab Med
2014;52:309–11.
929.
Genetic polymorphisms of human cardiac troponins as an unrecognized challenge for diagnosing myocardial
injury. Lippi G, Cervellin G. Int J Cardiol 2014;171:467-70.
930.
E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism. Lippi G, Favaloro EJ, Meschi T, Mattiuzzi
C, Borghi L, Cervellin G. Semin Thromb Hemost 2014;40:60-5.
931.
Analytical and clinical evaluation of Sysmex UF1000i for autom ated screening of cerebrospinal fluids. Buoro
S, Ottomano C, Appassiti Esposito S, Gherardi P, Alessio MG, Crippa A, Farina C, Raglio A, Lippi G. J Med Biochem
2014;33:191-6.
932.
Physical activity - an important preanalytical variable. Sanchis-Gomar F, Lippi G. Biochem Med (Zagreb)
2014;24:68–79.
933.
Interference of medical contrast media on laboratory testing. Lippi G, Daves M. Mattiuzzi C. Biochem Med
(Zagreb) 2014;24:80–8.
934.
The concentration of high-sensitivity troponin I increases with ageing in patients admitte d to the emergency
department without acute coronary syndrome. Lippi G, Aloe R, Meschi T, Borghi L, Cervellin G. Eur Geriatr Med
2014;5:52-4.
935.
Low volume tubes are not effective to reduce the rate of hemolyzed specimens from the emergency
department. Lippi G, Bonelli P, Graiani V, Caleffi C, Cervellin G. Clin Biochem 2014;47:227-9.
936.
Laboratory diagnostics of spontaneous bacterial peritonitis. Lippi G, Danese E, Cervellin G, Montagnana M. Clin
Chim Acta 2014;430:164–70.
937.
Quality in Hemostasis and Thrombosis - Part III. Favaloro EJ, Lippi G, Plebani M. Semin Thromb Hemost
2014;40:140-5.
938.
Standardization and Harmonization of Antiphospholipid Antibody Assays. Favaloro EJ, Plebani M, Lippi G.
939.
Technological Advances in the Hemostasis Laboratory. Lippi G, Plebani M, Favaloro EJ. Semin Thromb Hemost
2014;40:178-85.
940.
The role of neutrophil gelatinase-associated lipocalin (NGAL) in cerebrospinal fluids for screening of acute
bacterial meningitis. Lippi G, Avanzini P, Calzetti C, Caleffi A, Pipitone S, Musa R, Aloe R, Ferrari C. Clin Lab
2014;60:377-81.
941.
Thrombophilia testing. Useful or hype? Lippi G. Clin Chem Lab Med 2014;52:467-9.
942.
Processing of diagnostic blood specimens: Is it really necessary to mix the primary blood tubes after
collection with evacuated tube system? Lima-Oliveira G, Lippi G, Salvagno GL, Brocco G, Gaino S, Dima F,
Volaski W, Gomes Rego F, Picheth G, Guidi GC. Biopreserv Biobank 2014;12:53-9.
943.
Acetaminophen and sport performance. Doping or what? Lippi G, Sanchis-Gomar F. Eur J Appl Physiol
2014;114:881-2.
944.
Homocysteine and migraine. A narrative review. Lippi G, Mattiuzzi C, Meschi T, Cervellin G, Borghi L. Clin Chim
Acta 2014;433:5-11.
945.
Consensus document of Academy of Emergency Medicine and Care, Italian Committee for Standa rdization of
Hematology and Laboratory Methods, SIBioC-Laboratory Medicine and Italian Society of Laboratory Medicine
on D-dimer testing for suspected venous thromboembolism in emergency departments. Lippi G, Cervellin G,
Casagranda I, Morelli B, Testa S, Tripodi A. Biochim Clin 2014;38:136-8.
946.
Altitude exposure in sports: the Athlete Biological Passport standpoint. Sanchis-Gomar F, Galeano HP, Brioche
T, Martinez-Bello V, Lippi G. Drug Test Anal 2014;6-190-3.
947.
Red blood cell distribution width predicts results of dipyridamole stress testing. Lippi G, Ruffini L, Cervellin
G. Clin Biochem 2014;47:494-5.
948.
Interference from heterophilic antibodies in D -dimer assessment. A case report. Lippi G, Ippolito L, Tondelli
MT, Favaloro EJ. Blood Coagul Fibrinolysis 2014;25:277-9.
949.
D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document
of AcEMC, CISMEL, SIBioC, and SIMeL. Lippi G, Cervellin G, Casagranda I, Morelli B, Testa S, Tripodi A. Clin
Chem Lab Med 2014;52:621-8.
950.
Stat testing utilization in clinical laboratories. National survey of Italian Society of Clinical Biochemistry and
Molecular Biology (SIBioC). Lippi G, Mattiuzzi C, Plebani M. Clin Chem Lab Med 2014;52:e79-84.
951.
Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma.
Daves M, Giacomuzzi K, Tagnin E, Jani E, Adcock Funk DM, Favaloro EJ, Lippi G. Blood Coagul Fibrinolysis
2014;25:292-5.
952.
Epidemiological and biological evidence of neutrophil gelatinase -associated lipocalin (NGAL) in cancer. Lippi
G, Meschi T, Nouvenne A, Mattiuzzi C, Borghi L. Adv Clin Chem 2014;64:179-219.
953.
Influence of training and a maximal exercise test in analytical variability of muscular, hepatic, and
cardiovascular biochemical variables. Romagnoli M1, Alis R, Aloe R, Salvagno GL, Basterra J, Pareja -Galeano H,
Sanchis-Gomar F, Lippi G. Scand J Clin Lab Invest 2014;74:192-8.
954.
Blood collection from intravenous lines: is one drawing site better than others? Lippi G, Avanzini P, Aloe R,
Cervellin G. Lab Medicine 2014;45:172-5.
955.
The concentration of troponin I is increased in patients with acute -onset atrial fibrillation. Lippi G, Picanza A,
Formentini A, Bonfanti L, Cervellin G. Int J Cardiol 2014;173:579-80.
956.
Protein S100B and neuron-specific enolase (NSE) for the initial evaluation of mild head trauma in adults:
ready for prime time? Cervellin G, Benatti M, Carbucicchio A, Aloe R, Lippi G. Biochim Clin 2014;38:227-33.
957.
Dizziness and syncope in young people: keep yourmind open! Case report and literature review of the
challenging differentiation between arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) and
catecholaminergic polymorphic ventricular tachycardia (CPVT). Comelli I, Gonzi G, Mossini G, Lippi G, Meschi
T, Borghi L, Cervellin G. Acta Biomed 2014;85:73-80.
958.
Multicenter comparison of four contemporary sensitive troponin immunoassays. Salvagno GL, Giavarina G,
Meneghello M, Musa R, Aloe R, Da Rin G, Lippi G. J Med Biochem 2014;33:271–7.
959.
Diagnosis of diabetes mellitus: reiterated responsibil ities for the clinical laboratory. Gillery P, Lippi G,
960.
Automated screening of bacterial meningitis by cytofluorimetric analysis of cerebrospinal fluid: preliminary
results. Buoro S, Apassiti Esposito S, Ottomano C, Alessio MG, Fumagalli S, Caleffi A, Farina C, Raglio A, Crippa
A, Lippi G. Biochim Clin 2014;38:208-12.
961.
Standardization of collection requirements for fasting samples: For the Working Group on Preanalytical Phase
(WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Simundic AM,
Cornes M, Grankvist K, Lippi G, Nybo M. Clin Chim Acta 2014;432:33-7.
962.
Multiple Hormonal Dysregulation as Determinant of low Physical Performance and Mobility in older Persons.
Maggio M, Lauretani F, De Vita F, Basaria S, Lippi G, Butto V, Luci M, Cattabiani C, Ceresini G, Verzicco I,
Ferrucci L, Ceda GP. Curr Pharm Des 2014;20:3119-48.
963.
Biological markers in older people at risk of mobility limitations. Lippi G, Sanchis-Gomar F, Montagnana M. Curr
Pharm Des 2014;20:3222-44.
964.
The Assessment of C-Reactive Protein Does Not Improve the Diagnosis of Myocardial Infarction Using a High Sensitivity Troponin Immunoassay. Lippi G, Cervellin G. Arch Pathol Lab Med 2014;138:725-6.
965.
No evidence for an association of Vitamin D deficiency and migraine. A systematic review of the literature.
Lippi G, Cervellin G, Mattiuzzi C. Biomed Res Int 2014;2014:827635.
966.
Prevalence of anemia and critical anemia in elderly patients admitted to a large urban emergency
department. Lippi G, Meschi, T Nouvenne A, Bonelli P, Borghi L, Cervellin G. Eur Geriatr Med 2014;5:214-5.
967.
Cogan's syndrome: Anti-Hsp70 antibodies are a serological marker in the typical form. Bonaguri C, Orsoni JG,
Russo A, Rubino P, Bacciu S, Lippi G, Melegari A, Zavota L, Ghirardini S, Mora P. Isr Med Assoc J 2014;16:285-8.
968.
Platelets and migraine. Danese E, Montagnana M, Lippi G Thromb Res 2014;134:17-22.
969.
Inversion of lithium heparin gel tubes after centrifugation is a significant source of bias in clinical chemistry
testing. Lippi G, Salvagno GL, Danese E, Lima-Oliveira G, Brocco G, Guidi GC. Clin Chim Acta 2014;436:183-7.
970.
The mystifying nomenclature of cardiac troponin immunoassays. Lippi G. Scand J Clin Lab Invest 2014;74:2737.
971.
Early kinetics of heart-type fatty acid binding protein in patients undergoing dipyridamole stress
echocardiography and relationship with high -sensitivity troponin. Lippi G, Dipalo M, Aloe R, Robuschi F,
Scioscioli F, Ruffini L, Cervellin G. Kardiol Pol 2014;72:527-33.
972.
Response to "comment on e-cigarettes and cardiovascular risk: beyond science and mysticism". Lippi G,
Cervellin G, Favaloro EJ. Semin Thromb Hemost 2014;40:519-20.
973.
The latest generation of troponin immunoassays: the "cholesterol" of the third millennium? Lippi G, Cervellin
G. J Am Coll Cardiol 2014;63:2883-4.
974.
Harmonization of contemporary-sensitive troponin I immunoassays: calibration may only be a part of the
problem. Lippi G, Salvagno GL, Da Rin G, Giavarina D. RIMeL/IJLM 2014;10:108-114.
975.
Application of the new cholesterol gu idelines. Lippi G, Mattiuzzi C. N Engl J Med 2014;371:78.
976.
Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based
on routine laboratory tests. Lippi G, Ardissino D, Quintavalla R, Cervellin G. J Thromb Thrombolysis
2014;38:269-74.
977.
Interference of spurious haemolysis on prothrombin time, activated partial thromboplastin time, and
fibrinogen. Lippi G, Ippolito L. N Z J Med Lab Sci 2014;68:52-4.
978.
Do clinicians decide relying primarily on Bayesians princip les or on Gestalt perception? Some pearls and
pitfalls of Gestalt perception in medicine. Cervellin G, Borghi L, Lippi G. Intern Emerg Med 2014;9:513-9.
979.
Management of preanalytical phase for routine hematological testing: Is the pneumatic tube system a sou rce
of laboratory variability or an important facility tool? Lima-Oliveira G, Lippi G, Salvagno GL, Dima F, Brocco G,
Picheth G, Guidi GC. Int J lab Hematol 2014;36:e37-40.
980.
Total laboratory automation of routine hemostasis testing. Da Rin G, Lippi G. J Lab Autom 2014;19:419-22.
981.
Practicing appropriateness: the case of troponin. Daves M, Cemin R, Jani E, Sacco G, Lippi G. RIMeL/IJLM
2014;10:82–8.
982.
Lack of association of the mean platelet volume with plasma lipids in a general population of unselected
outpatients. Lippi G, Danese E, Mattiuzzi C, Montagnana M. RIMeL/IJLM 2014;10:97-101.
983.
Adiponectin and migraine: systematic review of clinical evidence. Lippi G, Meschi T, Mattiuzzi C, Borghi L,
Targher G. Neurol Sci 2014;35:1167-71.
984.
Sometimes they come back! A case of Shoshin Beriberi in Northern Italy (2012). Comelli I, Lippi G, Merli MF,
Cervellin G. Recenti Prog Med 2014;105:303-6.
985.
Of MIs and Men-A Historical Perspective on the Diagnostics of Acute Myocardial Infarction. Cervellin G, Lippi
986.
Incidence of acute-onset atrial fibrillation correlates with air temperature. Results of a nine -years survey.
Comelli I, Ferro J, Lippi G, Comelli D, Sartori E, Cervellin G. J Epidemiol Global Health 2014;4:151–7.
987.
Red blood cell distribution width (RDW) and human pathology. One size fits all. Lippi G, Plebani M. Clin Chem
Lab Med 2014;52:1247-9.
988.
C-reactive protein and migraine. Facts or speculations? Lippi G, Mattiuzzi C, Cervellin G. Clin Chem Lab Med
2014;52:1265-72.
989.
Red blood cell distribution width is significantly associated with aging and gender. Lippi G, Salvagno GL, Guidi
GC. Clin Chem Lab Med 2014;52:e197-9.
990.
Calprotectin and cardiovascular events. A narrative review. Montagnana M, Danese E, Lippi G. Clin Biochem
2014;47:996-1001.
991.
Lack of harmonization of red blood cell distribution width (RDW). Evaluation of four hematological analyzers.
Lippi G, Pavesi F, Bardi M, Pipitone S. Clin Biochem 2014;47:1100-3.
992.
A false positive case of cardiac troponin I identified with CK -MB reflex testing. Lippi G, Ardissino D, Aloe R,
Cervellin G. Int J Cardiol 2014;176:e3-4.
993.
Variation of red blood cell distribution width and mean platelet volume after moderate endurance exercise.
Lippi G, Salvagno GL, Danese E, Taperi C, Guidi GC, Schena F. Adv Hematol 2014;2014:192173.
994.
Influence of dipyridamole stress echocardiography on galectin -3, amino-terminal B-type natriuretic peptide
(NT-proBNP) and high-sensitivity troponin T. Lippi G, Salvagno GL, Robuschi F, Scioscioli F, Ruffini L, Cervellin
G. Acta Cardiol 2014;69:377-83.
995.
Evaluation of the current prognostic role of heart diseases in the history of patients with syncope. Numeroso
F, Mossini G, Lippi G, Cervellin G. Europace 2014;16:1379-83.
996.
Inhibition of xanthine oxidase and exercise on serum uric acid, 25(OH) D3, and calcium concentration.
Sanchis-Gomar F, Salvagno GL, Lippi G. Clin Lab 2014;60:1409-11.
997.
A four-year survey on unexpected pregnancy diagnoses in a large urban emergency department in Parma,
Italy. Cervellin G, Comelli I, Sartori E, Lippi G. Int J Gynaecol Obstet 2014;127:51-4.
998.
Hypercoagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence. Danese E,
Montagnana M, Cervellin G, Lippi G. Ann Med 2014;46:364-71.
999.
New guidelines on treatment of blood cholesterol: too m uch of a good thing? Lippi G, Mattiuzzi C. Recenti Prog
Med 2014;105:317-21.
1000. Dipyridamole stress echocardiography does not trigger release of highly -sensitive troponin I and T. Cervellin
G, Robuschi F, Scioscioli F, Ruffini L, Dipalo M, Salvagno GL, Lippi G. J Med Biochem 2014;33:376–83.
1001. Prevalence of hyponatremia in femur neck fractures. A one -year survey in an urban Emergency Department.
Cervellin G, Mitaritonno M, Pedrazzoni M, Picanza A, Lippi G. Adv Orthop 2014;2014:397059. Doi:
10.1155/2014/397059.
1002. Relation of D-dimer and Troponin I in Patients with New -onset Atrial Fibrillation. Cervellin G, Bonfanti L,
Picanza A, Lippi G. Am J Cardiol 2014;114:1129-30.
1003. Sample rerun after short-term refrigerated storage: impact on routine coagulation testing . Da Rin G, Lippi G.
Int J Lab Hematol 2014;36:e71-3.
1004. Check-in and sorting of centrifuged serum and lithium -heparin tubes may be unsuitable using a bulk input
module. Da Rin G, Lippi G. J Lab Autom 2014;19:474-7.
1005. Biomarkers in the emergency department. Handle with c are. Lippi G, Di Somma D, Plebani M. Clin Chem Lab
Med 2014;52:1387-9.
1006. A Review of the Value of D-dimer Testing for Prediction of Recurrent Venous Thromboembolism with
Increasing Age. Lippi G, Favaloro EJ, Cervellin G. Semin Thromb Hemost 2014;40:634-9.
1007. Aging Hemostasis: Changes to Laboratory Markers of Hemostasis as We Age - A Narrative Review. Favaloro EJ,
Franchini M, Lippi G. Semin Thromb Hemost 2014;40:621-33.
1008. Genetic risk factors of atherothrombosis. Montagnana M, Danese E, Lippi G. Pol Arch Med Wewn 2014;124:47482.
1009. Erythroblasts count by ADVIA 2120i in patients with thalassemia and sickle cell disease and in newborns.
Buoro S, Pipitone S, Benegiamo A, Pavesi F, Gennai D, Saleri C, Gustinetti R, Dominoni P, Falanga A, Marchetti M,
Crippa A, Ottomano C, Lippi G. RIMeL/IJLM 2014;10:157-66.
1010. The quality of diagnostic testing may be impaired during shipment of lithium -heparin gel tubes. Da Rin G,
1011. Could light meal jeopardize laboratory coagulation tests? Lima-Oliveira G, Salvagno GL, Lippi G, Danese E,
Gelati M, Montagnana M, Picheth G, Guidi GC. Biochem Med (Zagreb) 2014;24:343-9.
1012. Contamination of lithium heparin blood by K2-ethylenediaminetetraacetic acid (EDTA). An experimental
evaluation. Lima-Oliveira G, Salvagno GL, Danese E, Brocco G, Guidi GC, Lippi G. Biochem Med (Zagreb)
2014;3:359-67.
1013. Comorbidities and disease severity as risk factors for carbapenem -resistant Klebsiella pneumoniae
colonization: report of an experience in an internal medicine unit. Nouvenne A, Ticinesi A, Lauretani F, Maggio
M, Lippi G, Guida L, Morelli I, Ridolo E, Borghi L, Meschi T.
Plos One 9;10:e110001.
doi:10.1371/journal.pone.0110001.
1014. Assessment of bile and serum mucin5AC in cholangiocarcinoma: Diagnostic performance and biologic
significance. Danese E, Ruzzenente O, Ruzzenente A, Iacono C, Bertuzzo F, Gelati M, Conci S, Bendinelli S,
Bonizzato G, Guglielmi A, Salvagno GL, Lippi G, Guidi GC. Surgery 2014;156:1218-24.
1015. Dangers in the Practice of Defensive Medicine in Hemostasis Testing fo r Investigation of Bleeding or
Thrombosis: Part I-Routine Coagulation Testing. Lippi G, Favaloro EJ, Franchini M. Semin Thromb Hemost
2014;40:812-24.
1016. Combined administration of antibiotics and direct oral anticoagulants: a renewed indication for laboratory
monitoring? Lippi G, Favaloro EJ, Mattiuzzi C. Semin Thromb Hemost 2014;40:756-65.
1017. Laboratory preparedness to face infectious outbreaks. Ebola and beyond. Lippi G, Mattiuzzi C, Plebani M. Clin
Chem Lab Med 2014;52:1681-4.
1018. Mean platelet volume (MPV) predicts middle distance running performance. Lippi G, Salvagno GL, Danese E,
Skafidas S, Tarperi C, Guidi GC, Schena F. Plos One 2014;9:e112892.
1019. The clinical laboratory and infectious outbreaks emergencies. Ebola and beyond. Lippi G, Mattiuzzi C, Plebani
M. Biochim Clin 2014;38:604-6.
1020. Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg? Lippi G,
Cervellin G, Sanchis-Gomar F. Ann Med 2014;46:456-63.
1021. NovoSeven (Recombinant Factor VIIa) for the treatment of bleeding episodes and perioperative management
in patients with Glanzmann's Thrombasthenia. Franchini M, Lippi G. Expert Rev Hematol 2014;7:733-40.
1022. Migraine and erythrocyte biology: a review. Lippi G, Cervellin G, Mattiuzzi C. Int J Lab Hematol 2014;36:591-7.
1023. Urgent monitoring of dabigatran plasma levels. Less is sometimes more. Lippi G, Favaloro EJ. Pol Arch Med
Wewn 2014;124:639-640.
1024. Anti-gout drugs as potential therapy for atrial fibrillation. Sanchis-Gomar F, Perez-Quilis C, Cervellin G, Lucia
A, Lippi G. Int J Cardiol 2014;177:1061-2.
1025. Circulating cardiac troponin T is not influenced by postural changes during venous blood collection. Lippi G,
Salvagno GL, Lima-Oliveira G, Montagnana M, Danese E, Guidi GC. Int J Cardiol 2014;177:1076-7.
1026. Colorectal cancer and screening programs: not only analytical issues. Plebani M, Lippi G, Melichar B. Clin Chem
Lab Med 2014;52:1087-90.
1027. Initial blood lactate correlates with carboxyhemoglobin and clinical severity in carbon monoxide poisoned
patients. Cervellin G, Comelli I, Rastelli G, Al essandra P, Lippi G. Clin Biochem 2014;47:298-301.
1028. Increased red blood cell distribution width (RDW) is associated with higher glycosylated hemoglobin (HbA1c)
in the elderly. Lippi G, Targher G, Salvagno GL, Guidi GC. Clin Lab 2014;60:2095-8.
1029. Mean speed in professional cycling: no evidence of decline. Lippi G, Mattiuzzi C, Sanchis-Gomar F. Perfor
Enhan Health 2014;3:48-50.
1030. Relationship between body weight and total weight lifted in the 2013 World Weightlifting Championships.
Mattiuzzi C, Lippi G. Perfor Enhan Health 2014;3:49-50.
1031. Causes of Ferritin Elevation. Lippi G. JAMA 2014;312:2572.
1032. Chocolate and migraine: the history of an ambiguous association. Lippi G, Mattiuzzi C, Cervellin G. Acta
Biomed 2014;85:216-21.
1033. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker for the early diagnosis of acute
kidney injury (AKI). Antonucci E, Lippi G, Ticinesi A, Pigna F, Guida L, Morelli I, Novenne A, Borghi L, Meschi T.
Acta Biomed 2014;85:289-94.
1034. B-type natriuretic peptide may be unsuitable for dia gnosing central acute pulmonary embolism: a case
report. Lippi G, Bellini C, Giuliotti S, Sandei F, Meschi T, Borghi L, Cervellin G. Indian J Chest Dis Allied Sci
2014;56:233-4.
1035. Serum and urine osmolality: clinical and laboratory features. Trepiccione F, Capasso G, Lippi G. G Ital Nefrol.
2014 Settembre-Ottobre;31(5):1-9. pii: gin/31.5.6
1036. Postural change during venous blood collection is a major source of bias in clinical chemistry testing. Lippi G,
Salvagno GL, Lima-Oliveira G, Brocco G, Danese E, Guidi GC. Clin Chim Acta 2015;440:164-8.
1037. Effects of allopurinol on exercise-induced muscle damage: new therapeutic approaches? Sanchis-Gomar F,
Pareja-Galeano H, Perez-Quilis C, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Lucia A. Cell Stress
Chaperone 2015;20:3-13.
1038. Meta-analysis of factor V Leiden and prothrombin G20210A polymorphism in migraine. Lippi G, Mattiuzzi C,
Cervellin G. Blood Coagul Fibrinolysis 2015;26:7-12.
1039. Biological variation: back to basic. Plebani M, Padoan A, Lippi G. Clin Chem Lab Med 2015;53:155-6.
1040. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs):
Is there consensus? Lippi G, Favaloro EJ. Clin Chem Lab Med 2015;53:185-97.
1041. The intriguing relationship between ABO blood group, cardi ovascular disease and cancer. Franchini M, Lippi G.
BMC Med 2015;13:7.
1042. Serum Copeptin and Midregion Proadrenomedullin (MR-proADM) After an Ultramarathon. Lippi G, Schena F,
Salvagno GL, Sanchis-Gomar F, Guidi GC. J Clin Lab Anal 2015;29:15-20.
1043. A global quality control system to check PT-INR portable monitor for Antivitamin K antagonists. Testa S,
Paoletti O, Bassi L, Dellanoce C, Morandini R, Lippi G. Int J Lab Hematol 2015;37:71-8.
1044. What Do Hemolyzed Whole-Blood Specimens Look Like? Analysis with a CellaVis ion DM96 Automated Image
Analysis System. Lippi G, Pavesi F, Benegiamo A, Pipitone S. J Lab Autom 2015;20:60-3.
1045. Epidemiological association between migraine and lipoprotein(a): a systematic review. Mattiuzzi C, Cervellin
G, Lippi G. J Thromb Thrombolysis 2015;39:113-7.
1046. The prevalence of hyponatremia increases with ageing in an Italian emergency department population. Lippi
G, Meschi T, Picanza A, Nouvenne A, Borghi L, Cervellin G . Eur Geriatr Med. 2015;6:76-7.
1047. Evaluation of mean platelet volume with four hematological analyzers: harmonization is still an unresolved
issue. Lippi G, Pavesi F, Pipitone S. Blood Coagul Fibrinolysis 2015;26:235-7.
1048. Casual identification of severe gastric atrophy with macrocytosis complicated by acute coronary syndrome.
Caleffi A, Mercadanti M, Di Mario F, Lippi G. Biochim Clin 2015;39:68-72.
1049. Allopurinol prevents cardiac and skeletal muscle damage in soccer players. Sanchis-Gomar F, Pareja-Galeano
H, Gomez-Cabrera MC, Candel J, Lippi G, Salvagno GL, Mann GE, Viña J. Scand J Sports Med Sci 2015;25:e110-5.
1050. Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Sanchis-Gomar
F, Lucia A, Yvert T, Ruiz-Casado A, Pareja-Galeano H, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G,
Bouchard C, Berger NA. Cancer Prev Res (Phila) 2015;8:105-10.
1051. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical
Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG -PRE). Lippi G, Banfi G,
Church S, Cornes M, De Carli G, Grankvist K, Kristensen GB, Ibarz M, Panteghini M, Plebani M, Nybo M, Smellie S,
Zaninotto M, Simundic AM; on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine
Working Group for Preanalytical Phase. Clin Chem Lab Med 2015;53:357-70.
1052. Colour coding for blood collection tube closures – A call for harmonisation. Simundic AM, Cornes MP, Grankvist
K, Lippi G, Nybo M, Ceriotti F, Theodorsson E, Panteghini M. Clin Chem Lab Med 2015;53:371-6.
1053. The baseline serum value of α-amylase is a significant predictor of distance running performance. Lippi G,
Salvagno GL, Danese E, Tarperi C, La Torre A, Guidi GC, Schena F. Clin Chem Lab Med 2015;53:469–76.
1054. The use of S-Monovette is effective to reduce the burden of hemolysis in a la rge urban emergency
department. Lippi G, Bonelli P, Bonfanti L, Cervellin G. Biochem Med (Zagreb) 2015;25:69-72.
1055. Incidence of acute-onset atrial fibrillation correlates with air temperature. Results of a nine -year survey?
Comelli I, Cervellin G, Ferro J, Comelli D, Sartori E, Lippi G. J Epidemiol Global Health 2015;5:95-7.
1056. Do clinicians decide relying primarily on Bayesian principles or on gestalt perception? Authors' reply. Cevellin
G, Borghi L, Lippi G. Intern Emerg Med 2015;10:257-8.
1057. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
Danese E, Montagnana M, Nouvenne A, Lippi G. J Diabetes Sci Technol 2015;9:169-76.
1058. Analytical evaluation of Diazyme procalcitonin (PCT) latex -enhanced immunoturbidimetric assay on Beckman
Coulter AU5800. Dipalo M, Buonocore R, Gnocchi C, Picanza A, Aloe R, Lippi G. Clin Chem Lab Med 2015;53:5937.
1059. Ranking prestige of medical and laboratory technology journals. Lippi G, Mattiuzzi C, Plebani M. Clin Chem Lab
Med 2015;53:e85-7.
1060. Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI. Lippi G,
Harenberg J, Mattiuzzi C, Favaloro EJ. Semin Thromb Hemost 2015;41:255-62.
1061. Preanalytical variability and quality of diagnostic testing. Looking at the moon and gazing beyond the finger.
Lippi G, Mattiuzzi C, Favaloro EJ. N Z J Med Lab Sci 2015;69:4-8.
1062. Laboratory Testing in the Era of Direct or Non-Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to
Measuring Their Activity and Avoiding Diagnostic Errors. Favaloro EJ, Lippi G. Semin Thromb Hemost
2015;41:208-27.
1063. Serum potassium levels inversely correlate with D -dimer in patients with acute-onset atrial fibrillation.
Cervellin G, Bonfanti L, Picanza A, Lippi G. Arq Bras Cardiol 2015;104:181-4.
1064. Measurement of iron in serum and EDTA plasma for screening of blood transfusion in sports. Lippi G, Aloe R,
Avanzini P, Banfi G. Drug Test Anal 2015;7:253-4.
1065. Development of simple equations for effective screening of spurious hemolysis in whole -blood specimens.
Lippi G, Pavesi F, Avanzini P, Chetta F, Aloe R, Pipitone S. Int J Lab Hematol 2015;37:253-8.
1066. Preface: Quality in Hemostasis and Thrombosis - Part IV. Lippi G, Favaloro EJ, Plebani M. Semin Thromb Hemost
2015;41:263-6.
1067. International Survey on D-Dimer Test Reporting: A Call for Standardization. Lippi G, Tripodi A, Simundic AM,
1068. The Changing Face of Hemostasis Testing in Modern Laboratories: Consolidation, Automation, and Beyond.
Lippi G, Plebani M, Favaloro EJ. Semin Thromb Hemost 2015;41:294-9.
1069. Quality and Safety Issues of Direct Oral Anticoagulants in the Emergency Department. Cervellin G, Benatti M,
Bonfanti L, Lippi G. Semin Thromb Hemost 2015;41:348-54.
1070. Error rates during blood collection in emergency departments and outpatient clinics: results of a prospective
multicenter study. Lippi G, Caola I, Cervellin G, Milanesi B, Morandini M, Giavarina D. Clin Chim Acta
2015;445:91-2.
1071. Iron concentration increases after moderate endurance exercise: implicati ons for screening of blood
transfusion in sports. Salvagno GL, Lippi G, Tarperi C, Guidi GC, Schena F. Drug Test Anal 2015;7:346-7.
1072. The effect of hyperglycaemia on haemostasis testing – a volunteer study. Lippi G, Buonocore R, Musa R,
Ippolito L, Picanza A, Favaloro EJ. Anaesthesia 2015;70:549-54.
1073. Squamous cell carcinoma antigen in hepatocellular carcinoma: ready for the prime time? Montagnana M,
Danese E, Lippi G. Clin Chim Acta 2015;445:161-6.
1074. Fried food consumption and ischemic heart disease. A systemati c literature review. Lippi G, Mattiuzzi C,
Cervellin G. Int J Cardiol 2015;190:201-1.
1075. The burden of vitamin D deficiency in a Mediterranean country without a policy of food fortification. Lippi G,
Nouvenne A, Ticinesi A, Bonelli P, Salvagno GL, Cervellin G , Guidi GC. Acta Biomed 2015;86:59-62.
1076. Mean corpuscular volume and red blood cell distribution width are independent predictors of serum
potassium concentration in healthy individuals. Lippi G, Salvagno GL, Guidi GC. Clin Chim Acta 2015;446:117-8.
1077. The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of
unselected outpatients. Lippi G, Salvagno GL, Nouvenne A, Meschi T, Borghi L, Targher G. Prim Care Diabetes
2015;9:226-30.
1078. The biomarker paradigm: between diagnostic efficiency and clinical efficacy. Lippi G, Mattiuzzi C. Pol Arch
Med Wewn 2015;125:282-8.
1079. Sodium citrate blood contamination by K2-ethylenediaminetetraacetic acid (EDTA): impact on routine
coagulation testing. Lima-Oliveira G, Salvagno GL, Danese E, Favaloro EJ, Guidi GC, Lippi G. Int J Lab Hematol
2015;37:403-9.
1080. Cancer-associated thrombosis: investigating the role of new oral anticoagulants. Franchini M, Bonfanti C, Lippi
G. Thromb Res 2015;135:777-81.
1081. Comparison of genetic and epigenetic alter ations of primary tumors and matched plasma samples in patients
with colorectal cancer. Danese E, Minicozzi AM, Benati M, Montagnana M, Paviati E, Salvagno GL, Lima -Oliveira
G, Gusella M, Pasini F, Lippi G, Guidi GC. Plos One 2015;10:e0126417.
1082. Energy drink overconsumption in adolescents: implications for arrhythmias and other cardiovascular events .
Sanchis-Gomar F, Pareja-Galeano H, Cervellin G, Lippi G, Earnest CP. Can J Cardiol 2015;31:572-5.
1083. Cardiac troponin I is increased in patients admitted to the eme rgency department with severe allergic
reactions. A case-control study. Lippi G, Buonocore R, Schirosa F, Cervellin G. Int J Cardiol 2015;194:68-9.
1084. Red meat consumption and ischemic heart disease. A systematic literature review. Lippi G, Mattiuzzi C,
Sanchis Gomar F. Meat Sci 2015;108:32-6.
1085. Red blood cell distribution width and mean platelet volume: surrogate markers for, or treatment targets in,
dyslipidemia? Lippi G. Clin Biochem 2015;48:555-6.
1086. Personalized medicine: moving from simple theory to daily pra ctice. Lippi G, Plebani M. Clin Chem Lab Med
2015;53:959-60.
1087. Diagnostics in Venous Thromboembolism: From Origin to Future Prospects. Lippi G, Danese E, Favaloro EJ,
Montagnana M, Franchini M. Semin Thromb Hemos 2015;41:374-81.
1088. The degree of acceptability of swine blood values at increasing levels of hemolysis evaluated through visual
inspection versus automated quantification. Di Martino G, Stefani AL, Lippi G, Gagliazzo L, McCormick W, Gabai
G, Bonfanti L. J Vet Diagn Invest 2015;27:306-12.
1089. In vitro diagnostic company recalls and medical laboratory practices: an Italian case. Lima-Oliveira G, Lippi G,
Salvagno GL, Brocco G, Guidi GC. Biochem Med (Zagreb) 2015;25:273-8.
1090. Abdominal migraine in the differential diagnosis of acute abdominal pain: Ca se report and literature review.
Cervellin G, Lippi G. Am J Emerg Med 2015;33:864.e3-5.
1091. Laboratory monitoring of warfarin in the era of direct oral anticoagulants. Lippi G, Favaloro EJ. Lancet
Haematol 2015;2:e223-4.
1092. Red blood cell distribution width: A simple paramete r with multiple clinical applications. Salvagno GL, SancisGomar F, Picanza A, Lippi G. Crit Rev Clin Lab Sci 2014;52:86-105.
1093. Meat consumption and gout: friend, foe or neither? Lippi G, Mattiuzzi C, Cervellin G. Rheumatol Int
2015;35:1443-4.
1094. Emergency physician's perception of cultural and linguistic barriers in immigrant care: results of a multiple choice questionnaire in a large Italian urban emergency department. Numeroso F, Benatti M, Pizzigoni C,
Sartori E, Lippi G, Cervellin G. World J Emerg Med 2015;6:111-7.
1095. Influence of spurious dilution and hyperglycaemia on erythrocytes and platelets evaluated with two different
hematological analyzers. Lippi G, Buonocore R, Musa R, Aloe R, Picanza A, Pipitone S, Sanchis -Gomar F. J Appl
Biomed 2015;13:233-8.
1096. Hs-cTnT levels in professional soccer players throughout a season: No evidence of sustained cardiac damage.
Sanchis-Gomar F, Alis R, Rampinini E, Bosio A, Romagnoli M, Lombardi G, Lippi G. Int J Cardiol 2015;197:292-3.
1097. Gum-chewing and headache: an underestimated trigger of headache pain in migraineurs? Lippi G, Cervellin G,
Mattiuzzi C. CNS Neurol Disord Drug Targets 2015;14:786-90.
1098. Detection of mild inherited disorders of blood coagulation: current options and personal recommendations.
Lippi G, Pasalic L, Favaloro EJ. Expert Rev Hematol 2015;8:527-42.
1099. Effect of contaminant 0.9% saline on tests of haemostasis. Lippi G, Buonocore R, Di Pietro M, Ippolito L,
Favaloro EJ. Anaesthesia 2015;70:1001-2.
1100. Circulating irisin detection: Does it really work? Sanchis-Gomar F, Alis R, Lippi G. Trends Endocrinol Metab
2015;26:335-6.
1101. Severe allergic reaction, adrenaline and the heart. Out of the maze? Lippi G, Cervellin G. Int J Cardiol
2015;199:63-4.
1102. Response to letter from Dr Hoffmann. Lippi G. Int J Lab Hematol 2015;37:e89-90.
1103. Laboratory diagnostics and quality of blood collection. Lima-Oliveira G, Lippi G, Salvagno GL, Picheth G, Guidi
GC. J Med Biochem 2015;34:288-94.
1104. Multicenter comparison of seven 25OH Vitamin D automated immunoassays. Lippi G, Salvagno GL, Fortunato A,
Dipalo M, Aloe R, Da Rin G, Giavarina D. J Med Biochem 2015;34:344-50.
1105. Venous thromboembolism and coffee. Critical review and meta -analysis. Lippi G, Mattiuzzi C, Franchini M. Ann
Transl Med 2015;3:152.
1106. Evaluation of reference intervals for complete blood coun t on Sysmex XN 9000. Buoro S, Apassiti Esposito S,
Mecca T, Azzarà G, Cerutti L, Dominoni P, Crippa A, Ottomano C, Lippi G. Biochim Clin 2015;39:256-63.
1107. Multicenter comparison of automated procalcitonin immunoassays. Dipalo M, Guido L, Micca G, Pittalis S,
Locatelli M, Motta A, Bianchi V, Callegari T, Aloe R, Da Rin G, Lippi G. Pract Lab Med 2015;2:22-8.
1108. Compliance of blood sampling procedures with the CLSI H3 -A6 guidelines: An observational study by the
European Federation of Clinical Chemistry and Laborat ory Medicine (EFLM) working group for the
preanalytical phase (WG-PRE). Simundic A, Church S, Cornes MP, Grankvist K, Lippi G, Nybo M, Nikolac N, van
Dongen-Lases E, Eker P, Kovalevskaya S, Kristensen GB, Sprongl L, Sumarac Z. Clin Chem Lab Med 2015;53:132131.
1109. Fried food and prostate cancer risk: systematic review and meta -analysis. Lippi G, Mattiuzzi C. Int J Food Sci
Nutr 2015;66:587-9.
1110. Red meat, processed meat and the risk of venous thromboembolism: friend or foe? Lippi G, Cervellin G,
Mattiuzzi C. Thromb Res 2015;136:208-11.
1111. Galectin-3 in atrial fibrillation: simple bystander, player or both? Lippi G, Cervellin G, Sanchis-Gomar F. Clin
Biochem 2015;48:818-22.
1112. Venous stasis and whole blood platelet aggregometry: a question of data reliability and patient safety. LimaOliveira G, Lippi G, Salvagno GL, Gaino S, Poli G, Gelati M, Picheth G, Guidi GC. Blood Coagul Fibrinolysis
2015;26:665-8.
1113. Influence of posture on routine hemostasis testing. Lippi G, Salvagno GL, Lima-Oliveira G, Danese E, Favaloro
EJ, Guidi GC. Blood Coagul Fibrinolysis 2015;26:716-9.
1114. Lipoprotein(a)-lowering therapies: a double edged sword? Lippi G. Atherosclerosis 2015;242:504–5. doi:
10.1016/j.atherosclerosis.2015.08.018.
1115. Usefulness of suPAR in the risk stratification of patients with sep sis admitted to the emergency department.
Casagranda I, Vendramin C, Callegari T, Vidali M, Calabresi A, Ferrandu G, Cervellin G, Cavazza M, Lippi G,
Zanotti I, Negro S, Rocchetti A, Arfini C. Intern Emerg Med 2015;10:725-30.
1116. Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from
patients with brain injury. Martínez-Morillo E, Childs C, García BP, Álvarez Menéndez FV, Romaschin AD,
Cervellin G, Lippi G, Diamandis EP. Clin Chem Lab Med 2015;53:1575–84.
1117. Laboratory biomarkers and frailty: presentation of the FRAILOMIC Initiative. Lippi G, Jansen-Duerr P, Viña J,
Durrance-Bagale A, Abugessaisa I, Gomez-Cabrero D, Tegnér J, Grillari J, Erusalimsky J, Sinclair A, Rodriguez Manãs, on behalf of the FRAILOMIC consortium. Clin Chem Lab Med 2015;53:e253-5.
1118. Serum bilirubin value predicts hospital admission in carbon monoxide poisoned patients. Active player or
simple bystander. Cervellin G, Comelli I, Buonocore R, Picanza A, Rastelli G, Lippi G. Clinics 2015;70:628-31.
1119. Platelets and immunity – the interplay of Mean Platelet Volume in health and disease. Lippi G, Franchini M.
Exp Rev Hematol 2015;8:555-7.
1120. Association of hyponatremia and hypovitaminosis D in ambulatory adults. Cervellin G, Salvagno GL, Bonfanti L,
Bonelli P, Guidi GC, Lippi G. J Med Biochem 2015;34:450-4.
1121. Birth season and vitamin D concentration in adulthood. Lippi G, Bonelli P, Buonocore R, Aloe R. Ann Transl Med
2015;3:231.
1122. “Real life use” of troponin in the emergency department: a survey of over 3000 cases. Vidali M, Verzotti E,
Cabraz N, Santi F, Puma A, Bellomo G, Lupi A, Lippi G, Avanzi GC. Biochem Med (Zagreb) 2015;25:421–9.
1123. Systematic assessment of the hemolysis index: pros and cons. Lippi G. Adv Clin Chem 2015;71:157-70.
1124. Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it. Lippi G, Plebani M.
1125. Comparison of nucleated red blood cell count with four commercial hematological analyzers. Pipitone S,
Buonocore R, Gennari D, Lippi G. Clin Chem Lab Med 2015;53:e315-8.
1126. Newer Hemostatic Agents. Franchini M, Favaloro EJ, Lippi G. Semin Thromb Hemost 2015;41:802-8.
1127. Extended leukocyte differential count and C -reactive protein in septic patients with liver impairment:
diagnostic approach to evaluate Se psis in Intensive Care Unit. Buoro S, Mecca T, Azzarà G, Apassiti Esposito S,
Seghezzi M, Vavassori M, Crippa A, Marchesi G, Castellucci E, Ottomano C, Lippi G. Ann Transl Med 2015;3:244.
1128. Recommendations for the quantification of serum monoclonal component s (MC). Vernocchi A, Dolci A, Ceriotti
F, Lippi G, Merlini G, Graziani MS, Caldini A, Mussap M, Natali P, Patelli G, Maoggi S, Righetti G, Lalli A. Biochim
Clin 2015;39:199-207.
1129. Letter by Cervellin et al Regarding Article, "Allergic Inflammation Is Associ ated With Coronary Instability and
a Worse Clinical Outcome After Acute Myocardial Infarction" . Cervellin G, Lippi G, Kounis NG. Circ Cardiovasc
Interv 2015;8:e003166.
1130. Mean platelet volume is significantly associated with serum levels of thyroid -stimulating hormone in a cohort
of older euthyroid subjects. Lippi G, Danese E, Montagnana M, Nouvenne A, Meschi T, Borghi L. Endocr Res
2015;40:227-30.
1131. Spurious hyperglycaemia impairs automated leukocyte counting. A pilot study with two different
hematological analyzers. Buonocore R, Picanza A, Gennari D, Pipitone S, Lippi G. Blood Transfus 2015;13:656-61.
1132. Evaluation of nucleated red blood cell count by Sysmex XE -2100 in patients with thalassaemia or sickle cell
anaemia and in neonates. Buoro S, Vavassori M, Pipitone S, Benegiamo A, Lochis E, Fumagalli S, Falanga A,
Marchetti M, Crippa A, Ottomano C, Lippi G. Blood Transfus. 2015 Oct;13(4):588-94.
1133. Sample stability for complete blood cell count using the Sysmex XN haematological analyser. Daves M, Zagler
EM, Cemin R, Gnech F, Joos A, Platzgummer S, Lippi G. Blood Transfus 2015;13:576-82.
1134. How we define hyponatremia? Cervellin G, Lippi G. Eur J Clin Invest 2015;45:1219.
1135. Sleep apnea and venous thromboembolism. A systematic review. Lippi G, Mattiuzzi C, Franchini M. Thromb
Haemost 2015;114:958-63.
1136. Effectiveness of a computerized alert system based on re -testing intervals for limiting the inappropriateness
of laboratory test requests. Lippi G, Brambilla M, Bonelli P, Aloe R, Balestrino A, Nardelli A, Ceda GP, Fabi M.
Clin Biochem 2015;48: 1174-6.
1137. Red blood cell distribution width and cardiovascular diseases. Danese E, Lippi G, Montagnana M. J Thorac Dis
2015;7:E402-11.
1138. Cylindruria. Caleffi A, Lippi G. Clin Chem Lab Med 2015;53 Suppl 2:s1471-7.
1139. Biomarkers of inflammatory bowel disease: ready for prime time? Plebani M, Basso D, Lippi G. Clin Chem Lab
Med 2015;53:1881-2.
1140. Cell-free DNA for diagnosing myocardial infarction: not ready for prime time. Lippi G, Sanchis-Gomar F,
Cervellin G. Clin Chem Lab Med 2015;53:1895-901.
1141. Adjustment of serum potassium for age and platelet count. A simple step forward towards personalized
medicine. Lippi G, Salvagno GL, Guidi GC. Clin Chem Lab Med 2015;53:e325-7.
1142. Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coult er AU5800. Dipalo
M, Dipietro M, Gnocchi C, Musa R, Aloe R, Lippi G. Clin Chem Lab Med 2015;53:e355-8.
1143. Thalidomide for hereditary haemorrhagic telangiectasia . Franchini M, Lippi G. Lancet Haematol 2015;2:e457-8.
doi: 10.1016/S2352-3026(15)00222-7.
1144. Troponin in Stable Ischemic Heart Disease and Diabetes. Lippi G, Cervellin G, Targher G. N Engl J Med
2015;373:1976.
1145. Alcohol consumption and venous thromboembolism : friend or foe? Lippi G, Mattiuzzi C, Franchini M. Intern
Emerg Med 2015;10:907-13.
1146. Hemoconcentration induced by exercise: Revisiting the Dill and Costill equation. Alis R, Sanchis-Gomar F,
Primo-Carrau C, Lozano-Calve S, Dipalo M, Aloe R, Blesa JR, Romagnoli M, Lippi G. Scand J Sports Med Sci
2015;25:e630-7.
1147. A multicentre observational study evaluating the effectiveness of a phlebotomy check -list in reducing
preanalytical errors. Lippi G, Caola I, Cervellin G, Ferrari A, Milanesi B, Morandini M, Piva E, Ramponi C,
Giavarina D. Biochim Clin 2015;39:559-62.
1148. A survey on D-dimer test reporting in Italian laboratories and some suggestions for its harmonization. Lippi G,
Morelli B, Tripodi A. Biochim Clin 2015;39:591-4.
1149. Influence of air temperature variations on incidence of epistaxis. Comelli I, Vincenti V, Benatti M, Macri GF,
Comelli D, Lippi G, Cervellin G. Am J Rhinol Allergy 2015;29:175-81.
1150. Analytical assessment of the novel Maglumi squamous cell carcinoma antigen (SCCA) immunoluminometric
assay. Dipalo M, Gnocchi C, Aloe R, Lippi G. Ann Transl Med 2015;3:351.
1151. Immature granulocyte count on new Sysmex XN-9000: performances and diagnosis of sepsis in the intensive
care unit. Buoro S, Mecca T, Vavassoir M, Azzara G, Apassiti Esposito S, Dominono P, Papagni G, Marchesi G,
Ottomano C, Crippa A, Lippi G. Signa Vitae 2015;10:4.
1152. A case of factitious hyponatremia and hypokalemia due to the presence of fibrin gel in serum. Cervellin G,
Aloe R, Lippi G. Diagnosis 2015;2:73-4.
1153. Seasonal variation in the frequency of myocardial infarction diagnosed in a large emergency department of an
European country with a temperate climate. Lippi G, Mattiuzzi C, Cervellin G. Emerg Care J 2015;11:47-9.
1154. Cisplatin-induced bradycardia: Cardiac toxicity or cardiac hypersensitivity and Kounis syndrome? Kounis NG,
Cervellin G, Lippi G. Int J Cardiol 2016;202:817-8.
1155. Cell population data and reflex testing rules of cell analysis in pleural and ascitic fluids using body fluid mode
on Sysmex XN-9000. Buoro S, Mecca T, Azzarà G, Seghezzi M, Dominoni P, Crippa A, Ottomano C, Lippi G. Clin
Chim Acta 2016;452:92.8.
1156. Effects of 12-week endurance training at natural low-altitude on the blood redox homeostasis of professional
adolescent athletes: A quasi-experimental field trial. Tong TK, Kong Z, Lin H, He Y, Lippi G, Shi Q, Zhang H, Nie
J. Ox Med Cell Longevity 2016;2016: 4848015.
1157. Biomarkers: Novel troponin immunoassay for early ACS rule-out. Lippi G. Nat Rev Cardiol 2016;13:9-10.
1158. Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes
v 5 for differentiating sensitization to Vespula and Polistes subspeci es. Caruso B, Bonadonna P, Bovo C, Melloni
N, Lombardo C, Senna G, Lippi G. Clin Chim Acta 2016;453:170-3.
1159. Meat consumption and cancer risk: a critical review of published meta -analyses. Lippi G, Mattiuzzi C, Cervellin
G. Crit Rev Oncol Hematol 2016;97:1-14.
1160. Integration of Diagnostic Microbiology in a Model of Total Laboratory Automation . Da Rin G, Zoppelletto M,
Lippi G. Lab Medicine 2016;47:73-82.
1161. Building a bridge to safe diagnosis in health care. The role of the clinical laboratory. Lippi G, Plebani M,
Graber ML. Clin Chem Lab Med 2016;54:1-3.
1162. Capillary electrophoresis for the screening and diagnosis of inherited hemoglobin disorders. Ready for prime
time? Lippi G, Plebani M. Clin Chem Lab Med 2016;54:5-6.
1163. Harmonisation of D-dimer – a call for action. Longstaff C, Adcock D, Olson JD, Jennings I, Kitchen S, Mutch N,
Meijer P, Favaloro EJ, Lippi G, Thachil J. Thromb Res 2016;137:19-20.
1164. How to report results of prothrombin and activated partial thromboplastin times. Tripodi A, Lippi G, Plebani
M. Clin Chem Lab Med 2016;54:215-22.
1165. The impact of seasonality and other determinants on vitamin D concentration in childhood and adulthood:
still an unresolved issue. Lippi G, Mattiuzzi C, Aloe R. Ann Transl Med 2016;4:21.
1166. Red blood cell distribution width and cardiovascular disorders. Does it really matter which comes first, the
chicken or the egg? Lippi G, Cervellin G, Sanchis-Gomar F. Int J Cadiol 2016;206:129-30.
1167. Genetic and nongenetic determinants of mean platelet volume. Lippi G. Blood 2016;127:179-80.
1168. The association of serum procalcitonin and high -sensitivity C-reactive protein with pneumonia in elderly
multimorbid patients with respiratory symptoms: retrospective cohort study. Nouvenne A, Ticinesi A, Folesani
G, Cerundolo N, Prati B, Morelli I, Guida L, Laureta ni F, Maggio M, Aloe R, Lippi G, Meschi T. BMC Geriatr
2016;16:16.
1169. Kounis syndrome triggered by a spider bite. A case report . Cervellin G, Neri G, Lippi G, Curti M, Kounis NG. Int
J Cardiol 2016;207:23-4.
1170. Energy drinks: Increasing evidence of negative card iovascular effects. Sanchis-Gomar F, Leischik R, Lippi G. Int
J Cardiol 2016;206:153.
1171. Increased monoclonal components: prevalence of 44.474 italian outpatient population detected by capillary
electrophoresis. Vernocchi A, Longhi E, Lippi G, Gelsumini S. J Med Biochem 2016;35:50-4.
1172. Genetic determinants of extreme longevity: the role of ABO blood group. Franchini M, Mengoli C, Bonfanti C,
Rossi C, Lippi G. Thromb Haemost 2016;115:458-460.
1173. Value of Red Blood Cell Distribution Width on Emergency Department Admi ssion in Patients with Venous
Thrombosis. Lippi G, Buonocore R, Cervellin G. Am J Cardiol 2016;117:670-5.
1174. STARD guidelines: another piece of an intricate puzzle for evaluating the quality of scientific publishing.
Lippi G. Ann Transl Med 2016;4:42.
1175. Improving accuracy of diagnostic studies in a world with limited resources: a road ahead. Lippi G, Plebani M.
Ann Transl Med 2016;4:43.
1176. The impact of preanalytical variability in clinical trials: are we underestimating the issue? Banfi G, Lippi G.
1177. Editorial Compilation I. Favaloro EJ, Lippi G. Semin Thromb Hemost 2016;42:5-8.
1178. Correlation between ABO Blood Group, and Conventional Hematological and Metabolic Parameters in Blood
Donors. Franchini M, Mengoli C, Capuzzo E, Terenziani I, Bonfa nti C, Lippi G. Semin Thromb Hemost 2016;42:7586.
1179. Allergy and Venous Thromboembolism: A Casual or Causative Association. Lippi G, Favaloro EJ. Semin Thromb
Hemost 2016;42:63-8.
1180. Letter by Lippi and Cervellin Regarding Article, "Optimal Cutoff Levels of Mor e Sensitive Cardiac Troponin
Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction". Lippi G, Cervellin
G. Circulation 2016;133:e374.
1181. Spring season birth is associated with higher emergency department admission for acut e allergic reactions.
Cervellin G, Schirosa F, Buonocore R, Nouvenne A, Borghi L, Meschi T, Lippi G. Eur J Intern Med 2016:28;97-101.
1182. Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: a Case -Control Study. Ticinesi A, Nouvenne A,
Ferraro PM, Folesani G, Lauretani F, Allegri F, Guerra A, Cerundolo N, Aloe R, Lippi G, Maggio M, Gambaro G,
Borghi L, Meschi T. Urology 2016;87:40-5.
1183. In Search of ‘Omics'-Based Biomarkers to Predict Risk of Frailty and Its Consequences in Older Individuals:
The FRAILOMIC Initiative. Erusalimsky JD,Grillari J, Grune T, Jansen -Duerr P, Lippi G, Sinclair A, Tegnér J, Viña
J, Durrance-Bagale A, Miñambres R, Viegas M, Rodríguez -Mañas L, on behalf of the FRAILOMIC Consortium.
Gerontology 2016;62:182-90.
1184. Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups. Franchini F, Lippi G. Semin Thromb
Hemost 2016;42:112-7.
1185. Macroprolactin: searching for a needle in a haystack? Lippi G, Plebani M. Clin Chem Lab Med 2016;54:519-22.
1186. Birth season predicts the values of red bloo d cell distribution width (RDW) in adulthood. Lippi G, Salvagno GL,
Montagnana M, Danese E, Guidi GC. Clin Chem Lab Med 2016;54:667-71.
1187. The prognostic value of high-sensitivity C-reactive protein and prealbumin for short -term mortality in acutely
hospitalized multimorbid elderly patients: A prospective cohort study. Nouvenne A, Ticinesi A, Lauretani F,
Maggio M, Lippi G, Prati B, Borghi L, Meschi T. J Nutr Health Aging 2016;20:462-8.
1188. Potassium measurement in the ED: intepret with caution. Cervellin G, Lippi G. Am J Emerg Med 2016;34:753.
1189. Reflex Testing Rules for Cell Count and Differentiation of Nucleated Elements in Pleural and Ascitic Fluids on
Sysmex XE-5000. Buoro S, Appassiti Esposito S, Vavassori M, Mecca T, Ottomano C, Dominoni P, Seghezzi M,
Candiago E, Farina C, Gianatti A, Crippa A, Lippi G. J Lab Autom 2016;21:297-304.
1190. Vegetables intake and venous thromboembolism: a systematic review. Lippi G, Mattiuzzi C, Franchini M. Blood
Coagul Fibrinolysis 2016;27:242-5.
1191. Does fist pumping/clenching during venipuncture activate blood coagulation? Lippi G, Lima-Oliveira G, Guidi
1192. Analytical imprecision of lactate dehydrogenase in primary serum tubes. Buonocore R, Avanzini P, Aloe R,
Lippi G. Ann Clin Biochem 2016;53:405-8.
1193. Fish intake and venous thromboembolism : A systematic literature review. Mattiuzzi C, Cervellin G, Franchini
M, Lippi G. Clin Appl Thromb Hemost 2016;22:309-13.
1194. The evolution of anticoagulant therapy. Franchini M, Liumbruno GM, Bonfanti C, Lippi G. Blood Transfus
2016;14:175-84.
1195. Red Blood Cell Distribution Width in Iron -deficient Young Children. Lippi G, Danese E, Montagnana M. Pediatr
Hematol Oncol 2016;33:49-50.
1196. Biological samples transportation by drones: ready for prime time? Lippi G, Mattiuzzi C. Ann Transl Med
2016;4:92.
1197. ‘Mitotherapy’ for Heart Failure. Sanchis-Gomar F, Lippi G, Lucia A. Trends Mol Med 2016;22:267-9.
1198. Reflections on the next generation of hemostasis instrumentation. A glimpse into the future? Lippi G, Bovo C,
Favaloro EJ. Med Lab 2016;40:1-7.
1199. Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury. Lippi G, Cervellin G.
1200. EFLM WG-Preanalytical phase opinion paper: local validation of blood collection tubes in clinical labo ratories.
Lippi G, Cornes MP, Grankvist K, Nybo M, Simundic AM. European Federation of Clinical Chemistry and Laboratory
Medicine (EFLM) EFLM WG-Preanalytical phase. Clin Chem Lab Med 2016;54:755-60.
1201. Chest pain, dyspnea and other symptoms in patients with type 1 and 2 myocardial infarction. A literature
review. Lippi G, Sanchis-Gomar F, Cervellin G. Int J Cardiol 2016;215:20-2.
1202. Cardiospecific troponin immunoassays: how low is it worth to go? Lippi G, Cervellin G. Eur J Intern Med
2016;30:e7-8.
1203. Fully-automated, chemiluminescence IgA and IgG anti -tissue transglutaminase (tTG) antibodies serum assays
for the screening of celiac disease. Daves M, Cemin R, Perkmann V, Bernard P, Caprioli G, Platzgummer S, Lippi
G. J Immunol Methods 2016;429:57-9.
1204. More pistachio nuts for improving the blood lipid profile. Systematic review of epidemiological evidence.
Lippi G, Cervellin G, Mattiuzzi C. Acta Biomed 2016;87:5-12.
1205. Is adrenaline misused in anaphylaxis treatment? Experience of a large, urban Emergency Department: review
of 589 cases. Cervellin G, Schirosa F, Ridolo E, Lippi G, Meschi T. Signa Vitae 2016;11:90-102.
1206. Blood sampling seasonality as an important preanalytical factor for assessment of vitamin D status. Bonelli P,
Buonocore R, Aloe R, Lippi G. J Med Biochem 2016;35:113–7.
1207. Microcentrifuge or automated hematological analyzer to assess hematocrit in exercise? Effect on plasma
volume loss calculations. Alis R, Sanchis-Gomar F, Lippi G, Roamgnoli M. J Lab Autom 2016;21:470-7.
1208. Red blood cell distribution width and hemo globin are associated with hospital admission in patients with
acute allergic reactions. Lippi G, Buonocore R, Picanza A, Schirosa F, Cervellin G. Br J Biomed Sci 2016;73:21-4.
1209. Andexanet: Effectively Reversing Anticoagulation . Lippi G, Sanchis-Gomar F, Favaloro EJ. Trends Pharmacol Sci
2016;37:413-4.
1210. Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine. Plebani M, Lippi
G. Clin Chem Lab Med 2016;54:1117-8.
1211. Adrenaline in anaphylaxis treatment. Balancing benefits and ha rms. Cervellin G, Sanchis-Gomar F, Lippi G.
Expert Opin Drug Saf 2016;15:741-6.
1212. Standardizing in vitro diagnostics tasks in clinical trials. A call for action. Lippi G, Simundic AM, RodriguesManas L, Bossuyt P, Banfi G. Ann Transl Med 2016;4:181.
1213. Plasma Expression Levels of Circulating miR-21 are not Useful for Diagnosing and Monitoring Colorectal
Cancer. Montagnana M, Benati M, Danese E, Minicozzi AM, Paviati E, Gusella M, Pasini F, Bovo C, Guidi GC, Lippi
G. Clin Lab 2016;62:967-70.
1214. Acute coronary syndrome: many doubts, some answers. Lippi G, Cervellin G. Ann Transl Med 2016;4:187.
1215. High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I
concentration. Lippi G, Lo Cascio C, Brocco G, Danese E, Montagnana M, Bassi A, Caruso B, Bovo G, Salvagno GL.
1216. Diagnostic algorithms for acute coronary syndrome -is one better than another? Cervellin G, Mattiuzzi C, Bovo
C, Lippi G. Ann Transl Med 2016;4:193.
1217. Energy Drinks and Myocardial Ischemia: A Review of Case Reports. Lippi G, Cervellin G, Sanchis-Gomar F.
Cardiovasc Toxicol 2016;16:207-12.
1218. No correlation between health care expenditure and mortality in the European Union. Lippi G, Mattiuzzi C,
Cervellin G. Eur J Intern Med 2016;32:e13-4.
1219. Monitoring B-Type Natriuretic Peptide in patients undergoing therapy with neprilysin inhibitors. An emerging
challenge? Lippi G, Sanchis-Gomar F. Int J Cardiol 2016;219:111-4.
1220. Patient identification and tube labelling – a call for harmonisation. van Dongen-Lases EC, Cornes MP, Grankvist
K, Ibarz M, Kristensen GB, Lippi G, Nybo M, Simundic AM; Working Group for Preanalytical Phase (WG -PRE),
European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) . Clin Chem Lab Med 2016;54:1141-5.
1221. Spurious elevation of serum potassium concentration measured in samples with thrombocytosis. Roccaforte V,
Daves M, Alfreijat A, Riva M, Leitner M, Filippi S, Angaroni G, Montani F, Platzgummer S, Lippi G. Diagnosis
2016;3:71-4.
1222. Mobile phone exposure influences some erythro cytes parameters in vitro. A novel source of preanalytical
variability? Danese E, Lippi G, Brocco G, Montagnana M, Salvagno GL. Diagnosis 2016;3:75-9.
1223. Assessment of reticulated platelets with automated hemocytometers: are we measuring the same thing? Dima
F, Hoffmann JJML, Montolli V, Lippi G. Diagnosis 2016;3:91-3.
1224. Practices for Identifying and Rejecting Hemolyzed Specimens in Europe. Lippi G. Arch Pathol Lab Med
2016;140:622.
1225. DNA injury is acutely enhanced in response to increasing bulks of aerobic physic al exercise. Lippi G,
Buonocore R, Tarperi C, Montagnana M, Festa L, Danese E, Benati M, Salvagno GL, Bonaguri C, Roggenbuck D,
Schena F. Clin Chim Acta 2016;460:146-51.
1226. Comparison of the novel Maglumi ferritin immunoluminometric assay with Beckman Coulter DxI 800 ferritin.
Dipalo M, Gnocchi C, Aloe R, Lippi G. Med Lab 2016;40:221-3.
1227. Diagnostics of Inherited Bleeding Disorders of Secondary Hemostasis: An Easy Guide for Routine Clinical
Laboratories. Lippi G, Franchini M, Favaloro EJ. Semin Thromb Hemost 2016;42:471-7.
1228. Low serum bilirubin values are associated with pulmonary embolism in a case -control study. Cervellin G,
Buonocore R, Sanchis-Gomar F, Lippi G. Clin Chem Lab Med 2016;54:e229-30.
1229. The risks of defensive (emergency) medicine. The laboratory perspe ctive. Montagnana M, Lippi G. Emerg Care
J 2016;12:17-9.
1230. Thirty-minutes' exposure to smartphone call triggers neutrophil activation in vitro . Lippi G, Danese E, Brocco
G, Benati M, Salvagno GL, Montagnana M, Franchini M. Clin Chem Lab Med 2016;54:1497-1501.
1231. Toxic Alcohol Calculations and Misinterpretation of Laboratory Results. Lippi G, Plebani M. JAMA Intern Med
2016;176:1228-9.
1232. Cardiac troponin I is increased in patients with polytrauma and chest or head trauma. Results of a
retrospective case-control study. Lippi G, Buonocore R, Mitaritonno M, Cervellin G. J Med Biochem 2016;35:27581.
1233. The Theranos phenomenon, scientific transparency and freedom of speech. Lackner KJ, Gillery P, Lippi G,
Melichar B, Schlattmann P, Tate JR, Plebani M. Clin Chem Lab Med 2016;54:1403-5.
1234. Short-term Prognosis and Current Management of Syncopal Patients at Intermediate Risk: Results from the
IRiS (Intermediate-Risk Syncope) Study. Numeroso F, Mossini G, Giovanelli M, Lippi G, Cervellin G. Acad Emerg
Med. 2016;23:941-8.
1235. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay. Ruzzenente O, Salvagno
GL, Gelati M, Lippi G. Pract Lab Med 2016;6:8-13.
1236. Evidence and pitfalls in diagnosis and prognostication of acute coronary syndrome. Lippi G, Cervellin G. Ann
1237. Red blood cell distribution width independently predicts medium term mortality and major adverse cardiac
events after an acute coronary syndrome. Turcato G, Serafini V, Dilda A, Bovo C, Caruso B, Ricci G, Lippi G.
1238. Predictive significance of detectable cardiac troponin I measured with a contemporary -sensitive assay in a
real life experience. Bonfanti L, Lippi G, Ciullo I, Meschi T, Ticinesi A, Aloe R, Di Spigno F, Cervellin G. Ann
1239. High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages. Galli C,
Lippi G. Ann Transl Med 2016;4:250.
1240. Inside out the thrombus: Defining the role of von Willebrand factor. Franchini M, Lippi G. Thromb Res
2016;144:234-5.
1241. Assessment of blood sample stability for complete blood count using the Sysmex XN -9000 and Mindray BC6800 analyzers. Buoro S, Mecca T, Seghezzi M, Cerutti M, Dominoni P, Manenti B, Crippa A, La Gioia A, Ottomano
C, Lippi G. Rev Bras Hematol Hemoter 2016;38:225-39.
1242. Red blood cell distribution width at emergency department admission increases the accuracy of the HEART
score for predicting death in patients with chest pain. Turcato G, Serafini V, Dilda A, Caruso B, Zannoni M,
Ricci G, Lippi G. Int J Cardiol 2016;222:999–1000.
1243. Column in laboratory medicine. Lippi G. Ann Transl Med 2016;4:274.
1244. The role of European Federation of Clinical Chemistry and Laboratory Medicine Working Group for
Preanalytical Phase in standardization and harmonization of the preanaly tical phase in Europe. Cornes MP,
Church S, van Dongen-Lases E, Grankvist K, Guimarães JT, Ibarz M, Kovalevskaya S, Kristensen GB, Lippi G, Nybo
M, Sprongl L, Sumarac Z, Simundic AM; Working Group for Preanalytical Phase (WG -PRE) and European Federation
of Clinical Chemistry and Laboratory Medicine (EFLM) . Ann Clin Biochem 2016;53:539-47.
1245. Optimization of Cellular Analysis of Synovial Fluids by optical microscopy and automated count using the
Sysmex XN Body Fluid Mode. Seghezzi M, Buoro S, Manenti B, Mecca T , Ferrari R, Zappalà G, Castelli CC, Balboni
F, Pezzati P, Ottomano C, Lippi G. Clin Chim Acta 2016;462:41-8.
1246. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers
and still many questions. Kotani K, Serban MC, Penson P, Lippi G, Banach M. Crit Rev Clin Lab Sci 2016;53:370-8.
1247. Reference intervals for cell counts of umbilical cord blood. Dima F, Montagnana M, Raffaelli R, Cascella S, Bovo
C, Franchi M, Lippi G. Biochim Clin 2016;40:204-7.
1248. Assessment of the analytical performance of novel parameters of automated blood count on Sysmex XN -9000.
Mecca T, Seghezzi M, Gherardi P, Resmini S, Napolitano G, Parimbelli M, Crippa A, Manenti B, Ottomano C, Lippi
G, Buoro S. Biochim Clin 2016;40:217-24.
1249. Dogs’ olfactory diagnostics applied on human species: state of the art and clinical perspectives. Palmieri B,
Nardo B, Lippi G, Palmieri L, Vadalà M, Laurino C. Clin Ter 2016;167:e78-84.
1250. Serum myoglobin immunoassays: obsolete or still clinically useful? Lippi G, Plebani M. Clin Chem Lab Med
2016;54:1541-3.
1251. Editorial Compilation-II. Favaloro EJ, Lippi G. Semin Thromb Hemost 2016;42:599-602.
1252. The Mean Platelet Volume Is Decreased in Patients Diagnosed with Venous Thromboembolism in the
Emergency Department. Lippi G, Buonocore R, Cervellin G. Semin Thromb Hemost 2016;42:632-5.
1253. Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander? Danese E, Montagnana M,
1254. The prognostic value of ABO blood group in cancer patien ts. Franchini M, Liumbruno GM, Lippi G. Blood
Transfus 2016;14:434-40.
1255. Evaluation of capillary haemoglobin determination for anaemia screening in blood donation settings. Daves M,
Cemin R, Zagler EM, Joos A, Platzgummer S, Hueber R, Lippi G. Blood Transfus 2016;14:387-90.
1256. Relationship between ABO blood group and pregnancy complications: a systematic literature analysis.
Franchini M, Mengoli C, Lippi G. Blood Transfus 2016;14:441-8.
1257. Letter by Lippi and Franchini Regardin Article "ABO Blood Group and Risk of Thromboembolic and Arterial
Disease: A Study of 1.5 Million Blood Donors". Lippi G, Franchini M. Circulation 2016;134:e258-9.
1258. Clinical perception and simple laboratory tests: do not mistake the finger pointing at the moon. Lippi G. Ann
1259. Analytical Evaluation of Free Testosterone and Cortisol Immunoassays in Saliva as a Reliable Alternative to
Serum in Sports Medicine. Lippi G, Dipalo M, Buonocore R, Gnocchi C, Aloe R, Delsignore R. J Clin Lab Anal
2016;30:732-5.
1260. Automated Cerebrospinal Fluid Cell Counts Using the New Body Fluid Mode of Sysmex UF -1000i. Buoro S,
Apassiti Esposito S, Alessio MG, Crippa A, Ottomano C, Lippi G. J Clin Lab Anal 2016;30:381-91.
1261. Access to scientific information. A national survey of the Italian Society of Clin ical Biochemistry and
Laboratory Medicine (SIBioC). Lippi G, Ciaccio M, Giavarina D. Diagnosis 2016;3:129-34.
1262. Laboratory economics. Risk or opportunity? Lippi G, Plebani M. Clin Chem Lab Med 2016;54:1701-3.
1263. Abnormal gel flotation caused by contrast media d uring adrenal vein sampling. Lima-Oliveira G, Lippi G,
Salvagno GL, Gelati M, Bassi A, Contro A, Pizzolo G, Guidi GC. Biochem Med (Zagreb) 2016;26:444-50.
1264. Autumn season birth is associated with a lower frequency of diagnosis of unprovoked deep vein thrombo sis in
the emergency department. Cervellin G, Lippi G. Blood Coagul Fibrinolysis 2016;27:776-8.
1265. Nonalcoholic Fatty Liver Disease Is Independently Associated With An Increased Incidence of Cardiovascular
Disease In Adult Patients With Type 1 Diabetes. Mantovani A, Mingolla L, Rigolon R, Pichiri I, Cavalieri V,
Zoppini G, Lippi G, Bonora E, Targher G. Int J Cardiol 2016;225:387-91.
1266. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all -cause and cardiovascular
mortality in patients with type 2 diabetes. Zoppini G, Cacciatori V, Negri C, Stoico V, Lippi G, Targher G,
Bonora E. Medicine (Baltimore) 2016;95:e4821.
1267. Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from
Patients with Cystic Fibrosis. Prandini P, De Logu F, Fusi C, Provezza L, Nassini R, Montagner G, Materazzi S,
Munari S, Gilioli E, Bezzerri V, Finotti A, Lampronti I, Tamanini A, Dechecchi MC, Lippi G, Ribeiro CM, Rimessi A,
Pinton P, Gambari R, Geppetti P, Cabrini G. Am J Respir Cell Mol Biol 2016;55:645-56.
1268. Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future? Franchini M, Lippi G.
Thromb Res 2016;148:96-100.
1269. Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Departme nt: retrospective
analysis of 5,340 cases. Cervellin G, Mora R, Ticinesi A, Meschi T, Comelli I, Catena F, Lippi G. Ann Transl Med
2016;4:362.
1270. The first case report of mefloquine-associated rhabdomyolysis. Comelli I, Lippi G, Magnacavallo A, Cervellin G.
Am J Emerg Med 2016;34:2250.e5-2250.e6.
1271. Severe acute lactic acidosis and hypoglycemia due to isolate tramadol poisoning. Granauro P, Di Comite V,
Lippi G, Marzi U, Cervellin G. Emerg Care J 2016;12:5659.
1272. Hypoglycemia Alert Dogs: A Novel, Cost -effective Approach for Diabetes Monitoring? Lippi G, Cervellin G,
Dondi M, Targher G. Altern Ther Health Med 2016;22:14-8.
1273. Critical laboratory values communication: summary recommendations from available guidelines. Lippi G,
Mattiuzzi C. Ann Transl Med 2016;4:400.
1274. Re-engineering laboratory diagnostics for preventing preanalytical errors. Lippi G, Bowen R, Adcock DM. Clin
Biochem 2016;49:1313-4.
1275. Critical Pre-examination Variables in the Hemostasis Laboratory and Their Quality Indicators. Adcock DM,
Favaloro EJ, Lippi G. Clin Biochem 2016;49:1315-20.
1276. Estimation of the imprecision on clinical chemistry testing due to fist clenching and maintenance during
venipuncture. Lima-Oliveira G, Guidi GC, Salvagno GL, Brocco G, Danese E, Lippi G. Clin Biochem 2016;49:13647.
1277. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? Lima-Oliveira G,
Adcock DM, Salvagno GL, Favaloro EJ, Lippi G. Clin Biochem 2016;49:1399-1401.
1278. The impact of different sample matrices in delayed measurement of glucose. Roccaforte V, Daves M,
Platzgummer S, Lippi G. Clin Biochem 2016;49:1412-5.
1279. Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of
Western patients undergoing surgery for colorectal cancer. Pedrazzani C, Mantovani G, Salvagno GL, Baldiotti
E, Ruzzenente A, Iacono C, Lippi G, Guglielmi A. World J Gastroenterol 2016;22:9994-10001.
1280. Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute
myocardial infarction. A paradigmatic case report. Poli G, Castiglioni P, Montagnana M, Favaloro EJ, Lippi G.
1281. Streamlining laboratory expenditures through direct to consumer testing and reference prices: first do not
harm. Lippi G, Plebani M. Ann Transl Med 2016;4:424.
1282. Clinical significance of cell population data (CPD) on Sysmex XN -9000 in septic patients with our without liver
impairment. Buoro S, Seghezzi M, Vavassori M, Dominoni P, Apassiti Esposito S, Manenti B, Mecca T, Marchesi G,
Castellucci E, Azzarà G, Ottomano C, Lippi G. Ann Transl Med 2016;4:418.
1283. MiR-199a and miR-125b expression levels in serum of patients affected by epithelial ovarian cancer. Benati M,
Montagnana M, Danese E, Giudici S, Ruzzenente O, Guidi GC, Franchi M, Lippi G. Biochim Clin 2016;40:328-33.
1284. Blood collection systems in clinical laboratories: local adaptation of the EFLM guidelines . Giavarina D, Banfi
G, Daves M, Dolci A, Farci Santarcangeli D, Lima -Oliveira G, Miconi V, Milanesi B, Montagnana M, Morandini M,
Piva E, Salvagno GL, Troiano T, Lippi G. Biochim Clin 2016;40;347-52.
1285. The interplay between genetics, epigenetics and environment in modulating the risk of coronary heart
disease. Lippi G, Cervellin G. Ann Transl Med 2016;4:460.
1286. Learning more and spending less with neglected la boratory parameters: the paradigmatic case of red blood
cell distribution width. Lippi G, Mattiuzzi C, Cervellin G. Acta Biomed 2017;87:323-8.
1287. In the kingdom of “tortelli” (ravioli-like pasta) plant poisoning is still a threat. A case report of near -fatal
poisoning from Digitalis Purpurea accidentally confused with Borago Officinalis. Bonfanti L, Lippi G, Ciullo I,
Robuschi F, Aloe R, Tarasconi S, Vassallo R, Cervellin G. Acta Biomed 2017;87:353-7.
1288. Atrial fibrillation in highly trained endurance athletes − Description of a syndrome. Sanchis-Gomar F, PerezQuilis C, Lippi G, Cervellin G, Leischik R, Löllgen H, Serrano -Ostáriz E, Lucia A. Int J Cardiol 2017;226:11-20.
1289. Order of blood draw: Opinion Paper by the European Federation for Clinical Chemistry and Laboratory
Medicine (EFLM) Working Group for the Preanalytical Phase (WG -PRE). Cornes M, van Dongen-Lases E, Grankvist
K, Ibarz M, Kristensen G, Lippi G, Nybo M, Simundic AM; Working Group for Preanaly tical Phase (WG-PRE),
European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chem Lab Med 2017;55:27-31.
1290. Thrombocytopenia and infections. Franchini M, Veneri D, Lippi G. Expert Rev Hematol 2017;10:99-106.
1291. Cardiac troponins and mortality in type 1 and 2 myocardial infarction. Lippi G, Sanchis-Gomar F, Cervellin G.
1292. Repeated potassium testing in hemolyzed specimens collected in the emergency department: more pros than
cons. Cervellin G, Lippi G. J Emerg Med 2017;52:105-6.
1293. C-reactive protein as early predictor of complications after minimally invasive colorectal resection.
Pedrazzani C, Moro M, Mantovani G, Lazzarini E, Conci S, Ruzzenente A, Lippi G, Guglielmi A. J Surg Res
2017;210:261-8.
1294. Acute effect of dark chocolate on red blood cell distribution width. Montagnana M, Danese E, Montolli V,
Salvagno GL, Lippi G. Eur J Intern Med 2017;37:e29-e30.
1295. Statins for primary prevention of cardiovascular disease. Lippi G, Plebani M. Trends Pharmacol Sci 2017;38:1112.
1296. The role of red blood cell distribution width for predicting 1 -year mortality in patients admitted to the
emergency department with severe dyspnoea. Turcato G, Cervellin G, Salvagno GL, Zaccaria E, Bartucci G,
David M, Bonora A, Zannoni M, Ricci G, Lippi G. J Med Biochem 2017;36:32–8.
1297. Preanalytical nonconformity management regarding primary tube mixing. A Brazilian survey. Lima-Oliveira G,
Guidi GC, dos Santos F, Thalisson Almeida A, Carlos de Carvalho A, Lippi G. J Med Biochem 2017;36:39–43.
1298. Alpha-amylase serum levels in professional soccer players are not related with physical fitness . Sanchis-Gomar
F, Alis R, Rampinini E, Bosio A, Romagnoli M, Lombardi G, Lippi G. J Sports Med Phys Fitness 2017;57:214-8.
1299. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators. Lippi G,
Sciacovelli L, Simundic AM, Plabani M. Clin Chem Lab Med 2017;55:e51-3.
1300. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group "Laboratory
Errors and Patient Safety" project. Sciacovelli L, Lippi G, Sumarac Z, West J, Garcia Del Pino Castro I, Furtado
Vieira K, Ivanov A, Plebani M; Working Group “Laboratory Errors and Patient Safety” of International Federation
of Clinical Chemistry and Laboratory Medicine (IFC C). Clin Chem Lab Med 2017;55:348-57.
1301. Obstructive sleep-disordered breathing, enuresis and combined disorders in children: chance or related
association? Zaffanello M, Piacentini G, Lippi G, Fanos V, Gasperi E, Nosetti L. Swiss Med Wkly 2017;147:w14400.
1302. Laboratory monitoring of direct oral anticoagulants (DOACs). The perfect storm? Lippi G, Favaloro EJ. Ann
1303. Exercising recommendations for paroxysmal AF in young and middle -aged athletes (PAFIYAMA) syndrome.
Perez-Quilis C, Lippi G, Cervellin G, Löllgen H, Sanchis-Gomar F. Ann Transl Med 2017;5:24.
1304. The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a
literature review. Maierean S, Serban MC, Rizzo M, Lippi G, Sahebkar A, Banach M. Lipids Health Dis 2017;16:35.
1305. Editorial Compilation III. Favaloro EJ, Lippi G. Semin Thromb Hemost 2017;43:4-7.
1306. Red Blood Cell Distribution Width Is an Independent Predictor of Outcome in Patients Undergoing
Thrombolysis for Ischemic Stroke. Turcato G, Cappellari C, Follador L, Dilda A, Bonora A, Zannoni M, Bovo C,
Ricci G, Bovi P, Lippi G. Semin Thromb Hemost 2017;43:30-5.
1307. Aberrant MicroRNA Expression in Patients With Endometrial Cancer. Montagnana M, Benati M, Danese E, Giudici
S, Perfranceschi M, Ruzzenenete O, Salvagno GL, Bassi A, Gelati M, Paviati E, Guidi GC, Franchi M , Lippi G. Int J
Gynecol Cancer 2017;27:459-66.
1308. Heart-type Fatty Acid-Binding Protein after ultramarathon running and relationship with high -sensitivity
troponin I. Lippi G, Dipalo M, Aloe R, Salvagno GL, Schena F. J Cardiovasc Med (Hagerstown). 2014 May 6. doi:
10.2459/JCM.0000000000000066. [Epub ahead of print].
1309. An 18-minute submaximal exercise test to assess cardiac fitness in response to aerobic training. Romagnoli M,
Alis R, Sanchis-Gomar F, Lippi G, Arduini A. J Strength Cond Res.
2014 Sep 15. doi:
10.1519/JSC.0000000000000685. [Epub ahead of print].
1310. Limits of ventricular function: from athlete's heart to a failing heart . Forteza-Albertí JF, Sanchis-Gomar F,
Lippi G, Cervellin G, Lucia A, Calderón-Montero FJ. Clin Physiol Funct Imaging. 2016 Jan 12. doi:
10.1111/cpf.12341. [Epub ahead of print].
1311. Acute effects of 30-min exposure to a smartphone call on in vitro platelet function. Lippi G, Danese E, Brocco
G, Gelati M, Salvagno GL, Montagnana M . Blood Transfus. 2016 May 6:1-5. doi: 10.2450/2016.0327-15. [Epub
ahead of print].
1312. Misuse of the metabolic modulator meldonium in sports. Lippi G, Mattiuzzi C. J Sport Health Sci. 2016 Jun 24.
doi: 10.1016/j.jshs.2016.06.008. [Epub ahead of print].
1313. Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes
Mellitus. Montagnana M, Fava C, Targher G, Franchini M, Danese E, Bonafini S, De Cata A, Salvagno GL,
Ruzzenente O, Guidi GC, Lippi G. J Clin Lab Anal. 2016 Jul 29. doi: 10.1002/jcla.22031. [Epub ahead of print].
1314. Validation rules for blood smear revision after automated hematological testing using Mindray CAL -8000.
Buoro S, Mecca T, Seghezzi M, Azzarà G, Ottomano C, Lippi G. J Clin Lab Anal. 2016 Oct 6. doi:
10.1002/jcla.22067. [Epub ahead of print].
1315. Opportunities and drawbacks of nonstandard body fluid analysis. Lippi G, Plebani M. Clin Chem Lab Med. 2016
Oct 18. doi: 10.1515/cclm-2016-0862. [Epub ahead of print].
1316. A narrative review about blood laboratory testing for early prediction of preeclampsia: chasing the finish line
or at the starting blocks? Montagnana M, Danese E, Lippi G, Fava C. Ann Med. 2016 Oct 28:1-39. doi:
10.1080/07853890.2016.1255350. [Epub ahead of print].
1317. Estimating the intra- and inter-individual imprecision of manual pipetting. Lippi G, Lima-Oliveira G, Brocco G,
Bassi A, Salvagno GL. Clin Chem Lab Med. 2016 Nov 7. doi: 10.1515/cclm-2016-0810. [Epub ahead of print].
1318. Early function decline after ischemic stroke can be predicted by a nomogram b ased on age, use of
thrombolysis, RDW and NIHSS score at admission. Turcato G, Cervellin G, Cappellari M, Bonora A, Zannoni M,
Bovi P, Ricci G, Lippi G. J Thromb Thrombolysis. 2016 Nov 12. doi: 10.1007/s11239-016-1456-y. [Epub ahead of
print].
1319. The Impact of fist clenching and its maintenance during venipuncture on routine haematology testing. LimaOliveira G, Guidi GC, Salvagno GC, Lippi G. J Clin Lab Anal. 2016 Nov 29. doi: 10.1002/jcla.22108. [Epub ahead of
print].
1320. Short-term effect of dark chocolate consumption on routine haemostasis testing. Montagnana M, Danese E,
Salvagno GL, Lippi G. Int J Food Sci Nutr. 2016 Dec 14:1-4. doi: 10.1080/09637486.2016.1268101. [Epub ahead of
print].
1321. AMP-activated protein kinase (AMPK) signaling pathway: A potential mechan ism involved in PAFIYAMA
syndrome?
Sanchis-Gomar
F,
Perez-Quilis
C,
Lippi
G.
Int
J
Cardiol.
2016
Dec
21.
doi:
10.1016/j.ijcard.2016.12.142. [Epub ahead of print].
1322. High-sensitivity cardiac troponin in the emergency department: the perfect storm? Lippi G, Cervellin G. Int J
Cardiol. 2016 Dec 23. doi: 10.1016/j.ijcard.2016.12.034. [Epub ahead of print] .
1323. Critical laboratory values in hemostasis: towards consensus. Lippi G, Adcock D, Simundic AM, Tripodi A,
Favaloro EJ. Ann Med. 2016 Dec 31:1-20. doi: 10.1080/07853890.2016.1278303. [Epub ahead of print] .
1324. The serum concentrations of leptin and MCP-1 independently predict low back pain duration. Lippi G,
Dagostino C, Buonocore R, Aloe R, Bonaguri C, Fanelli G, Allegri M. Clin Chem Lab Med. 2017 Jan 11. doi:
10.1515/cclm-2016-0942. [Epub ahead of print].
1325. PPARδ modulation by GW501516: an unsuccessful exercise mimetic. Sanchis-Gomar F, Lippi G, Perez-Quilis C.
Clin Pharmacol Ther. 2017 Jan 25. doi: 10.1002/cpt.632. [Epub ahead of print] .
1326. Managing the patient identification crisis in healthcare and laboratory medicine. Lippi G, Mattiuzzi C, Bovo C,
Favaloro EJ. Clin Biochem. 2017 Feb 5. doi: 10.1016/j.clinbiochem.2017.02.004. [Epub ahead of print].
1327. Reporting altered test results in hemolyzed samples: is the cure worse than the disease? Lippi G, Cervellin G,
Plebani M. Clin Chem Lab Med. 2017 Feb 16. doi: 10.1515/cclm-2017-0011. [Epub ahead of print].
1328. Improving quality in the preanalytical phase through innovation, on behalf of European Federation for
Clinical Chemistry and Laboratory Medicine (EFLM) Working gro up for Preanalytical Phase (WG-PRE). Lippi G,
Baird GS, Banfi G, Bölenius K, Cadamuro J, Church S, Cornes MP, Dacey A, Guillon A, Hoffmann G, Nybo M,
Premawardhana LD, Salinas M, Sandberg S, Slingerland R, Stankovic A, Sverresdotter SM, Vermeersch P, Simun dic
AM. Clin Chem Lab Med. 2017 Feb 23. doi: 10.1515/cclm-2017-0107. [Epub ahead of print].
1329. Red Blood Cell Distribution Width in patients with limbs, chest and head trauma. Lippi G, Bovo C, Buoncore R,
Mitaritonno M, Cervellin G. Arch Med Sci, in stampa.
1330. Cortisol and migraine. A systematic literature review. Mattiuzzi C, Cervellin G, Lippi G. Acta Biomed, in
stampa.
1331. Analytical comparison between two haematological analyser systems CAL -8000 versus XN-9000. Buoro S,
Mecca T, Seghezzi M, Manenti B, Azzarà G, Dominoni P, Crippa A, Ottomano C, Lippi G. Int J Lab Hematol, in
stampa.
1332. Physical exercise and DNA injury: good or evil? Danese E, Lippi G, Sanchis-Gomar F, Brocco G, Rizzo M, Banach
M, Montagnana M. Adv Clin Chem, in stampa.
1333. Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives
and false negatives. Favaloro EJ, Lippi G. Blood Transfus, in stampa.
1334. Patient and sample identification. Out of the maze? Lippi G, Chiozza L, Mattiuzzi C, Plebani M. J Med Biochem,
in stampa.
1335. The Intriguing Link between the Intestinal Microbiota and Cardiovascular Disease. Lippi G, Danese E, Mattiuzzi
C, Favaloro EJ. Semin Thromb Hemost, in stampa.
1336. Dark chocolate intake acutely enhanced neutrophil count in peripheral venous b lood. Lippi G, Montagnana M,
Lima-Oliveira G, Danese E, Salvagno GL. Iran J Pathol, in stampa.
1337. Reliability of automated synovial fluid cell counting with Mindray BC -6800 Body Fluid Mode. Buoro S, Seghezzi
M, Manenti B, Mecca T, Candiago E, Ferrari R, Zappa là G, Castelli CC, Vidali M, Ottomano C, Lippi G. Int J Lab
Hematol, in stampa.
1338. Exploring the iceberg of inappropriateness in hemostasis testing. Lippi G, Favaloro EJ. Diagnosis, in stampa.
1339. Patient posture for blood collection by venipuncture: a recall for standardization 28 years afterwards. LimaOliveira G, Guidi GC, Salvagno GL, Danese E, Montagnana M, Lippi G. Rev Bras Hematol Hemoter, in stampa.
1340. Pre-analytical phase management: a review of the procedures from patient preparation to laboratory
analysis. Lima-Oliveria F, Volanski W, Lippi G, Picheth G, Guidi GC. Scand J Clin Lab Invest, in press. Doi:
10.1080/00365513.2017.1295317.
1341. Inappropriateness in laboratory medicine: an elephant in the room? Lippi G, Bovo C, Ciaccio M. Ann Transl
Med, in stampa.
1342. Emerging Treatments for Hemophilia: Patients and their treaters spoilt for choice, but laboratories face a
difficult path? Favaloro EJ, Lippi G. Ann Transl Med, in stampa.
1343. Thromboprophylaxis after knee arthroscopy: out of the maze? Lippi G, Cervellin G. Trends Pharmacol Sci, in
stampa. doi: 10.1016/j.tips.2017.02.004.
1344. Non-traumatic rhabdomyolysis: background, laboratory features, and acute clinical management . Cervellin G,
Comelli I, Benatti M, Sanchis-Gomar F, Bassi A, Lippi G. Clin Biochem, in stampa.
1345. Blood venous Sample Collection: an overview. Giavarina D, Lippi G. Clin Biochem, in stampa.
Pubblicazioni in extenso su riviste scientifiche internazionali non indicizzate
1.
Standardization of lipoprotein(a) measurements: an overwiev. Guidi G, Lippi G. Biochim Clin 1995;19:703-9.
2.
Medicina di Laboratorio e Doping. Lippi G. Biochim Clin 1999;23:131-41.
3.
Aggiornamenti in tema di Medicina di Laboratorio e Doping. La nuova Campagna del CONI "Io non rischio la
salute!". Lippi G, Guidi G. Biochim Clin 2000;24:87-95.
4.
Linee guida per l'identificazione del doping con eritropoietina umana ricombinante. Lippi G. Biochim Clin
2001;25:425-9.
5.
Approccio multidisciplinare alla diagnosi delle malattie emorragiche congenite. Franchini M, Lippi G. Biochim
Clin 2002;27:10-5.
6.
Il valore della produzione scientifica in medicina di laboratorio: tra educazione e formazione. Lippi G. Biochim
Clin 2003;27:120-31.
7.
Severe Acute Respiratory Sindrome (SARS): una nuova ed intrigante sfida diagnostica. Lippi G, Mattiuzzi C.
Biochim Clin 2003;27:177-85.
8.
Fisiopatologia della coagulazione: nuove acquisizioni. Manzato F, Lippi G, Franchini M, Guidi G. Biochim Clin
2004;28:1-13.
9.
Linee guida sull'impiego clinico del D-dimero. Legnani C, Palareti G, Prisco D, Mannucci PM, Tripodi A, Ciavarella
N, Lippi G, Manotti C, Rodeghiero F, per il Sottocomitato Emostasi del CISMEL. Riv Med Lab - JLM 2004;5:225-39.
10.
Nuove realtà in politica sanitaria: benchmarking e laboratorio clinico. Lippi G, Mattiuzzi C. Clinical Governance
2005:2:25-29.
11. Recenti sviluppi degli esami antidoping. Presupposti giuridici e ricadute pratiche. Lippi G, Banfi G, Dolci A,
Mattiuzzi C, Guidi GC. Biochim Clin 2005;29:360-66.
12. Variabilità preanalitica e Medicina di Laboratorio. Lippi G, Mattiuzzi C, Salvagno GL, Montagnana M, Guidi GC.
Clinical Governance 2005;2:30-36.
13. State-of-the-art coagulation testing. Lippi G, Franchini M. Hospital Healthcare Europe 2006/7 L50-L53.
14. Quality in routine coagulation testing. Lippi G, Franchini M. Hospital Healthcare Europe 2006/7:L50-L53.
15. Troponine cardiospecifiche nella patologia cardiaca non ischemica. Lippi G, Montagnana M, Guidi GC. Emerg Care
J 2006;2:6-13.
16. La fase post analitica: refertazione dei valori critici. Lippi G. RIMeL/IJLM 2006;2 (Suppl.):83-7.
17. Aggiornamenti in tema di auto-monitoraggio glicemico nei pazienti diabetici. Lippi G, Montagnana M. Biochim
Clin 2006;30:482-6.
18. Formazione in Medicina di Laboratorio. Guidi GC, Lippi G. Biochim Clin 2007;31:127-30.
19. L’automazione della fase pre-analitica. Lippi G, Salvagno GL, Guidi GC. Biochim Clin 2007;31:131-7.
20. Appropriateness of laboratory testing. Lippi G, Fostini R. Hospital Healthcare Europe 2007/8:L14-L15.
21. Implementazione di un sistema automatico di verifica e validazione dei risultati di laboratorio: esperienza
personale. Guidi GC, Poli G, Bassi A, Giobe lli L, Benetollo PP, Lippi G. Biochim Clin 2009;33:249-54.
22. Laboratory diagnostics in septic disseminated intravascular coagulation. Lippi G, Guidi GC. European Hematology
2010;2:6-11.
23. EFCC/Bio-Rad Symposium in Portugal Treats Challenges of Quality Manageme nt and Accreditation. Lippi G.
LabMedica International 2010;November:71.
24. Il suicidio ed il tentato suicidio: una sfida in emergenza -urgenza. Rassegna critica ed esperienza del PS della
provincia di Parma. Rastelli G, Trevia M, Lippi G, Cervellin G. Emerg Care J 2011;7:40-4.
25. Appropiateness of cholesterol screening: from recommendations to clinical practice. Lippi G, Salvagno GL,
Mattiuzzi C, Fostini R, Montagnana M, Guidi GC. Medlab Magazine 2012;2:35-8.
26. Diagnostic significance of haematological testing in p atients presentino at the emergency department. Lippi G,
Targher G, Neri G, Cattabiani C, Pipitone S, Cervellin G. Emerg Care J 2012;8:7-12.
27. Gli organi endocrini bioartificiali: prospettive della ricerca traslazionale applicata alla medicina rigenerativa i n
endocrinologia. Strusi V, Mastrogiacomo S, Zini N, Dallatana D, Spaletta G, Bassoli E, Gatto A, Zamparelli A, Lippi
G, Iafisco M, Sandri M, Tampieri A, Toni R. L’endocrinologo 2012;13:1-10.
28. Il dosaggio ematico dei farmaci antidiabetici: importanza nelle sindromi ipoglicemiche. Lippi G, Montagnana M.
L’endocrinologo 2012;13:163-8.
29. A rare case of emergency department visit for melena: gastric mucormycoma mimicking adenocarcinoma.
Comelli I, Bosi S, Caruana P, Lippi G, Cervellin G. Emerg Care J 2012;8:6-8.
30. The dark side of the QT interval. The Short QT Syndrome: pathophysiology, clinical presentation and
management. Comelli I, Lippi G, Mossini G, Gonzi G, Meschi T, Borghi L, Cervellin G. Emerg Care J 2012;8:41-7.
31. Ischemic heart disease in the emergency room: state of the art, innovation and research. Lippi G, Cavazza M,
Peracino A, Tubaro M, Nechita A, Ballarino P, Peacock FW, Di Somma S. Emerg Care J 2013;9:e7. Doi:
10.4081/ecj.2013.e7.
32. Red Blood Cell distribution width and erythrocyte parameters in patients with brain injury after mild head
trauma. Lippi G, Carbucicchio A, Avanzini P, Dipalo M, Benfatti M, Cervellin G. Emerg Care J 2013;9:e13. Doi:
10.4081/ecj.2013.e13.
33. Highly-sensitive troponin immunoassays in the emergency department: counterpoint. Lippi G, Cervellin G. Emerg
Care J 2013;9:e16. Doi: 10.4081/ecj.2013.e16.
34. Bad news about an old poison. A case of nicotine poisoning due to both ingestion and injection of the content of
an electronic cigarette refill. Cervellin G, Luci M, Bellini C, Lippi G. Emerg Care J 2013;9:e18. Doi:
10.4081/ecj.2013.e18.
35. Copeptin for risk stratification in acute illness: beyond cardiological problems. Cemin R, Lippi G, Donazzan L,
Manfrin M, Daves M. Emerg Care J 2013;9:e19. Doi: 10.4081/ecj.2013.e19.
36. Biomarker validation in the emergency department. General criteria and clinical implications. Lippi G, Mattiuzzi
C, Cervellin G. Emerg Care J 2014;10:1860. Doi:10.4081/ecj.2014.1860.
37. Emergency Department utilization rates and modalities among immigrant population. A 5 -years survey in a large
Italian urban Emergency Department. Zinelli M, Musetti V, Comelli I, Lippi G, Cervellin G. Emerg Care J
2014;10:1896. Doi:10.4081/ecj.2014.1896.
38. Phlebotomist Labelling Primary Blood Tubes for Clinical Laboratory Tests: An Important Step to Me dical
Diagnostics. Lima-Oliveira G, Lippi G, Salvagno GL, Picheth G, Guidi GC. J Med Diagn Meth 2014;4:e111.
doi:10.4172/2168-9784.1000155.
39. Analytical assessment of the Beckman Coulter Unicel DxI AccuTnI+3 immunoassay. Lippi G, Dipalo M, Avanzini P,
Formentini A, Aloe R. Diagnosis 2014;1:193-5. doi: 10.1515/dx-2013-0039.
40. Less is more, but do not throw out the baby with the bathwater either! Lippi G, Cervellin G, Plebani M. Diagnosis
2014;1:199-201.
41. Thrombophilia testing in patients taking direct oral antico agulants. Handle with care. Lippi G, Mattiuzzi C,
Favaloro EJ. Diagnosis 2014;1:311-2.
42. The Digital View. Lippi G. The Pathologist 2015;0815(11):14-5.
43. Neoglycoconjugates Derived from Deoxynojirimycin as Possible Therapeutic Agents for Cystic Fibrosis Lung
Disease, by Modulation of the Sphingolipid Metabolism. Munari S, Loberto N, Aureli M, Vauzeilles B, Baron A,
Guisot N, Schiumarini D, Bassi R, Tironi M, Giri MG, Tamanini A, Lippi G, Cabrini G, Sonnino S, Dechecchi MV. JSM
Genetics & Genomics 2016;3:1015.
44. A new generation of hemostasis instrumentation. Lippi G, Bovo C, Favaloro EJ. Labbook 2016, 44-5.
45. Laboratory and precision medicine: the reasons for the birth of a new journal. Lippi G, Montagnana M. J Lab Prec
Med 2016;1:3.
46. Cardiac troponin testing in acute coronary syndrome: personalized thresholds or generalized cut -offs? Lippi G,
Cervellin G. J Lab Prec Med 2016;1:6.
47. The future of laboratory medicine in the era of precision medicine. Lippi G, Bassi A, Bovo C. J Lab Prec Med
2016;1:7.
48. PAFIYAMA Syndrome: prevention is better than cure. Perez-Quilis C, Lippi G, Mena S, Löllgen H, García-Giménez
JL, Sanchis-Gomar F. J Lab Prec Med 2016;1:8.
49. Worldwide culture in science and laboratory medicine: an attainable target. Lippi G, Ciaccio M. J Lab Precis Med
2017;2:3.
Pubblicazioni in extenso su riviste scientifiche nazionali non indicizzate
1.
Determinazione automatica degli indici piastrinici e CBC (Complete Blood Count): un problema solo
parzialmente risolto. Lippi U, Schinella M, Modena N, Nicoli M, Lippi G. Citoematologia ed Automazione 1990:1341.
2.
Risposte funzionali dei neutrofili e loro regolazione in vivo e in vitro. Bellavite P, Schinella M, Andrioli G, Lippi
G, Lussignoli S, Carletto A, Lippi U. Med Lab 1994;2:192-206.
3.
Elevato scatter dei neutrofili su Baye r Technicon H*2: una nuova informazione funzionale? Lippi U, Schinella M,
Nicoli M, Lippi G. Citoematologia ed Automazione 1994;10:61-5.
4.
Standardizzazione dei metodi per il dosaggio della lipoproteina(a). Guidi G, Lippi G. Med Lab 1995;3:233-9.
5.
Navigando su Internet: il caso dell’emofilia. Lippi G. Med Lab 1998;6:52-4.
6.
Disordini congeniti rari dei fattori della coagulazione. Mengoni A, Manzato F, Lippi G. Med Lab 1998;6:256-64.
7.
Navigando su Internet: le società di Medicina di Laboratorio, Chimica e Biochimi ca Clinica e Patologia Clinica di
Laboratorio. Lippi G. Med Lab 1998;6:210-2.
8.
Ruolo del laboratorio nella diagnosi del tromboembolismo venoso. Lippi G, Manzato F. VIP 1999;5:8-9.
9.
I test di screening della trombofilia. Lippi G. Med Lab 1999;7:107-9.
10. L’Impact Factor. Lippi G. Med Lab 1999;7:149-55.
11. Applicazioni dei database relazionali in laboratorio: archiviazione delle componenti monoclonali mediante
Microsoft Access © . Lippi G. Med Lab 1999;7:156-60.
12. Approccio multidisciplinare alla diagnosi di tromboemboli smo venoso. Lippi G, Antonucci G, Tripodi A. Med Lab
1999;7:356-9.
13. Dalle frontiere della medicina al doping: il NESP. Lippi G. Riv Med Lab - JLM 2001;2:74-5.
14. Le coagulopatie congenite emorragiche. Gandini G, Franchini M, Lippi G, Manzato F, Zatti M, Degani D, Balter R,
Marradi P, Tatò L, Aprili G. Verona Medica 2001;5:20-5.
15. Emocitometria e Medicina dello Sport. Lippi G. Atti corso CEFAR “Il laboratorio di Ematologia”, Abano Terme (PD),
10-11 aprile 2002 (http://www.areamedlab.it/).
16. Doping e sport: il ruolo della medicina moderna. Lippi G, Mattiuzzi C, Franchini M, Guidi GC. Verona Medica
2005;2:11-17.
17. Il ruolo della medicina di laboratorio nella coagulopatie emorragiche. Lippi G, Franchini M. Emostasi Oggi
2006;3:10-3.
18. Doping e sport. Lippi G, Mattiuzzi C. Vascular Informer 2007:18-22.
19. Diagnostica delle coagulopatie emorragiche acquisite. Lippi G. One Minute in Ematologia 2007:1-6.
20. Errori in Medicina di Laboratorio. Lippi G, Mattiuzzi C, Plebani M, Guidi GC. Rischio Sanità 2007;25:31-4.
21. Troponine cardiache: storia e significato di un test. Cervellin G, Lippi G. Parma Medica 2011;1:12-5.
22. Utilità del marcatoew HE4 nella diagnosi e nel monitoraggio del tumore epiteliale ovario. Montagnana M, Danese E, Guidi GC,
Lippi G. EsaDia 2012;14(41):20-6.
23. Introduzione dell'automazione nei modelli organizzativi. Lippi G. EsaDia 2012;14(42):2-6.
24. Diagnosi d’infarto acuto del miocardio nel terzo millennio. Lippi G. Il Giornale dell’AMMI 2013;2:6-7.
25. Evoluzione nell’utilizzo del dosaggio della troponina. Aspetti Analitici. Lippi G. Ligand Assay 2013;18:135-7.
26. Neutrophil gelatinase associated lipocalin (NGAL): Analytical issues. Lippi G, Aloe R. Ligand Assay 2013;18:236-40.
27. Problematiche pre-analitiche in immunometria. Lippi G, Picanza A, Buonocore R. Ligand Assay 2014;19:208-11.
Monografie
1.
Medicina di Laboratorio. L'interpretazione in biochimica e patologia clinica. II Edizione. Zatti M, Lechi C, Guidi
GC, Manzato F, Lippi G. Gruppo Editoriale Idelson-Gnocchi, Napoli, 2002.
2.
Medicina di Laboratorio. Zatti M, Coglio A, Grigis A, Guidi GC, Lechi Santonastaso C, Lippi G, Manzato F, Marchiaro
G, Spandrio L. Casa Editrice Idelson -Gnocchi, Napoli, 2006.
3.
Vecchi e nuovi marcatori di Sindrome Coronarica Acuta. “Ischemia Modified Albumin”: storia di un marcatore
cardiaco. Montagnana M, Lippi G, Salvagno GL, Guidi GC. Caleidoscopio 2010;26(226). Medical System SPA Editore.
4.
In vitro and in vivo hemolysis. Lippi G, Cervellin G, Favaloro EJ, Plebani M. De Gruyter. 1 edition (July 16, 2012).
Capitoli in monografie
1.
Nonlinear dose-dependent metabolic and adhesive responses of human neutrophils to chemotactic agents.
Bellavite P, Lippi G, Signorini A, Andrioli G, Piovesan P, Chirumbolo S. In: Omeomed92, First International Congress:
The homoepathic medicine in Europe 1993. Physical - Chemical - Biological and clinical research. Ed. Compositori.
Roma 1993; pp. 135-50.
2.
Lipoprotein(a): Structure, Measurement and clinical significance. Marcovina S, Levine DM, Lippi G. In: Rifai N,
Warnick R. Laboratory Measurement of Lipids, Lipoproteins and Apolipoproteins . AACC Press, Washington DC, 1994;
pp. 235-63.
3.
Ipertrigliceridemia. Lippi U, Lippi G. In: Guida di laboratorio per il medico pratico. C.G. Edizioni Medico
Scientifiche, Torino, 1996; pp. 669-83.
4.
Iperuricemia e gotta. Lippi U, Lippi G. In: Guida di laboratorio per il medico pratico. C.G. Edizioni Medico
Scientifiche, Torino, 1996; pp. 684-97.
5.
Finalità, applicazione e standardizzazione dei controlli antidoping. Lippi G, Guidi GC. In: Doping. Aspetti medici,
nutrizionali, psicopedagogici, legali ed etici e ind icazioni per la prevenzione. Serpelloni G, Rossi AL. Assessorato
alle Politiche Sociali, Programmazione Socio Sanitaria, Volontariato e non Profit, Regione Veneto, Verona 2006; pp.
87-95.
6.
Parametri di laboratorio nello sport di resistenza. Lippi G. In: La corsa della Maratona. Associazione Medici dello
Sport di Verona, Verona 2007; pp. 32-8.
7.
Autoantibodies against coagulation factors. Franchini M, Veneri D, Lippi G. In: New Research on Autoantibodies.
Claude T. Petrelli Editor. Nova Science Publishers, Inc . 2009. ISBN 978-1-60456-055-8. pp. 1-10.
8.
“Omics” Translation: A Challenge for Laboratory Medicine. Plebani M, Zaninotto M, Lippi G. In: Principles of
Translational Science in Medicine From Bench to Bedside. Ed. Wehling M. Cambridge University Press, New Y ork,
USA, 2010. First and Second Edition. ISBN: 9780521888691.
9.
Introduzione storica. Guidi GC, Lippi G. In: Biochimica clinica generale. Galzigna L & Plebani M Editori. Ed. Piccin,
Padova, 2010.
10. Teoria e pratica decisionale in medicina di laboratorio. Guidi GC, Lippi G. In: Biochimica clinica generale.
Galzigna L & Plebani M Editori. Ed. Piccin, Padova, 2010.
11. Preparazione del paziente e raccolta dei campioni. Lippi G, Mattiuzzi C, Plebani M. In: Biochimica clinica
generale. Galzigna L & Plebani M Editori. E d. Piccin, Padova, 2010.
12. Il laboratorio nella diagnosi e nel monitoraggio delle malattie neoplastiche. Lippi G. In: Biochimica clinica
generale. Galzigna L & Plebani M Editori. Ed. Piccin, Padova, 2010.
13. Thromboembolic Complications in Childhood Nephropathi es. Zaffanello M, Lippi G, Brugnara M, Franchini M. In:
Thrombosis: Causes, Treatment and Prevention (Cardiology Research and Clinical Developments) . Macri DG,
Procaccini LD Editors. Nova Science Pub Inc, Hauppauge (US), 2010. pp 53 -92. ISBN-13: 978-1616686963.
14. Ipovitaminosi D in adolescenza: un aspetto spesso trascurato. Bertelloni S, Lippi G, Montagnana M, Chiavetta S,
De Luca G, Baroncelli GI. In: Ipovitaminosi D. Prevenzione e trattamento nel neonato, nel bambino e
nel’adolescente. Baroncelli GI Editor. Mattioli 1885 spa, Fidenza, 2011.
15. L'attività sportiva. Lippi G, Maffulli N. In: Medicina di Laboratorio - Logica & Patologia Clinica. Antoniozzi I,
Gulletta E Editori. Ed. Piccin, Padova, 2012.
16. Causes of Errors in Medical Laboratories. Lippi G, Favaloro EJ. In: Quality in Laboratory Hemostasis and
Thrombosis, 2nd Edition. Kitchen S, Olson JD, Preston FE Editors. John Wiley & Sons Ltd, Oxford, UK, 2013. ISBN:
978-0-470-67119-1 (Doi: 10.1002/9781118543467.ch3); pp 22 -31.
17. Iron Requirements and Iron Status of Athletes. Lombardi G, Lippi G, Banfi G. In: The Encyclopaedia of Sports
Medicine: An IOC Medical Commission Publication, Volume 19 . International Olympic Committee. John Wiley & Sons
Ltd, Oxford, UK, 2013. ISBN: 9781118275764 (Doi: 10.1002/9781118692318.ch 19); pp 229-241.
18. Target Identification and Validation: "Omics" Translation: A Challenge for Laboratory Medicine . Plebani M,
Zaninotto M, Lippi G. In: Principles of Translational Science in Medicine: From Bench to Bedside: Second Edition .
Ed. Wehling M. Elsevier Inc, 2015. ISBN: 978-012800721-1. Doi: 10.1016/B978-0-12-800687-0.00002-5.
19. Bioartificial Endocrine Organs: At the Cutting Edge of Translational Research in Endocrinology. Toni, R, Bassi E,
Barbaro F, Zini N, Zamparelli A, Alfieri M, Dallatana D, Mos ca S, Della Casa C, Gnocchi C, Lippi G, Spaletta G,
Bassoli E, Denti L, Gatto A, Ricci F, Tazzari PL, Parrilli A, Fini M, Sandri M, Sprio S,Tampieri A. I n: Bio-Inspired
Regenerative Medicine. Materials, Processes, and Clinical Applications . Pan Stanford, Stanford, USA, 2016. pp. 35787. doi: 10.1201/b19914-16.
20. Stress, Exercise, and Epigenetic Modulation of Cancer. Lippi G, Danese E, Sanchis-Gomar F. In: Epigenetics,
Energy Balance, and Cancer, Energy Balance and Cancer. Ed. Berger NA, Springer International Publishing,
Switzerland, 2016. ISBN: 978-3-319-41608-3; ISSN: 2199-2622. pp.147-166. Doi: 10.1007/978-3-319-41610-6_6.
Commentaries/rapid responses/e-letters su riviste scientifiche indicizzate
Vedi sezione - Allegato Poster/E-Letters.
Poster e Comunicazioni ad Incontri Nazionali ed Internazionali
Vedi sezione - Allegato Poster/E-Letters.
Comunicazioni Orali ad incontri internazionali
1. Fattori biochimici di rischio ed outcome: il caso della lipoproteina(a). Lippi G, Guidi G. International Conference
on Laboratory Medicine, Laboratory and Clinical Reasoning. Padova (Italy), 10-11 October 1997.
2. Individual response of hematologic parameters after altitude exposure in endurance athletes. Lippi G, Salvagno
GL. International Conference on Mountain and Sport. Rovereto, TN (Italy), 11 Novembre 2005.
3. Improving patient outcomes through excellence in the preanalytical phase. What can we do (Solutions). Lippi G.
17th IFCC - FESCC European Congress of Clinical Chemistry and Laboratory Medicine. RAI Congress Centre, Ams terdam
(The Netherlands), 3-7 giugno 2007.
4. Governance of the preanalytical phase: error detection. Lippi G. 4 t h European Federation of Clinical Chemistry
(EFCC) Symposium for Balkan Region. Belgrad (Serbia), 19-20 giugno 2008.
5. Risk management in the pre-analytical phase of laboratory testing. Lippi G. Errors in Medicine, Laboratory
Performance and Patient Safety. International Conference on Laboratory Medicine. Padova (Italy), 22-23 Ottobre
2008.
6. Gene doping, hypoxia and enhanced erythropoiesis. Lippi G. International Symposium on Gene Doping in Sports.
Firenze (Italy), 25-27 Ottobre 2008.
7. Haemolysis: causes, affects & prevalence. Lippi G. Haemolysis: causes, affects, prevalence, measurement &
solutions in Pathology. 18th IFCC - FESCC European Congress of Clinical Chemistry and Laboratory Medicine.
Innsbruck (Austria), 7-11 giugno 2009.
8. Problem solving and risk management in the pre -analytical phase. Lippi G. Laboratory performance and patient
safety. 18th IFCC - FESCC European Congress of Clinical Chemistry and Laboratory Medicine. Innsbruck (Austria), 7-11
giugno 2009.
9. The management of the pre-analytical phase in the process of accreditation. Lippi G. Secon Symposium on Quality
Management, 1st EFCC Congress of Laboratory Medicine in Health Care. Lisbona (P ortugal), 13-16 Ottobre 2010.
10. Governance of the preanalytical variability. Lippi G. 1 st European Federation of Clinical Chemistry and Laboratory
Medicine (EFCC)-BD European Conference on Preanalytical Phase. Parma (Italy), 1-2 Aprile 2011.
11. Automation of the preanalytical phase: models and personal experience. Lippi G, Dazzi P, Fontana R. 1 st European
Federation of Clinical Chemistry and Laboratory Medicine (EFCC) -BD European Conference on Preanalytical Phase.
Parma (Italy), 1-2 Aprile 2011.
12. The impact of preanalytical errors on patients’ treatment. Lippi G. 21st International Congress of Clinical
Chemistry and Laboratory Medicine. 19th IFCC -EFCC European Congress of Clinical Chemistry and Laboratory
Medicine. Berlino (Germany), 15-19 Maggio 2011.
13. Risk management in the pre-analytical phase. Lippi G. 21 st International Congress of Clinical Chemistry and
Laboratory Medicine. 19th IFCC-EFCC European Congress of Clinical Chemistry and Laboratory Medicine . Berlino
(Germany), 15-19 Maggio 2011.
14. Blood doping: facts and speculations. Lippi G. Mini-symposium on exercise, brain and doping. Valencia (Spain), 5-6
Maggio 2011.
15. High sensibility troponins in the emergency department: an asset or a disadvantage? The laboratory phisycians
opinion. Lippi G. Second Italian Global Research on Acute Conditions Team (GREAT) Network Congress. Roma (Italy),
18-21 Ottobre 2011.
16. Increased cardiac biomarkers in sports: a ir(resolved) dilemma? Lippi G. First international Parma conference on
rehabilitation, recreational and sports medici ne. Parma (Italy), 24 Ottobre 2011.
17. Historical and contemporary perspectives of doping in sports. Lippi G. Laboratory medicine and sports: between
Scylla and Charybdis. International Conference on Laboratory Medicine. Padova (Italy), 25 Ottobre 2011.
18. Management of mild and moderate haemophilia. Lippi G. Global Haemophilia Network Meeting - Collaboration and
Innovation in Clinical Research. Barcellona (Spain), 5–6 Marzo 2012.
19. Daily and routine quality control in POC test settings. Lippi G. 2012 Convocation of Experts on Laboratory Quality.
Colonia (Germany), 5-6 Giugno 2012.
20. The relationship between exercise and heart. Lippi G. Second international Parma conference on rehabilitation,
recreational and sports medicine. Parma (Italy), 14 Giugno 2012.
21. Sample collection including effects of anticoagulant and tube and sample preparation. Lippi G. 2012 Congress of
the World Federation of Hemophilia. Parigi (France), 8-12 Luglio 2012.
22. Biomarkers for acute coronary syndrome early diagnosis: only troponin? Lippi G. Third Italian Global Research on
Acute Conditions Team (GREAT) Network Congress. Roma (Italy), 15-19 Ottobre 2012.
23. Blood gas collection. Lippi G. 2 nd European Federation of Clinical Chemistry and Laboratory Medicine (EFCC) -BD
European Conference on Preanalytical Phase. Zagreb (Croatia), 1-2 Marzo 2013.
24. Hemolysis – Clinical. Lippi G. Critical Care Scientific Advisory Committee. Barcelona (Spain), 9-10 Maggio 2013.
25. Ensuring stability through transportation. Lippi G. 20 t h IFCC - EFLM European Congress of Clinical Chemistry and
Laboratory Medicine. Milano (Italy), 19-23 Maggio 2013.
26. The influence of the blood drawing technique. Lippi G. 20 t h IFCC - EFLM European Congress of Clinical Chemistry
and Laboratory Medicine. Milano (Italy), 19-23 Maggio 2013.
27. Coagulation sample stability. Lippi G. Clinical and Laboratory Haemostasis. 2013 Annual Scientific Meeting of UK
NEQAS for Blood Coagulation. Sheffield (UK), 3 -4 Settembre 2013.
28. Differences among biomarkers of acute kidney injuries. Lippi G. Fourth Italian Global Research on Acute Conditions
Team (GREAT) Network Congress. Roma (Italy), 14-18 Ottobre 2013.
29. Harmonization of pre-analytical processes. Lippi G. Harmonization in Laboratory Medicine: the complete picture.
International Conference on Laboratory Medicine. Padova (Italy), 25 Ottobre 2013.
30. Pre-analytical Issues Specific to Coagulation Testing. Lippi G. Pearls of Laboratory Medicine – American Association
of
Clinical
Chemistry
(AACC).
Available
at:
http://media.aacc.org/Shows/Pearls/Lippi -Final4-1414/Lippi/player.html.
31. Quality indicators for monitoring preanalytical Phase. Lippi G. 22 n d International Congress of Clinical Chemistry and
Laboratory Medicine - IFCC WorldLab Istanbul 2014.Istanbul (Turkey), 22-26 Giugno 2014.
32. Biomarkers of fibrosis. Lippi G. 1 st Meeting of the Multinational Chapter of the International Union of Angiology (IUA
and XXIV Congress of the Mediterranean League of Angiology and Vascular Surgery (MLAVS). Palermo (Italy), 2-5
Ottobre 2014.
33. Advantages and drawback of Automation . Lippi G. Quality and harmonization in laboratory medicine as a global
picture. Torino (Italy), 16-17 Dicembre 2014.
34. Interference of medical contrast media on laboratory testing. Lippi G. 3 rd European Federation of Clinical
Chemistry and Laboratory Medicine (EFCC) -BD European Conference on Preanalytical Phase. Porto (Portugal), 20-21
Marzo 2015.
35. Preanalytical Variability: The Dark Side of the Moon in the Quality of Laboratory Diagnostics. Lippi G. Expomedia
& Turkish Biochemical Society Event. Istanbul (Turkey), 28 Marzo 2015.
36. Whole blood hemolysis detection: dream or reality? Lippi G. 6th International Symposium “Critical care testing and
blood gases”. Parigi (France), 18-19 Giugno 2015.
37. Pre-analytical Variability and Patient Safety. Lippi G. 2015 Annual Meeting of the American Association of Clinical
Chemistry (AACC). Atlanta (USA), 26-30 Luglio 2015.
38. Preanalytical Errors: Cause and Consequences. Lippi G. NZIMLS & AIMS South Pacific Congress, The Value of Medical
Laboratory Science. Auckland (NZ), 18-21 Agosto 2015.
39. Preanalytical issues in quality of point of care testing. Lippi G. NZIMLS & AIMS South Pacific Congress, The Value of
Medical Laboratory Science. Auckland (NZ), 18-21 Agosto 2015.
40. Pre-analytical Processes and Variables – What is Changing? Lippi G. NZIMLS & AIMS South Pacific Congress, The
Value of Medical Laboratory Science. Auckland (NZ), 18-21 Agosto 2015.
41. Preanalytical Errors: Prevention and Management. Lippi G. NZIMLS & AIMS South Pacific Congress, The Value of
Medical Laboratory Science. Auckland (NZ), 18-21 Agosto 2015.
42. Automated microscopy in laboratory medicine. Lippi G. 8th Congress of the Croatian society of medical
biochemistry and laboratory medicine with internationa l participation. Rijeka (Croatia), 22-26 Settembre 2015.
43. Telomerase activity and new biomarkers to detect pain and pain -related stress. Lippi G. Study in Multidisciplinary
Pain Research. Roma, 7-9 Aprile 2016.
44. Why we need Hs Troponins. Lippi G. IX International Meeting of the Global Research on Acute Conditions Team
(GREAT). Roma (Italy), 1-2 Settembre 2016.
45. Quality and patient safety in laboratory medicine. Lippi G. Russian Congress of Laboratory Medicine. Moscow
(Russia), 12 Ottobre 2016.
46. Notification of critical values: a compelling need in laboratory medicine. Lippi G. Russian Congress of Laboratory
Medicine. Moscow (Russia), 12 Ottobre 2016.
47. Patient and sample identification. Lippi G. Towards performance specifications for the extra -analytical phases of
laboratory testing. International Conference on Laboratory Medicine. Padova (Italy), 27 Ottobre 2016.
48. Diagnostics in venous thromboembolism: from origin to future perspectives. Lippi G. 2016 Meeting of the External
quality Control for Assays and Tests (ECAT) Fundation. Leiden (The Netherlands), 10-11 Novembre 2016.
49. State of the art of pre-analytical variability. Lippi G. IX Congreso Argentino de la Calida en el Laboratorio Clinico
(CALILAB) & VII Jornadas Latinoamericanas del la Calidad en el Laboratorio C linico. Buenos Aires (Argentina), 30
Novembre-2 Dicembre 2016. Buenos Aires (Argentina), 30 Novembre -2 Dicembre 2016.
50. The phlebotomy check-list: an efficient toll for reducing pre-analytical errors. Lippi G. IX Congreso Argentino de
la Calida en el Laboratorio Clinico (CALILAB) & VII Jornadas Latinoamericanas del la Calidad en el Laboratorio
Clinico. Buenos Aires (Argentina), 30 Novembre-2 Dicembre 2016. Buenos Aires (Argentina), 30 Novembre -2 Dicembre
2016.
51. Quality indicators for the pre-analytical phase. Lippi G. IX Congreso Argentino de la Calida en el Laboratorio
Clinico (CALILAB) & VII Jornadas Latinoamericanas del la Calidad en el Laboratorio Clinico. Buenos Aires (Argentina),
30 Novembre-2 Dicembre 2016.
Prossime relazioni:
1.
Reflections on the next generation of hemostasis instrumentation. A glimpse into the future. Lippi G. Atellica
COAG 360 System Launch. Marburg (Germany), 28 Febbraio – 2 Marzo 2017.
2.
Preanalytical cases. Lippi G. 4 t h European Federation of Clinical Chemistry and Laboratory Medicine (EFCC)-BD
European Conference on Preanalytical Phase. Amsterdam (NL), 24-25 Marzo 2017.
3.
Preanalytical uncertainty in diagnostic testing. Lippi G. National Meeting of the Austrian Society for Quality
assurance and standardization of medical diagnostic inves tigations. Igls (Austria), 6 Ottobre 2017.
Comunicazioni Orali e Seminari d'aggiornamento ad incontri nazionali
1.
Reperti strumentali di aggregazione spontanea in vitro dei neutrofili. Lippi U, Schinella M, Ciaffoni S, Lippi G.
Incontro Interregionale utilizzatori sistemi di citoematologia automatizzata. Padova, 22 Gennaio 1993.
2.
Isoforme delle lipoproteine ed aterosclerosi. Guidi G, Lippi G. La malattia aterosclerotica: basi scientifiche,
aspetti diagnostico-clinici ed impatto socio-economico. Verona, 29 Settembre 1995.
3.
Significato clinico del dosaggio del D-Dimero. Lippi G, Manzato F. Diagnostica delle coagulopatie: linee guida e
prospettive. Verona, 17 Aprile 1998.
4.
Linee guida per i pazienti in TAO. Manzato F, Lippi G. Diagnosi clinica e terapia delle coagu lopatie. Rovereto
(TN), 24 Aprile 1998.
5.
Lo screening della trombofilia: quando e perché. Manzato F, Lippi G. Diagnosi clinica e terapia delle
coagulopatie. Rovereto (TN), 24 Aprile 1998.
6.
Tecniche di rilevamento in immunometria. Lippi G, Guidi G. Giornata di aggiornamento tecnico - diagnostico in
immunometria. Villalta di Gazzo Padovano (PD), 12 Giugno 1998.
7.
I nuovi fattori di rischio: Lp(a). Lippi G, Guidi G. La Cardiologia ed il Laboratorio Analisi, un rapporto da
rivisitare. Castello Scaligero di Bevilacq ua (VR), 24 Ottobre 1998.
8.
Epidemiologia, clinica e diagnosi del TEV. Lippi G. Diagnosi e terapia delle trombosi e delle trombofilie:
aggiornamenti di Medicina di Laboratorio. Sestri Levante (GE), 10 -12 Maggio 1999.
9.
Approccio multidisciplinare alla diagnosi di tromboembolismo venoso. Lippi G, Antonucci G, Tripodi A. XIII
Congresso Nazionale della Società Italiana di Medicina di Laboratorio. Roma, 4 -6 Novembre 1999.
10.
Aspetti analitici del Doping. Lippi G. II Convegno interregionale di tossicologia analitica. G iulianova (TE), 18
maggio 2000.
11.
Diagnostica di Laboratorio dell'emergenza emorragica. Manzato F, Lippi G. Diagnostica di Laboratorio delle
malattie emorragiche. Sestri Levante (GE), 3 -5 ottobre 2000.
12.
L’omocisteina. Lippi G. Corso Interregionale di Formazione e aggiornamento sulla Tecnica HPLC. Altavilla
Vicentina (VI), 30 marzo 2001.
13.
Trombofilia. Lippi G. Programma di Formazione a Distanza della Società Italiana di Medicina di Laboratorio
(SIMeL). Videoconferenza su CD ROM. Verona, 12 ottobre 2001.
14.
Ruolo dei lipidi nella patogenesi dell'aterotrombosi. Lippi G. Arteriosclerosi e trombosi: attualità in Medicina di
Laboratorio. Sestri Levante (GE), 16-17 ottobre 2001.
15.
Doping. No grazie. Lippi G. Naturopatia e Medicina. Isola della Scala (VR), 15 novembre 2001.
16.
Omocisteina. Lippi G Carta MR, Tripodi A. La malattia cardiovascolare nel diabete mellito: potenziale ruolo dei
nuovi fattori di rischio. Tirrenia (PI), 25 -26 gennaio 2002.
17.
Doping e sport. Lippi G. Valeggio sul Mincio (VR), 21 gennaio 2001.
18.
Biochimica clinica della nutrizione. Lippi G. Padova, 15 febbraio 2002.
19.
Emocitometria e Medicina Sportiva. Lippi G. Il Laboratorio di ematologia. Abano Terme (PD), 10 -11 Aprile 2002.
20.
Il profilo ematologico nell'atleta: esiste una normalità? Lippi G. Attività sportiva, uso di farmaci e doping. Le
reali necessità dell'atleta ed i limiti posti dalla nuova legge sul doping. Verona, 15 giugno 2002.
21.
Parametri biochimici per il monitoraggio dell'eritropoiesi. Lippi G. XVI Congresso Nazionale della Società Italiana
di Medicina di Laboratorio. Milano, 28-30 novembre 2002.
22.
Il profilo ematochimico nell'atleta. Adattamenti e riflessi nella lotta al Doping. Lippi G. Verona, 21 Gennaio
2003.
23.
La Sindrome Coronarica Acuta. Tavola Rotonda. Verona, 22 Gennaio 2003.
24.
Il sovrappeso ed i fattori di rischio cardiovascolari. Lippi G. Aggiornamento su metabolismo e naturopatia.
Fumane, 10 Marzo 2003.
25.
Standardizzazione ematologica: riflessi in medicina dello sport. Lippi G. Incontro di Aggiornamento. Ematologia e
Sport. Firenze, 13 Marzo 2003.
26.
Tireoglobulina: struttura e metabolismo. Lippi G. Il dosaggio della tireoglobulina: ruolo centrale del paziente
affetto da carcinoma differenziato della tiroide. Verona, 13 Giugno 2003.
27.
Metodi per incrementare ed ottimizzare il trasporto d'ossigeno ai tessuti.
Ematologica in Medicina dello Sport. Verona, 26 Marzo 2004.
28.
Parametri biochimici per il monitoraggio dell'eritropoiesi negli atleti. Lippi G. Standardizzazione Ematologica in
Medicina dello Sport. Verona, 26 Marzo 2004.
29.
I mezzi di controllo dell'allenamento: aspetti ematologici. Lippi G. Le nuove frontiere dell'allenamento nel
ciclismo. Verona, 8 maggio 2004.
30.
Variazione degli indici ematologici nell’esercizio fisico. Lippi G. 36° Congresso Nazionale Società Italiana di
Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Padova, 8 -11 giugno 2004.
31.
La malattia del sistema cardiovascolare. Lipidi e rischio cardiovascolare. Lippi G. Patologia clinica del cuore 20° Convegno Interregionale di studio della Società Italiana di Medi cina di Laboratorio (SIMeL). Vicenza, 26 -27
maggio 2005.
Lippi G. Standardizzazione
32.
Problemi irrisolti nella misura della tireoglobulina, Lippi G. Rossi G, Zucchelli GC. Carcinoma differenziato della
tiroide. Come sta cambiando la gestione clinica del paziente? Verona, 1 giugno 2005 .
33.
Doping ematico: stato delle conoscenze. Lippi G. Incontri-dibattito Associazione Medici Sportivi (AMS) –
Federazione Medico Sportiva Italiana (FMSI). Verona, 8 giugno 2005.
34.
Importanza del D-dimero nella diagnostica di laboratorio. Manzato F, Lippi G. Nuove frontiere in coagulazione.
Battaglia Terme, 16 giugno 2005.
35.
Nuovi marcatori nell'approccio diagnostico alla sindrome coronarica acuta. Guidi GC. Lippi G. Integrazione tra
clinica e laboratorio nella diagnostica delle sindromi coronariche acute. Villa Ta cchi (VI), 26 settembre 2005.
36.
Flogosi e rischio cardiovascolare. Lippi G. Seminario d'aggiornamento. Vicenza 26 Settembre 2005.
37.
Evidence of cardiac dysfunction in systemic sclerosis. Lippi G, Caramaschi P, Montagnana M, Salvagno GL, Volpe
A, Guidi GC. Simposio sui marcatori cardiaci. 37° Congresso Nazionale Società Italiana di Biochimica Clinica e
Biologia Molecolare Clinica (SIBioC). Roma, 11 -14 ottobre 2005.
38.
Influenza della fase preanalitica sui test emocoagulativi. Lippi G. Simposio sulla fase pre-analitica. 37° Congresso
Nazionale Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Roma, 11 -14 ottobre 2005.
39.
Automazione nella misurazione delle emoglobine umane. Lippi G. Attualità sulla determinazione delle
emoglobine umane per la diagnosi. 37° Congresso Nazionale Società Italiana di Biochimica Clinica e Biologia
Molecolare Clinica (SIBioC). Roma, 11-14 ottobre 2005.
40.
Influence of physical exercise on the preanalytical variability of proBNP and IMA. Salvagno GL, Lippi G,
Montagnana M, Schena F, Ballestrieri F, Guidi GC. 37° Congresso Nazionale Società Italiana di Biochimica Clinica e
41.
Il laboratorio nella malattia diabetica. Lippi G. 19° Congresso Nazionale della Società Italiana di Medicina di
Laboratorio (SIMeL). Trieste, 10-12 Novembre 2005.
42.
Influenza della variabilità preanalitica nei test di laboratorio. Lippi G. 19° Congresso Nazionale della Società
Italiana di Medicina di Laboratorio (SIMeL). Trieste, 10 -12 Novembre 2005.
43.
Lo screening preoperatorio. Lippi G. Verona, 16 dicembre 2005.
44.
L’eritropoietina. Lippi G. Le nuove frontiere del doping sportivo. Recanati, 21 Aprile 2006.
45.
BNP. Il ruolo del Laboratorio. Lippi G. Tavola rotonda sul BNP. Verona, 16 Maggio 2006.
46.
La variabilità preanalitica. Lippi G. Interpretare i risultati di laboratorio. Le fasi pre e post analitiche nella
definizione dell’informazione. 20° Convegno Interregionale di studio della Società Italiana di Medicina di
Laboratorio (SIMeL). Vicenza, 25-26 maggio 2006.
47.
Variabilità extra-analitica dei dati di Laboratorio. Lippi G. Colazione con l’esperto. 38° Congresso Nazionale
Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Torino, 19 -22 settembre 2006.
48.
Approccio laboratoristico all’emofilia acquisita. Lippi G. 38° Congresso Nazionale della Società Italiana di
Biochimica Clinica e Biologia Molecolare Clinica (SIBioC), Torino 19 -22 Settembre 2006. Biochim Clin 2006;30:SS15.
49.
Biological variability and critical differences of hemato logic parameters for the hematologic passport in
athletes. Lippi G, Solero GP, Salvagno GL, Balestrieri F, Montagnana M, Schena F, Guidi GC. 38° Congresso
Nazionale della Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC), Torino 19-22 Settembre
2006. Clin Chem Lab Med 2006;44:A25.
50.
Evaluation of the Primus CLC385 Ultra for separation and quantification of hemoglobin variants. Salvagno GL,
Lippi G, Montagnana M, Guidi GC. 38° Congresso Nazionale della Società Italiana di Biochimica Clinica e Biologia
Molecolare Clinica (SIBioC), Torino 19 -22 Settembre 2006. Clin Chem Lab Med 2006;44:A30.
51.
Ischemia modified albumin in gynecologic malignancies. Lippi G, Albiero A, Montagnana M, Salvagno GL,
Scevarolli S, Giudici S, Franchi M, Guidi GC. 38° Congresso Nazionale della Società Italiana di Biochimica Clinica e
Biologia Molecolare Clinica (SIBioC), Torino 19 -22 Settembre 2006. Biochim Clin 2006;30:363.
52.
Automazione e variabilità preanalitica. Lippi G. Qualità, Efficienza ed Automazione nel Lab oratorio Clinico.
Roma, 13 Ottobre 2006.
53.
Parametri di Laboratorio nello sport di resistenza. Lippi G. La preparazione per la maratona a livello agonistico e
amatoriale. Verona, 14 Ottobre 2006.
54.
La fase post analitica: refertazione dei valori critici. Lippi G. 20° Congresso Nazionale della Società Italiana di
Medicina di Laboratorio (SIMeL). Altavilla Milizia (PA), 26 -28 Ottobre 2006.
55.
La qualità del campione ed il suo impatto nelle decisioni cliniche. Lippi G. Lab Automation and Decision Making.
Villa Tacchi, 9 ottobre 2006.
56.
Albumina modificata dall’ischemia. Lippi G. Il laboratorio per la cardiologia. Pisa, 6 novembre 2006.
57.
Il ruolo del laboratorista nella diagnosi di emofilia acquisita . Lippi G. Emorragie critiche e coagulopatie. Percorsi
di aggiornamento nella gestione clinica e sulla terapia. Verona, 10 novembre 2006.
58.
Vecchi e nuovi marcatori cardiaci nella diagnostica dell’infarto. Marcatori cardiaci: passato, presente e futuro.
Lippi G. Adria (RO), 14 novembre 2006.
59.
Governo della fase preanalitica: Variabilità extra-analitica. Lippi G, Salvagno GL. Casalecchio di Reno (BO), 5
dicembre 2006.
60.
Esercizio fisico e rischio cardiovascolare. Rischi e benefici dell’esercizio fisico. Lippi G. Villalta , Gazzo Padovano
(PD), 14 dicembre 2006.
61.
Aspetti biochimici, fisiopatologici e clinico-applicativi della determinazione della Lipoproteina(a) ”. Lippi G.
Azienda Ospedaliera “Luigi Sacco”. Milano, 19 dicembre 2006.
62.
Trombosi e cancro. Lippi G. Verona, 5 luglio 2007.
63.
Le anemie in corso di insufficienza renale cronica. Lippi G. Società Italiana di Medicina di Laboratorio (SIMeL).
Master in ematologia di laboratorio. Monastier di Treviso (TV), 21 Settembre 2007.
64.
Transferability of laboratory data and standardization of preanalytical variables. Lippi G, Guidi GC. 39°
Congresso Nazionale della Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC), Rimini, 2 -5
Ottobre 2007.
65.
Influence of storage temperature on routine coagulation testing. Salvagno GL, Lippi G, Montagnana M, Franchini
M, Gelati M, Guidi GC. 39° Congresso Nazionale della Società Italiana di Biochimica Clinica e Biologia Molecolare
Clinica (SIBioC), Rimini, 2-5 Ottobre 2007.
66.
Informatica in laboratorio per il miglioramento delle cure. Tracciabilità e gestione degli errori nelle fasi extra analitiche. Lippi G. 21° Congresso Nazionale della Società Italiana di Medicina di Laboratorio (SIMEL), Riva del
Garda (TN), 25-27 Ottobre 2007.
67.
Il laboratorio di diabetologia del 2010. I sistemi POCT: oggi e domani. Lippi G, Montagnana M. 21° Congresso
Nazionale della Società Italiana di Medicina di Laboratorio (SIMEL), Riva del Garda (TN), 25 -27 Ottobre 2007.
68.
Il laboratorio di diabetologia del 2010: considerazioni conclusive. Testa R, Massi Benedetti M, Mosca A, Lippi G,
Falorni A, Bonadonna R, Fazioli F, Penco S. 21° Congresso Nazionale della Società Italiana di Medicina di
Laboratorio (SIMEL), Riva del Garda (TN), 25 -27 Ottobre 2007.
69.
Tecniche di laboratorio per la determinazione delle varianti emoglobiniche. Lippi G. Diagnostica delle
emoglobinopatie: tra clinica e laboratorio. Verona, 25 gennaio 2008.
70.
Intervalli di riferimento condivisi: tra sogno e realtà. Guidi GC, Lippi G. Corso di Aggiornamento VEQ in
Ematologia e Coagulazione Regione Veneto biennio 2006 -2007. Verona, 15 febbraio 2008.
71.
Errori e standardizzazione della dase pre-analitica. Lippi G. Workshop - Soluzioni su misura per l’area siero.
Hotel Le Padovanelle, Pinte di Brenta (PD), 16 Aprile 2008.
72.
Le coagulopatie acquisite viste dall'internista, il modello dell'emofilia acquisita. La gestione de l dato di
laboratorio. Lippi G. 13° Congresso Nazionale della Federazione delle Associazioni dei Dirigenti Ospedalieri
Internisti (FADOI), Firenze, 4-7 Maggio 2008.
73.
Ottimizzazione del monitoraggio glicemico. Lippi G. Diabete e rischio cardiovascolare: qual i parametri utilizzare.
Auditorium INRCA Ancona, 10 maggio 2008.
74.
Procalcitonina. Lippi G , Polati E. 14° Simposio Annuale ELAS-Italia "LIGAND ASSAY 2008". Bologna 6 -8 Ottobre
2008.
75.
Misura degli ormoni steroidei negli atleti: utilità e problemi. Lippi G, Schena F. 14° Simposio Annuale ELAS-Italia
"LIGAND ASSAY 2008". Bologna 6-8 Ottobre 2008.
76.
L’acido urico. Lippi G. 1° Evento Nazionale Congiunto SIBioC-SIMeL. 40° Congresso Nazionale Società Italiana di
Biochimica Clinica e Biologia Molecolare Clinica (SIBioC ). Rimini, 28-31ottobre 2008.
77.
Influence of chronic exercise on morning serum prolactin levels. Lippi G, De Vita F, Salvagno GL, Montagnana M,
Gelati M, Guidi GC. 1° Evento Nazionale Congiunto SIBioC -SIMeL. 40° Congresso Nazionale Società Italiana di
Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Rimini, 28 -31ottobre 2008.
78.
La gestione del rischio nella fase pre -analitica: criticità e soluzioni. Lippi G. Healthcare System Ergonomics and
Patient Safety. Arezzo, 26 Ottobre 2008.
79.
La gestione della fase preanalitica nel laboratorio di ematologia. Lippi G. Ematologia in Medicina di Laboratorio:
dalla teoria alla VEQ. San Bonifacio (VR), 27 Novembre 2008.
80.
La variabilità pre-analitica: cause cliniche, criticità del campione, modalità di conservazione e tr asporto. Lippi
G. Percorso Teorico-Pratico Biomarcatori in Oncologia. Milano 16 -18 Febbraio 2009.
81.
I sistemi POCT: oggi e domani. Lippi G, Montagnana M. Il diabete: laboratorio e tecnologie. II Mostra Convegno
della Tecnologia e Gestione Ospedaliera. Cremon a, 2-4 Aprile 2009.
82.
Linee guida per l’impiego dei marcatori tumorali. Lippi G. Innovazione nella diagnosi e terapia del carcinoma
ovario. Verona, 18 Aprile 2009.
83.
Epidemiologia delle varianti emoglobiniche e della talassemia. Lippi G, Montagnana M. Emoglobine: diagnostica,
standardizzazione e prospettive. Desenzano del Garda (BS), 9 Maggio 2009.
84.
Medicina di Laboratorio e Sport: “from the field to the benchside”. Lippi G. Medicina di Laboratorio e sport.
Monastier di Treviso (TV), 14 maggio 2009.
85.
Valutazione di casi in cui il passaporto biologico sia più utile dell'intervallo di riferimento. Lippi G. Medicina di
Laboratorio e sport. Monastier di Treviso (TV), 14 maggio 2009.
86.
La variabilità preanalitica nei test coagulativi . Lippi G. 24° Convegno Interregionale di Studio. Patologia Clinica
dell’Emostasi. Vicenza, 28-29 Maggio 2009.
87.
La qualità nella fase preanalitica. Lippi G. Il sistema qualità: un ponte oltre i confini del laboratorio. Bari, 19
Giugno 2009.
88.
Problemi, incertezze e governance della fase preanalit ica. Lippi G. 2° Evento Nazionale Congiunto SIBioC -SIMeL.
41° Congresso Nazionale Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Napoli, 27 -30
ottobre 2009.
89.
La composizione di un articolo scientifico. Lippi G. 2° Evento Nazionale Congiunto SIBioC-SIMeL. 41° Congresso
Nazionale Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Napoli, 27 -30 ottobre 2009.
90.
La farmacogenetica della terapia anticoagulante orale. Lippi G. 2° Evento Nazionale Congiunto SIBioC-SIMeL. 41°
Congresso Nazionale Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Napoli, 27 -30
ottobre 2009.
91.
Diagnostica delle emoglobinopatie. Lippi G. Emoglobinopatie. Impatto clinico e diagnostico. Verona, 5 Febbraio
2010.
92.
Errori e Risk Management nella fase preanalitica. Lippi G. Qualità e rischio clinico in medicina di laboratorio.
Parma, 12 Febbraio 2010.
93.
Medicina di Laboratorio e ricerca. Lippi G. Nuovi modelli organizzativi e competenze professionali in Medicina di
Laboratorio. Modena, 26 Febbraio 2010.
94.
Fisiopatologia dell’emostasi. Lippi G. Emostasi: un equilibrio instabile. Parma, 22 Aprile 2010.
95.
Farmacogenetica dei farmaci anticoagulanti. Lippi G, Trenti T. Emostasi: un equilibrio instabile. Parma, 22 Aprile
2010.
96.
Medicina di Laboratorio e Sport: “from the bench to the field”. Lippi G. Medicina di Laboratorio e Sport. Parma,
23 Aprile 2010.
97.
Il doping ematico. Lippi G. Medicina di Laboratorio e Sport. Parma, 23 Aprile 2010.
98.
L’idoneità del campione in biochimica cli nica. Lippi G. L’accettabilità del campione biologico. Vicenza, 30 Aprile
2010.
99.
Le troponine ad alta sensibilità. Lippi G. I Mercoledì del cuore. Parma, 16 giugno 2010.
100. I possibili errori nella fase Preanalitica di un processo. Lippi G. Il governo del processo emogasanalitico - 2nd
HTA Pavia Conference Technology And Management in the hospital. Pavia, 22 giugno 2010.
101. Laboratorio e Sport. Lippi G. Aspetti multidisciplinari della medicina dello sport. Parma, 27 settembre 2010.
102. La Medicina di Laboratorio nei disastri naturali. Lippi G, Plebani M. 42° Congresso Nazionale Società Italiana di
Biochimica Clinica e Biologia Molecolare Clinica (SIBioC). Roma, 5 -8 ottobre 2010.
103. Diagnostica del trombembolismo venoso. Lippi G. 42° Congresso Nazionale Società Italiana di Biochimica Clinica e
104. La comunicazione scientifica. Ceriotti F, Lippi G. 42° Congresso Nazionale Società Italiana di Biochimica Clinica e
105. Acute variation of Haematological parameters following a Ultra -marathon in Professional runners. Lippi G,
Salvagno GL. Convegno Nazionale di Ultramaratona. Padova, 23 Ottobre 2010.
106. Le troponine ad alta sensibilità: luci e ombre. Lippi G. La gestione del dolore toracico. Mesola (FE), 27-28 Maggio
2011.
107. Introduzione all’organizzazione di Laboratorio. Lippi G. Integrazione Clinica e Modelli Organizzativi nella
Medicina di Laboratorio. Castelbrando (TV), 14 -15 settembre 2011.
108. Le troponine ultrasensibili:problematiche analitiche. Lippi G. L’utilizzo dei biomarcatori in emergenza -urgenza:
attualita’ e prospettive future. Parma, 13 Ottobre 2011.
109. Incontri multidisciplinari di consenso: utilizzo della pro -calcitonina nel setting dell’urgenza. Lippi G. Academy
of Emergency Medicine and Care (AceMC). Congresso Nazionale Interdisciplinare “Buona pratica clinica e ricerca
scientifica nell’urgenza-emergenza”. Roma, 2-4 Novembre 2011.
110. Algoritmi diagnostici nell’approccio al paziente con sospetto di patologia emorragic a e trombotica. Il D-dimero.
Lippi G. 1° Congresso Nazionale Della Medicina Di Laboratorio, 43° Congresso Nazionale della SIBioC e 25°
Congresso Nazionale della Società Italiana di Medicina di Laboratorio (SIMeL) . Parma, 15-18 novembre 2011.
111. Valutazione preliminare delle performance diagnostiche del prototipo della troponina Beckman Coulter HS AccuTnI, della Beckman Coulter AccuTnI e della Roche HS -TnT in pazienti con sospetto infarto miocardico.
Lippi G. 1° Congresso Nazionale Della Medicina Di Laboratorio , 43° Congresso Nazionale della SIBioC e 25°
Congresso Nazionale della Società Italiana di Medicina di Laboratorio (SIMeL) . Parma, 15-18 novembre 2011.
112. Troponine vecchie e nuove e marcatori futuri. Lippi G. Appropriatezza prescrittiva degli esami di labora torio.
Fidenza, 10 Dicembre 2011.
113. Errori della fase preanalitica. Lippi G. Emogasanalisi: visione di un processo salvavita. Parma, 15 Dicembre 2011.
114. NGAL: tra ricerca e pratica clinica. Lippi G. Attualità e prospettive in diagnostica proteica. Parma, 22 M arzo 2012.
115. La variabilità preanalitica. Lippi G. Modelli clinico-organizzativi in medicina di laboratorio: storia, generalità,
problematiche ed evoluzione. Rho (MI), 20 Aprile 2012.
116. Determinazione della tireoglobulina. Lippi G. Tumori tiroidei. Lezioni Magistrali e Seminari anno 2012. Parma, 3
Maggio 2012.
117. Massimo Voltolina e Progetto Adritatico: prima traversata a nuoto NO STOP del mare Adriatico. Lippi G. III
Forum Multidisciplinare di Nutrizione. Parma, 7 -10 Maggio 2012.
118. Fattori di rischio cardiovascolari tradizionali ed emergenti. Lippi G. Le malattie cardiovascolari e metaboliche
nel soggetto adulto-anziano: dagli studi epidemiologici alla pratica clinica. Parma, 10 maggio 2012.
119. La Chimica Clinica. Lippi G. II Giornata di Medicina Generale. Workshop “Il MMG dialoga con lo Specialista”.
Parma, 12 Maggio 2012.
120. Doping genetico e blood doping. Lippi G. Doping genetico e farmacologico nello sport. Genetica e Doping. Firenze,
4 Giugno 2012.
121. Screening per trombofilia: perchè, quando e come? Lippi G. Medicina di Laboratorio e Medicina Generale:
un’alleanza strategica. Parma, 11 Settembre 2012.
122. Emorragia inattesa. Il contributo del laboratorio. Lippi G. Medicina di Laboratorio e Medicina Generale:
un’alleanza strategica. Parma, 11 Settembre 2012.
123. Gli Errori in Medicina di Laboratorio. Lippi G. Il rischio clinico nella diagnostica di laboratorio. Parma, 20
Settembre 2012.
124. Errori pre-analitici: frequenza e genere. Lippi G. 44° Congresso Nazionale della SIBioC. Roma, 5 -7 novembre
2012.
125. N-GAL: Quesiti clinici e risposte analitiche. Lippi G. 44° Congresso Nazionale della SIBioC. Roma, 5 -7 Novembre
2012.
126. Emofilia acquisita. Lippi G. 44° Congresso Nazionale della SIBioC. Roma, 5 -7 Novembre 2012.
127. Identificazione e gestione dei campioni emolitici. Lippi G. 44° Congresso Nazionale della SIBioC. Roma, 5-7
Novembre 2012.
128. Qualità analitica in Emostasi: dal paziente al risultato. Lippi G. 44° Congresso Nazionale della SIBioC. Roma, 5 -7
Novembre 2012.
129. La fase pre-analitica. Lippi G. Le fasi del processo di medicina di laboratorio: tra mito e realtà. Cosenza, 29
Novembre 2012.
130. Nuove acquisizioni sui marcatori cardiaci di danno e di funzione. Lippi G. 73° Congresso Nazionale della Società
Italiana di Cardiologia. Roma, 15-17 Dicembre 2012.
131. Il ruolo del laboratorio nella diagnostica e terapia della coagulopatia del trauma. Lippi G. Approccio al trauma
maggiore ATLS e ETC: due filosofie complementari? Parma, 23 Gennaio 2013.
132. Best practice in preanalitica. Lippi G. Focus sulle aree grigie della medicina di laboratorio. Chieti, 21 Marzo 2 013.
133. Sfide economico-organizzative in medicina di laboratorio. Il contesto economico e professionale. Lippi G.
Politiche sanitarie e modelli organizzativi in medicina di laboratorio: un ponte verso il futuro. Parma, 26 Giugno
2013.
134. Il valore della medicina di laboratorio per il paziente dislipidemico. Lippi G. Il valore della Medicina di
Laboratorio per il SSN. Impatto economico, politico e sociale. Roma, 1 Ottobre 2013.
135. Troponina ed oltre. Lippi G.
Torino, 9-10 Ottobre 2013.
27° Congresso Nazionale della Società Italiana di Medicin a di Laboratorio (SIMeL).
136. Il ruolo delle troponine di ultima generazione nel danno non -ischemico. Lippi G. Le Giornate Mediterranee di
Medicina di Laboratorio - 4° Congresso Interregionale SIBioC-Medicina di Laboratorio. Sorrento, 9-11 Ottobre 2013.
137. D-Dimero nella medicina d’urgenza. Lippi G. Aggiornamento in coagulazione. Padova, 13 Novembre 2013.
138. Evoluzione nell’utilizzo del dosaggio della troponina. Aspetti analitici. Lippi G. 19° Simposio annuale ELAS-Italia
- LIGAND ASSAY 2013. Bologna, 25-27 Novembre 2013.
139. I biomarcatori nella stratificazione del rischio cardiaco post -infartuale. Altri biomarcatori di rischio cardiaco.
Lippi G. 74° Congresso Nazionale della Società Italiana di Cardiologia. Roma, 14 -16 Dicembre 2013.
140. Il ruolo del Laboratorio nel Controllo dei NAO. Lippi G. Nuovi anticoagulanti orali (NAO) nella prevenzione del
cardioembolismo nel paziente con fibrillazione atriale non valvolare. Parma, 20 gennaio 2014.
141. Il laboratorio e i nuovi farmaci anticoagulanti. Lippi G. Bolzano, 12 maggio 2014.
142. La variabilità biologica nell’anziano. Lippi G. Geriatric Emergency Medicine Emergenze - Urgenze Nel Paziente
Anziano. Meeting Annuale dell’Academy of Emergency Medicine and Care. Verona, 17 Maggio 2014.
143. Fisiopatologia e marker biochimici di danno muscolare. Lippi G. 29° Convegno di Studio. Patologia Clinica del
Sistema Muscolo-Scheletrico. Altavilla Vicentina (VI), 29 -30 Maggio 2014.
144. The activated partial thromboplastin time is suitable for urgent screening of dabigatran activity. Ippolito L,
Mattiuzzi C, Lippi G. 46° Congresso Nazionale della SIBioC. Roma, 13 -15 Ottobre 2014.
145. Questionario SIBioC sugli esami in urgenza. Lippi G. Congresso Nazionale della SIBioC. Roma, 13 -15 Ottobre 2014.
146. La fase pre-analitica: criticità e prospettive . Lippi G. 28° Congresso Nazionale della Società Italiana di Medicina
di Laboratorio (SIMeL). Rimini, 28-30 Ottobre 2014.
147. Impatto della variabilità preanalitica in coagulazione. Lippi G. 9° TOP Hemostasis Meeting. Napoli, 27-28
Novembre 2014.
148. Il contesto economico e professionale. Lippi G. Acquisizione di beni e servizi in medicina di laboratorio. Verona, 3
Dicembre 2014.
149. La Medicina di Laboratorio nel monitoraggio delle performance atletiche. Lippi G. Il supporto multidisciplinare
della Medicina di Laboratorio: dalla ricerca alla clinica. 5° Congresso Interregionale SIBioC - Medicina di
Laboratorio. Ragusa, 4-5 Dicembre 2014.
150. Criticità della fase pre-analitica. Lippi G. La Medicina di Laboratorio in Scena. Bergamo, 10 Aprile 2015.
151. Importance of the preanalytical phase. Lippi G. Importance of the preanalytical phase in the research setting.
Milano, 5 Giugno 2015.
152. Linee guida SIBioC per prelievo venoso e check-list. Lippi G. 47° Congresso Nazionale della SIBioC. Firenze, 26-28
Ottobre 2015.
153. Development and implementation of a “pop-up” alert system for improving appropriateness of laboratory
testing. Lippi G. 47° Congresso Nazionale della SIBioC. Firenze, 26 -28 Ottobre 2015.
154. Caratteristiche delle troponine di ultima generazione. Lippi G. Medicina di Laboratorio nell'urgenza/emergenza:
appropriatezza ed efficacia diagnostica. Montebelluna, 13 Novembre 2015.
155. Iperuricemia e rischio cardiovascolare: tra mito e realtà. Lippi G. 29° Congresso Nazionale Società Italiana per lo
sudio dell’Ateresclerosi (SISA). Bologna, 2 2 Dicembre 2015.
156. Errori in Medicina di Laboratorio. Lippi G. La Qualità In Medicina di Laboratorio. Varese, 14 Dicembre 2015.
157. Nuovi anticoagulanti orali: Il ruolo del laboratorio. Lippi G. Aggiornamenti in Coagulazione. Potenza, 1 Aprile
2016.
158. La valorizzazione dei parametri di laboratorio trascurati. Lippi G. Congresso Nazionale AcEMC (Academy of
Emergency Medicine and Care). Parma, 19-20 Maggio 2016.
159. Health Technology Assessment (HTA) e Medicina di Laboratorio. Lippi G. Medicina di Laboratorio 2020. Roma, 5
Luglio 2016.
160. La fase pre analitica inerente il materiale biologico. Lippi G, Salvagno GL. Mestre, 14 Settembre 2016.
161. La fase pre-analitica nel Laboratorio di Ematologia e Coagulazione. Lippi G. Le nuove traiettorie della Medicina
di Laboratorio. Il Laboratorio in Ematologia e Coagulazione . Roma, 26 Settembre 2016
162. Raccomandazioni per l'identificazione e la gestione dei valori critici nei laboratori clinici. Lippi G. 48°
Congresso Nazionale della SIBioC. Torino, 18 -20 Ottobre 2016.
163. Un caso di rottura della parete ventricolare predetta da un valore estremamente elevato di RDW. Aloe R, Lippi
G, Cervellin G. 48° Congresso Nazionale della SIBioC. Torino, 18 -20 Ottobre 2016.
164. Le principali criticità della fase pre -esame pre-analitica. Lippi G. Aspetti critici della fase preanalitica (preesame) nella diagnostica di laboratorio: clinica, informatica e automazione. Castelfranco Veneto (TV), 4 Novembre
2016.
165. Il modello "ideale": il punto di vista del laboratorio. Lippi G. La rete dei laboratori clinici e la governance delle
urgenze. Padova, 6 Dicembre 2016.
166. L’importanza delle variabili preanalitiche nei test di laboratorio per l’emostasi. Emostasi 2016. Lippi G. Milano,
13-15 Dicembre 2016.
167. Manifestazioni cliniche di endocrinopatie nell’aging. Lippi G. Update in Endocrinologia. Dalla medicina generale
alla medicina specialistica. Padova, 16 Dicembre 2016.
168. Fisiopatologia dell’emostasi. Emostasi e trombosi: l’interfaccia tra laboratorio e clinica . Lippi G. Verona, 27
Gennaio 2017.
Prossime relazioni:
1.
Consolidamento ed integrazione del sottore di emostasi. Lippi G. Emostasi 2017. Mestre, 17 Marzo 2017.
2.
Panoramica sui nuovi farmaci anticoagulanti orali (DOAC). Lippi G. 49° Congresso Nazionale della SIBioC. Firenze,
16-18 Ottobre 2017.
Recensioni e traduzioni
1.
La troponina I: indicatore elettivo di danno miocardico in soggetti con funzione renale compromessa. Lippi G.
Med Lab 1997;5:296.
2.
Automazione e robotica nei laboratori. Lippi G. Med Lab 1997;5:297-8.
3.
Un testo di riferimento per la determinazione delle lipoproteine e p er l’utilizzo clinico dei dati. Lippi G. Med
Lab 1998;6:128-32.
4.
Contributo della proteina S nell’aumento della tendenza alla trombofilia in corso di importanti reazioni
flogistiche. Lippi G. Med Lab 1998;6:235.
5.
Fattori di rischio per una eccessiva anticoag ulazione da Warfarin. Lippi G. Med Lab 1998;6:236-7.
6.
Ruolo del laboratorio nella diagnosi del tromboembolismo venoso. Lippi G. Manzato F. Med Lab 1998;6:317-8.
7.
Le basi biochimiche della resistenza al Warfarin. Lippi G. Med Lab 1998;6:320-1.
8.
Le proteine della fase acuta ed altre risposte sistemiche all’infiammazione. Lippi G. Med Lab 1999;7:197-8.
9.
Resistenza alla proteina C attivata e fattore VIII nella postmenopausa. Lippi G. Med Lab 1999;7:309.
10. Il ruolo del laboratorio nell'identificazione degli atleti ded iti ad assunzione impropria di eritropoietina. Lippi G.
Med Lab 1999;7:310-11.
11. Pre-examination procedures in laboratory diagnostics. Lippi G. J Lab Med 2016;40:63.
12. L’assisino occulto. Lippi G. Biochim Clin 2016, in stampa. doi: 10.19186/BC_2016.011.
Partecipazione a Congressi, Corsi, Seminari
a. Organizzazione Congressi




Ha curato la segreteria scientifica di oltre 30 Congressi nazionali
Dal 2008 è Presidente della segreteria scientifica del Congresso Nazionale SIBioC
Dal 15 al 18 novembre 2011 ha organizaato a Parma il 1° CONGRESSO NAZIONALE DELLA MEDICINA DI
LABORATORIO - 43° Congresso Nazionale SIBioC e 25° Congresso Nazionale SIMeL
Membro dell'International Scientific Advisory Board di EuroMedLab Milano 2013 (Milano, 19-23 Maggio 2015) e di
EuroMedLab Paris 2015 (Parigi, 21-25 Giugno 2015)
b. Partecipazione a Congressi, Corsi, Seminari


Ha partecipato ad oltre 600 Congressi, Incontri o Seminari scientifici relativi alla Medicina di Laboratorio
Nel 2014 ha ottenuto il Certificato per il Corso di Formazione Manage riale per i Direttori di Struttura
Complessa, organizzato dalla Regione Emilia -Romagna
Affiliazione a Società scientifiche e Gruppi di Studio Internazionali

Dall'anno 1995 fa parte, in qualità di Membro Associato, del “ Working Group on Lp(a)” dell’IFCC (International
Federation of Clinical Chemistry and Laboratory Medicine ).

Dall'anno 1997 è iscritto alla New York Academy of Science.

Dall'anno 2006 è membro ordinario della AACC (American Association of Clinical Chemistry ).

Dall’anno 2006 è membro dell’ESAB (European Scientific Advisory Board).

Dall’anno 2007 è membro del Subcommittee on Protocols for Establishment of Sample Stability in Clinical Chemistry
and Toxicology del CLSI (Clinical and Laboratory Standards Institute ).

Dall’anno 2007 è membro dell’HEALTH-2007-1.2-5: Standardisation and improvement of pre -analytical procedures for
in vitro diagnostics.

Dall’anno 2007 è membro effettivo del Working Group on “Laboratory Errors and Patient Safety (WG-LEPS)” della
IFCC (International Federation of Clinical Chemistry and Laboratory Medicine).

Dall’anno 2011 è membro effettivo del “Working Group on Preanalytical Variability (WG-PA)” dell’EFLM (European
Federation of Clinical Chemistry and Laboratory Medicine ).

Dall’anno 2016 è membro effettivo del “Working Group on Geriatric Laboratory Medicine (TF-GLM)” della IFCC
(International Federation of Clinical Chemistry and Laboratory Medicine ).
Affiliazione a Società scientifiche e Gruppi di Studio Nazionali

Dall'anno 1992 è Associato alla SIMeL (Società Italiana di Medicina di Laboratorio).

Dall'anno 1993 è Associato alla SIBioC (Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica ) ed è
membro del Direttivo a vario titolo dal 1 gennaio 2007 ad oggi.

Dall'anno 1994 fa parte, in qualità di Segretario, del “Gruppo di Studio per la standardizzazione dei metodi di
laboratorio per la misurazione della lipoproteina(a) ” del CISMeL (Comitato Italiano per la Standardizzazione dei
Metodi Ematologici e di Laboratorio).

Dall'anno 1998 è Membro del GIRTE (Gruppo Italiano per la Ricerca sul Trombo-Embolismo venoso).

Dall'anno 2000 è Associato alla SISET (Società Italiana per lo Studio dell'Emostasi e della Trombosi ). Dall'anno 2002
al 2009 è Referente Regionale del Veneto della Società.

Dall'anno 2000 è membro del PROSIT (Protein S Italian Team) della SISET.

Dall'anno 2000 è Membro del "Gruppo di Studio per la Medicina di Laboratorio nello Sport " della SIBioC.

Dall'anno 2000 fa parte del “Gruppo di Studio per la standardizzazione dei metodi di laboratorio in coagulazi one” del
CISMeL (Comitato Italiano per la Standardizzazione dei Metodi Ematologici e di Laboratorio ).

Dall'anno 2001 è Membro Aggregato dell' AIMeC (Associazione Italiana Medici del Ciclismo ).

Dall'anno 2001 fa parte del “Gruppo di Studio sul diabete ” intersocietario SIMeL-SIBioC.

Responsabile dal 2001 ad oggi del monitoraggio biochimico ed ematologico degli atleti della Federazione Italiana
Sport Invernali (FISI)

Responsabile del monitoraggio biochimico ed ematologico di atleti professionisti e dilettanti, tesserati con l'Unione
Ciclistica Internazionale (UCI) e con la Federazione Ciclistica Italiana ( FCI).

Dall'anno 2004 è membro del Gruppo di Lavoro per il monitoraggio dei livelli di emoglobina negli atleti della
Commissione Medica della FISI (Federazione Italiana Sport Invernali).

Dall’anno 2006 al 2015 è coordinatore del Gruppo di Studio Intersocietario SIBioC-SIMeL-CISMEL sulla Variabilità
Extra-Analitica del Dato di Laboratorio.

Dall’anno 2006 è membro della Commissione Nazionale SIMeL per la Qualità e l’Accreditamento.

Nell’anno 2006 è membro della Commissione medico-scientifica della FCI (Federazione Ciclistica Italiana) e del CONI
(Comitato Olimpico Nazionale Italiano).

Nei bienni 2007/8 e 2009/2010 è Membro Eletto del Direttivo della SIBioC.

Nell’anno 2007 è curatore della Newsletter Scientifica della SIBioC.

Dall’anno 2009 ad oggi è Coordinatore della Divisione Scientifica della SIBioC.

Dall’anno 2010 ad oggi è membro del Comitato Scientifico SIMeL.

Nell’anno 2010 è Vice-Presidente della SIBioC.

Dall’anno 2012 è membro del Consorzio Interuniversitario Istituto Nazionale di Biostrutture e Biosistemi .

Dall’anno 2015 è membro dell’Albo degli esperti e collaboratori dell’AGENAS, per l'area tematica numero 4
(Clinico/Organizzativa/Epidemiologica/Sociale ).

Dall’anno 2015 è Consigliere e Delegato alla ricerca dell’Academy of Emergency Medicine and Care (AcEMC).
Attività redazionale e di "peer review"
Editor-in-Chief di:

Journal of Laboratory and Precision Medicine (dal 2016)
Executive Editor-in-Chief di:

Annals of Translational Medicine [ ISSN: 2305-5839] (dal 2016)
A ssociate Editor di:







Seminars in Thrombosis and Haemostasis [ISSN: 0094-6176] (dal 2008)
Clinical Chemistry and Laboratory Medicine [ISSN: 1437-4331] (dal 2009)
Biochemia Medica [ISSN: 1330-0962] (dal 2009) – Guest Editor
World Journal of Biological Chemistry [ISSN: 19498454] (dal 2009)
Emergency Care Journal [ISSN: 1826-9826] (dal 2013)
Clinical Biochemistry [ISSN: 0009-9120] (dal 2016) – Guest Editor
Diagnosis [ISSN: 2194-802X] (dal 2016)
Membro del Board Editoriale di:






European Journal of Laboratory Medicine [ISSN: 11228652] (dal 1997 al 1999)
Medicina di Laboratorio (dal 1997 al 1999), poi Rivista di Medicina di Laboratorio - Journal of Laboratory Medicine
(dal 2000 al 2004), ora Rivista italiana di Medicina di Laboratorio / Journal of Laboratory Medicine (RIMeL/IJLM; dal
2005) [ISSN: 1825-859X]
The Doping Journal [ISSN: 1812-948X] (dal 2005)
Proteomics Insight [ISSN: 1178-6418] (dal 2008)
Journal of Medical Biochemistry [ISSN: 1452-8258] (dal 2013)
British Journal of Biomedical Sciences [ISSN: 0967-4845] (dal 2016)
Editorialista di:

























Annals of Translational Medicine
BIochemia Medica
Biochimica Clinica
Blood
Blood Transfusion
Blood, Coagulation and Fibrinolysis
BMC Medicine
British Journal of Sports Medicine
Canadian Journal of Cardiology
Clinical Biochemistry
Clinical Chemistry and Laboratory Medicine
Expert Reviews in Hematology
International Journal of Sports Medicine
Journal of Diabetes
Journal of Laboratory and Precision Medicine
Journal of Sports Sciences
MLO: Medical Laboratory Observer
Nature Reviews Cardiology
Performance Enhancement and Health
Recenti Progressi in Medicina
Seminars in Thrombosis and Hemostasis
The Lancet Haematology
Thrombosis Research
Trends in Molecular Medicine
Trends in Pharmacological Sciences
Attività di “peer review” per:

Clinical Chemistry (dal 1994); European Journal of Clinical Chemistry and Clinical Biochem istry, ora Clinical
Chemistry and Laboratory Medicine (dal 1997); European Journal of Laboratory Medicin e (dal 1997); Medicina di
Laboratorio (dal 1997), poi Rivista di Medicina di Laboratorio - Journal of Laboratory Medicine, ora Rivista italiana
di Medicina di Laboratorio / Journal of Laboratory Medicine (RIMeL - IJLaM); Medical Science Monitor (dal 2001);
Haematologica (dal 2003); Molecular Therapy (dal 2004); Clinica Chimica Acta (dal 2005); Blood, Coagulation and
Fibrinolysis (dal 2004); Stroke (dal 2004); International Journal of Sports Medicine (dal 2005); Thrombosis &
Haemostasis (dal 2005); British Journal of Sports Medicine (dal 2006); Clinical and Laboratory
Hematology/International Laboratori Haematolgy (dal 2006); Blood (dal 2006); American Journal of Clinical
Pathology (dal 2006); Medicine & Science in Sports & Exercise (dal 2007); European Journ al of Clinical Investigation
(dal 2007), Biochemia Medica (dal 2007), Scandinavian Journal of Clinical and Laboratory Investigation (dal 2007),
Lab Medicine (dal 2007), Nutrition, Metabolism and Cardiovascular Diseases (dal 2008), Diabetes Care (dal 2012),
Cochrane Reviews (dal 2014); Lancet (dal 2014); New England Journal of Medicine (dal 2015) ; Jounal of Thrombosis
and Haemostasis (dal 2016); British Medical Journal (dal 2016) .
Ilsottoscritto autorizza al trattamento dei dati personali ai sensi del D.L. vo n.196/2003, Codice in materia di protezione dei
dati personali.
Verona,
25 febbraio 2017
“Il sottoscritto è a conoscenza che, ai sensi dell’art. art. 76 del DPR 445/2000, le dichiarazioni mendaci, la
falsità negli atti e l’uso di atti falsi sono puniti ai sensi del codice penale e delle leggi speciali. Inoltre, il
sottoscritto autorizza al trattamento dei dati personali, secondo quanto previsto dalla Legge 196/03.”

Curriculum Vitae - Dipartimento di Biotecnologie

Transcript

Documenti analoghi

n° 50, luglio 2010

Imp. 3 Maggio-Giugno 2006

Questo l`articolo dedicato sulla rivista “Starbene”

La testata di Zidane fu un fatto di testa - La Strada

Storie di successo “mondiali”, Marcello Lippi, allenatore dell`Italia

Celebrata nella nuova mostra al Private Banking di piazza del

telmo pievani - Dipartimento di Biologia

fogli per intestazione cv

frate Filippo Lippi - Vincenza Musardo Talò

Deliberazione Originale della Giunta Municipale